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Schistosomiasis is a parasitic disease caused by blood flukes of the genus Schistosoma 
(class of trematodes and phylum of Platyhelminthes (flatworms)). It is also referred to 
as bilharzia(sis) or snail fever. The word Schistosoma is derived from the two Greek 
words ‘σχιστος’, meaning ‘split’ and ‘σωμα’ meaning ‘body’. Split body refers to the 
adult male schistosome, having a flattened body with lateral folds that form a ventral 
groove, the gynecophoric canal. 
Schistosomes were first discovered by Theodor Bilharz in Egypt in 1851. He found 
different types of Schistosoma eggs in the feces of the same patient. In 1903, Patrick 
Manson proposed that these eggs were from different Schistosoma species which are 
now known as Schistosoma mansoni and S. haematobium (Blair, 1965) (Table 1.1). 
 
Table 1.1. Comparison of principal features of S. mansoni and S. haematobium. 
 S. mansoni S. haematobium 
Intermediate host snail 
   Biomphalaria    Bulinus 
Definitive host Human (also primates and rodents) Human 
Location adult worm Veins of the mesenteric plexus Veins of the pelvis 
Egg excretion via Feces Urine 
Egg morphology 
   
Lateral spine 
   
Terminal spine 
Organ-specific chronic disease Intestinal and hepatic Urinary and genital 
Geographic distribution Africa, Middle East, Caribbean and 
South America 
Africa and Middle East 
 
Geographic distribution 
With 200 to 250 million people infected, schistosomiasis is one of the most prevalent 
parasitic diseases worldwide (Chitsulo et al., 2000; Steinmann et al., 2006; WHO, 2010). 
Figure 1.1 shows the global distribution of the five Schistosoma spp. that are able to 
infect man: S. mansoni, S. haematobium, S. intercalatum, S. japonicum, and S. mekongi 
(Gryseels et al., 2006). Circa 90% of Schistosoma-infected people live in Africa 
(Steinmann et al., 2006). In this thesis, we focus on the two major Schistosoma spp., S. 
mansoni and S. haematobium. The global distribution map of Schistosoma shows a large 






Figure 1.1. Global distribution of schistosomiasis. 
Reprinted from The Lancet,  Vol. 368, Gryseels et al., ‘Human schistosomiasis’, pages 1106-18, 
2006, with permission from Elsevier and WHO (Doumenge et al., 1987). 
 
Within endemic regions, schistosomiasis occurs in focal pockets and is closely linked to 
the presence of water bodies that harbor compatible freshwater snails (Cook and 
Zumla, 2009). Natural streams, ponds and lakes are typical sources of infection, but 
over the past few decades, man-made reservoirs and irrigation systems have 
contributed to the spread of schistosomiasis (Gryseels et al., 2006; Steinmann et al., 
2006), e.g. in the north of Senegal. In such pockets of transmission, all three 
ingredients are present to drive the complex life cycles of S. mansoni and/or S. 
haematobium (Figure 1.2): 
 Contamination of surface water by excreta, 
 Presence of specific freshwater snails as intermediate hosts, and  
 Human water contact (e.g. agricultural, domestic, recreational). 
Schistosoma life cycle 
Figure 1.2 demonstrates the life cycle of S. mansoni and S. haematobium. Juvenile 
worms mature in the hepatic sinuses of the human portal system. The human host is 
the main definitive host for S. mansoni, and the only definitive host for S. haematobium. 
When the worms approach maturity they form male-female pairs. The 10-20 mm long 
male embraces the longer, cylindrical female in its gynecophoric canal. Subsequently, 




blood flow of the portal vein to the oviposition site. The adult S. mansoni male carries 
the female to the mesenteric plexus whereas the S. haematobium couple continues its 
way to the veins of the pelvis (Mahmoud, 2001). In these sites, where each couple 
produces hundreds of eggs a day, they usually survive for 3-5 years but their lifespan 
can be as long as 30 years (Jordan et al., 1993). Roughly half of the eggs traverse the 
blood vessel wall to reach the lumen of the intestine (S. mansoni) or bladder (S. 
haematobium). These eggs are excreted via the feces or urine, respectively. The other 
half of the eggs get trapped in host tissues, and can cause disease (King, 2011). 
 
 
Figure 1.2. Life cycle of S. mansoni and S. haematobium. 
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Under conditions of poor sanitation and hygiene, excreted eggs can reach freshwater. 
The egg hatches in the water and releases the free-living larval stage, i.e. the ciliated 
miracidium. The miracidium searches for a compatible intermediate host snail. After 
penetrating the snail, it will transform into a sporocyst, multiply asexually and then 
produce hundreds of thousands of cercarial larvae. These cercariae are then shed into 
the water following a circadian rhythm - most are shed around noon. Subsequently, the 
cercariae swim with their bifurcated tails in search for the (intact) skin of the human 
host (Mahmoud, 2001). 
While penetrating the skin, the cercariae transform into schistosomulae. They then 
enter the vascular system where they start to feed on blood. The blood stream carries 
them via the right heart to the lungs, to the left heart, to the systemic circulation, and 
then to the hepatic portal system, where the juveniles continue a new cycle 
(Mahmoud, 2001). 
Epidemiology 
Within endemic areas, schistosomiasis is characterized by a focal geographical 
distribution, even on the small scale (Pinot de Moira et al., 2007). This has been related 
to spatiotemporal variations in snail populations, cercarial densities, and patterns of 
human water contact, but other factors are probably involved too. 
Another typical feature of schistosomiasis is the convex age-infection curve: 
prevalences and intensities of infection almost invariably increase from an early age to 
a peak around adolescence and decline thereafter (Woolhouse, 1994; Gryseels et al., 
2006; Cook and Zumla, 2009). The mechanisms behind this phenomenon have not yet 
been fully elucidated. They may be related to the following three hypotheses that have 
been proposed (Dalton and Pole, 1978; Gryseels, 1994; Polman et al., 2002): 
 Water contact increases with age in children up to adolescence, and decreases 
in adults. 
 Cumulative exposure to Schistosoma antigens contributes to a slow 
acquisition of protective immunity with age. Around adolescence, the level of 
immunity is generally sufficient to counteract infection. 
 Innate age-related factors such as changes in skin properties, metabolism and 
growth, hormonal factors, and innate immunity may predispose adolescents 
for infection. 
The exact age at which Schistosoma infection peaks may vary from 10 to more than 20 
years (Woolhouse, 1998). Anderson and May (1985b) proposed that this variation may 
be due to differences in the level of transmission. In populations subject to high levels 
of transmission, peak infection levels are generally higher and occur at a younger age, 
while in populations with low levels of transmission, peak infection levels are lower and 




protective immunity is gradually acquired as a function of cumulative exposure to 
parasite antigens. Thus, levels of infection will rise more rapidly in populations with 
high transmission. However, acquired immunity will also develop more rapidly in these 
populations and so levels of infection will begin to decline at a younger age. The result 
is a negative correlation between peak levels of infection and the peak age: the so-
called ‘peak shift’ hypothesis. 
The strong geographical and age trends generally contribute to an uneven distribution 
of schistosomiasis in a given population. For this reason, infection intensities (see 
‘Diagnosis’) are generally summarized as geometric instead of simple arithmetic means 
on population level. 
Acute morbidity 
Acute disease is the result of a first encounter with schistosomes. It is exceptional in 
endemic areas where people are chronically exposed. Travelers or migrants mostly 
present with acute schistosomiasis. Cercariae that penetrate the skin can cause a 
temporary dermatitis, also known as swimmer’s itch. In other climate zones, animal 
trematodes can cause similar symptoms. Several weeks upon infection with S. mansoni 
or S. japonicum, Katayama fever suddenly follows (WHO, 1994). This is a systemic 
hypersensitivity reaction against migrating schistosomulae and gives rise to symptoms 
such as fever, fatigue, myalgia, malaise, and non-productive cough. Later on, abdominal 
symptoms can develop (Gryseels et al., 2006). 
Chronic morbidity 
Even though morbidity only develops in a minority of chronically infected people (King, 
2001), this group is still considerably large (King et al., 2005; Hotez et al., 2009). In 
contrast to acute disease, chronic schistosomiasis is a major public health concern. 
Organ-specific morbidity results from trapped Schistosoma eggs (see ‘Schistosoma life 
cycle’). Trapped in host tissue, the eggs provoke inflammatory and granulomatous host 
immune responses which are progressively replaced by fibrotic deposits (Gryseels et 
al., 2006). As the location of egg-producing adult worms differs between the two 
species, S. mansoni and S. haematobium infections affect different organs (see below). 
Intestinal and hepatic schistosomiasis 
Adult S. mansoni worms are located in the veins of the mesenteric plexus. Their eggs 
migrating through the intestinal wall cause lesions mainly in the large bowel and 
rectum, i.e. intestinal schistosomiasis. This can lead to nonspecific abdominal 
symptoms (Gryseels et al., 2006). Eggs that are swept away back to the liver by the 
blood stream initially give rise to inflammatory hepatic schistosomiasis and 
hepatosplenomegaly (Wilson et al., 2011). These early pathologies are mostly found in 
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children and adolescents and probably vary according to the intensity of infection. Egg-
induced hepatic lesions are gradually replaced by fibrotic deposits. After 5-15 years of 
cumulative exposure, this results in hepatic fibrosis, the late manifestation of S. 
mansoni. Fibrosis can lead to progressive occlusion of the portal veins, portal 
hypertension, splenomegaly, collateral venous circulation, porto-caval shunting, gastro-
intestinal varices, and ascites. In some individuals, portal hypertension eventually 
causes gastro-esophageal varices to erupt. This is the most serious complication of S. 
mansoni infection and often fatal (Gryseels et al., 2006). 
Urinary schistosomiasis 
Adult S. haematobium worms are located in the veins of the pelvis. Their eggs are 
deposited in the wall of the urinary and genital tract. In urinary schistosomiasis, egg-
induced immune responses lead to inflammation, ulceration and pseudopolyposis of 
bladder and ureteral walls. In children this is characteristically accompanied by 
hematuria. In addition, symptoms such as dysuria, increased urinary frequency and 
proteinuria can become apparent. Chronic lesions may evolve to fibrotic and sandy 
patches with severe sequelae such as hydroureter, hydronephrosis, and squamous cell 
bladder cancer (Smith and Christie, 1986; King, 2002; Gryseels et al., 2006). 
In females, S. haematobium eggs affect the cervix, Fallopian tubes and vagina, i.e. 
female genital schistosomiasis. This is clinically characterized by sandy patches, 
pathological vessel morphology and contact bleeding. The lesions can lead to reduced 
fertility, genital itch, and abnormal discharge (Gryseels et al., 2006; Kjetland et al., 
2012). In males, eggs affect the seminal vesicles and prostate. Hemospermia is a 
common symptom (Gryseels et al., 2006; Ramarakoto et al., 2008). 
Nonspecific morbidity and disease interactions 
In addition to the aforementioned organ-specific morbidity, chronic Schistosoma 
infection is thought to indirectly contribute to nonspecific and multifactorial morbidity. 
The process of chronic inflammation is likely to affect the host’s metabolism and thus 
impair child development and nutritional status (King, 2011). Moreover, Schistosoma-
induced lesions may lead to chronic blood loss, and indirectly contribute to anemia, 
malnutrition, and physical and cognitive impairment.  
Like schistosomiasis, other neglected tropical disease (NTDs), HIV, tuberculosis, and 
malaria are related to poverty. Hence, they frequently co-occur in the same 
disadvantaged populations. Some studies have demonstrated that schistosomiasis is 
likely to increase the transmission of these diseases or to worsen disease outcomes 
(Sangweme et al., 2010; Abruzzi and Fried, 2011). This possibly happens through lesions 
induced in local tissues (see above), or through its effect on host immunological 




Moreover, Schistosoma infections may reduce the effectiveness of immunization 
(Malhotra et al., 1999; King, 2011). 
Immunology 
Schistosomes live, grow, and reproduce in the blood circulation, where the host 
immune system is continuously on the look-out. In view of the fact that they can persist 
for up to 30 years, they have obviously found efficient ways to avoid host immune 
attack. Down-regulation of host immune responses is a prominent feature of chronic 
schistosomiasis, and assumed to be part of the parasite’s arsenal of evasion strategies 
(Maizels, 1993). At the same time however, the host would benefit from this down-
regulation which is likely to minimize egg-induced immunopathology (Burke et al., 
2009). Immune down-regulation is thought to contribute to the fact that severe 
symptoms develop only in a minority (5-10%) of chronic Schistosoma infections (King, 
2001). It has been hypothesized that severe disease may result from deregulated 
immune balances (see ‘Adaptive immunity’). 
On the other hand, it seems that the host’s immune system can eventually overcome 
immune evasion (at least in some people) and thus, reduce Schistosoma infection. 
There is longstanding epidemiological and clinical evidence that people living in 
endemic areas acquire some form of immunological protection after years of exposure 
(Jordan et al., 1993). The exact immunological pathways that underlie these 
phenomena have not been fully unraveled yet. An overview of general immunological 
principles is provided below. 
 
Table 1.2. Comparison between the innate and adaptive human immune system. 
 Innate Adaptive 
Main function Initiate and shape adaptive response Specific response and 
immunological memory 
Onset of response Rapid (hours) Slow (days) 
Specificity Pathogen-associated molecular patterns Antigen 
Cell Macrophage, dendritic cell, mast cell, natural 
killer cell, basophil, eosinophil, and neutrophil 
B and T cells 
(lymphocytes) 
Serum Complement proteins, collectins, pentraxins Antibodies 
 
Innate immunity 
Pathogens have a number of conserved molecular motifs, the so-called pathogen-
associated molecular patterns (PAMPs). PAMPs are generally essential for the survival 
of the pathogen, and the host has evolved a limited number of receptors for these 
PAMPs, i.e. pattern-recognition receptors (PRRs) (Iwasaki and Medzhitov, 2004; Lee 
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and Kim, 2007). PRRs can be expressed in the cell cytosol or on the surface of immune 
cells (e.g. Toll-like receptors (TLRs) or C-type lectins), or they can be soluble (e.g. 
collectins and complement receptors). In general, engagement of PRRs leads to 
activation of the innate immune system (Table 1.2), either via intracellular signaling 
pathways (cell-based PRRs) or via extracellular activation cascades (soluble PRRs). 
Numerous PAMPs have been described for Schistosoma with corresponding PRRs. 
Importantly however, schistosomes also mimic molecular patterns that the host 
recognizes as its own (Maizels, 1993). Instead of activation of the innate system, such 
human patterns would lead to its inhibition, and thus contribute to parasite survival. 
Innate immune cells are the first to come into contact with any invading pathogen. 
Upon recognition, innate effector cells such as granulocytes, natural killer cells, and 
mast cells rapidly attack the pathogen. At the same time, innate antigen-presenting 
cells (APCs) such as macrophages and dendritic cells (DCs), initiate, shape and regulate 
the subsequent and more specific adaptive immune response (Table 1.2). APCs express 
an array of different PRRs that can bind a wide range of potential pathogens. Upon 
recognition, they internalize the pathogen, and process and present the pathogen’s 
antigens on their surface to cells of the adaptive immune system (Figure 1.3). 
Adaptive immunity 
In contrast to innate cells, individual adaptive immune cells such as T and B cells 
recognize only one specific antigen. Antigen-specific naïve CD4 T helper (Th) cells 
recognize the presented antigen, and co-stimulatory and cytokine signals from the APC 
prime the subsequent response of these T cells (Medzhitov and Janeway, Jr., 1997). 
Depending on the signal provided, this response can be polarized into two ways. The 
naïve T cell will proliferate and differentiate into either a Th1 or a Th2 cell. Th1 cells 
secrete cytokines such as IL-2, interferon (IFN)-γ and IL-12, while Th2 cells secrete IL-4, 
IL-5 and IL-13. Th1 cytokines stimulate Th1 and inhibit Th2 responses, while Th2 
cytokines do the opposite. Th1 immunity is mainly cell-mediated and involves 
macrophages, neutrophils, natural killer cells and cytotoxic CD8 T cells. Th2 immunity 
on the other hand, mainly involves B cells, mast cells, and eosinophils. Th2 pathways 
induce B cells to produce antibodies. Later on in the course of events, immunoglobulin 
(Ig) class switching can occur (Figure 1.3). Theoretically, Th1 immunity is more effective 
against intracellular and Th2 immunity against extracellular infections. In chronic 
infections - analogous to their extracellular habitat - schistosomes skew the immune 
response towards Th2. Schistosoma infection also induces IgE class switching. IgE levels 
increase with age and decreasing levels of infection, suggesting that IgE may 
contribute to protective immunity in adults. However, also other Th2 as well as Th1 
effector mechanisms may be involved in immunoprotection. As yet, it is poorly 
understood which phenotype or which effector mechanisms actually contribute to 




Alternatively, naïve Th cells may differentiate into IL-10-producing regulatory T(reg) 
cells upon antigen recognition (Figure 1.3). Subsequent regulatory networks inhibit 
both Th1 and Th2 responses. Schistosomes are potent inducers of these regulatory 
mechanisms, and this greatly contributes to immune down-modulation. The down-
regulated Th2 phenotype that is characteristic for chronic schistosomiasis is referred to 




Figure 1.3. Schematic overview of classical induction of an adaptive immune response. 
Schistosoma life stages are several orders of magnitude larger than the depicted pathogen. APC: 
Antigen-presenting cell; Th0: Naïve CD4 T helper lymphocyte; Treg: Regulatory T cell; CTL: 
Cytotoxic CD8 T lymphocyte; NK cell: Natural killer cell. 
 
Diagnosis 
The gold standard for the diagnosis of schistosomiasis is microscopic examination of 
eggs in feces (S. mansoni) or urine (S. haematobium). Eggs can be quantified by Kato-
Katz as number of eggs per gram of feces (epg) (Katz et al., 1972), or by urine filtration 
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as number of eggs per 10ml of urine (ep10ml), respectively (WHO, 1991). Since there is 
considerable day-to-day variation in the number of excreted eggs, samples from 
consecutive days are usually examined (Jordan et al., 1993). Egg counts give a crude, 
indirect approximation of worm burden (Jordan et al., 1993), and are used as a measure 
of infection intensity (Table 1.3). In addition, immunological methods (antibody- or 
antigen-based assays) can be used (Polman, 2000). For S. haematobium, indirect 
methods are also available. Visual urine inspection for macrohematuria (red urine) can 
reveal heavy infections, while reagent strips can detect invisible hematuria, i.e. 
microhematuria, in lighter S. haematobium infections (Montresor et al., 1998). 
 
Table 1.3. Classes of intensity of infection (WHO, 2002). 
 S. mansoni (epg) S. haematobium (ep10ml) 
Light 1-99 1-49 
Moderate 100-399  
Heavy ≥400 ≥50 
 
Schistosoma-induced morbidity can be visualized by a variety of techniques such as 
tissue biopsy, endoscopy, and radiography (Gryseels et al., 2006). Ultrasonography is 
one of the least invasive techniques. Standard protocols are available to classify S. 
mansoni-specific hepatic fibrosis and S. haematobium-specific urinary tract morbidity by 
ultrasound (Figure 1.4). While such protocols are very useful for epidemiological 
studies, they are less suitable for routine clinical use in the primary health care setting 
as they require specific expertise and experience (Richter et al., 1996). 
Treatment 
Praziquantel is the recommended treatment for Schistosoma infections. It has been 
available since the 1980s and is administered as a single oral dose of 40 mg/kg. The 
drug is relatively cheap and effectively kills adult worm stages of all Schistosoma 
species. Side-effects are related to the intensity of infection. They are generally mild 
and include nausea, vomiting, malaise, and abdominal pain (Gryseels et al., 2006). Early 
morbidity regresses faster upon treatment than late and advanced disease, and in 
some cases, late disease does not regress at all (Richter et al., 1996). 
Control and elimination 
Schistosomiasis belongs to the so-called NTDs. Together with other (mainly helminthic) 
infections such as soil-transmitted helminthiases (STH), lymphatic filariasis, and 
onchocerciasis, it is among the most prevalent NTDs. The distribution of these diseases 





Figure 1.4. Diagnosis of Schistosoma-associated morbidity by ultrasound. 
Adapted from Richter et al. (1996). Panel A shows the classification of S. mansoni-specific hepatic 
fibrosis: from unaffected liver parenchyma, ‘image pattern A’ (score=0), on the left, to advanced 
periportal fibrosis, ‘pattern F’ (score=8), on the right. Panel B shows the classification of S. 
haematobium-specific lesions of the bladder wall: from ‘irregularity’ (score=1) on the left, to 
‘pseudopolyp’ (score=2) on the right. Panel C shows the measurement of upper urinary tract 
morbidity, i.e. congestive dilation of the renal pelvis, using a longitudinal scan on an empty 
bladder: from no dilation (score=0) on the left, to ‘marked hydronephrosis’ with compressed 
parenchyma (score=8) on the right. 
 
conditions with poor sanitation and hygiene. As a result many people are affected by 
multiple NTDs. 
For schistosomiasis, mass drug administration (MDA) with praziquantel is now the main 
component of most national control programs (WHO, 2002; WHO, 2013). 
Schistosomiasis MDA programs aim to reduce current infection and, by keeping 
infection intensity down, prevent the development of severe disease. Such MDA 
programs – often integrated in broader NTD control programs – mainly target school 
children. The rationale is that this age group typically has the highest infection 
intensities.  
The WHO recently put forward an ambitious goal for the year 2020: to control 
schistosomiasis globally, and to initiate interventions towards local elimination. To 
sustain control achievements, multi-faceted, integrated control packages are needed, 
including not only anti-schistosomal treatment, but also the provision of clean water 
and improved sanitation, snail control, and behaviour change (Sturrock, 1989; King, 
2009; Gray et al., 2010; Rollinson et al., 2013; Freeman et al., 2013). 
Schistosomiasis in northern Senegal 
The major part of the work described in this thesis (Chapters 2-5) was carried out on 
the Nouk Pomo peninsula in Lac de Guiers (Guiers Lake), in the north of Senegal. This 
lake is connected to the Senegal River, the longest river of West Africa. Following 









the mouth of the river (Figure 1.5). This dam prevents upstream intrusion of saltwater 
and thereby protects freshwater sources. It allows large areas to be irrigated for 
agriculture. Furthermore, the dam maintains several lakes, including Lac de Guiers. 
People living in the Senegal river basin greatly benefited from these positive effects of 
the dam (Organisation pour la Mise en Valeur du Fleuve du Sénégal, 2003), and the 
local economy improved (Talla et al., 1990). 
 
 
Figure 1.5. Lac de Guiers study area in northwest Senegal. 
 
Unfortunately, the water development had a downside too. Rates of water-borne 
diseases such as diarrhea and malaria increased (Sow et al., 2002; Organisation pour la 
Mise en Valeur du Fleuve du Sénégal, 2003). Schistosoma haematobium was since long 
endemic in the north of Senegal (Becker and Collignon, 1994), but around 1989, just 
upon completion of the dam in 1986, its prevalence and distribution suddenly 
expanded. Moreover, the dam led to the introduction of S. mansoni into the area in 
1988. The S. mansoni epidemic started in the community of Richard-Toll (Vercruysse et 
al., 1994). From this epicenter, S. mansoni rapidly spread throughout the region (Talla et 
al., 1990; Talla et al., 1992). In a few years, the prevalence in Richard-Toll rose from 0% to 
75-100% in 1992, with highest intensities of infection ever described (Picquet et al., 
1996). By 1994, virtually the whole Lac de Guiers area had become exposed to this 




Guiers area between 2000 and 2005 (Southgate et al., 2000). As a result, many 
communities became co-endemic for S. mansoni and S. haematobium (De Clercq et al., 
1999; Southgate et al., 2001; Ten Hove et al., 2008; Huyse et al., 2009). 
Co-endemic S. mansoni and S. haematobium 
There is a large overlap of S. mansoni- and S. haematobium-endemic areas in Africa 
(Figure 1.1). Thus, many areas are co-endemic for both species, implying that many 
people are at risk of co-infection. In spite of this, schistosomiasis studies generally 
investigate either S. mansoni or S. haematobium. Sometimes co-infected subjects are 
even purposely excluded from these investigations. So far, little is known about the 
epidemiology of Schistosoma infection and associated disease in co-endemic 
populations, and about their underlying mechanisms. Yet, the (potentially adverse) 
effects of co-infections on schistosomiasis transmission, morbidity and control can be 
significant (Robert et al., 1989; Ernould et al., 1999a; Koukounari et al., 2010; Webster et 
al., 2013; Gouvras et al., 2013). Table 1.4 gives an overview of the handful of studies on 
co-endemic S. mansoni and S. haematobium that have been described in literature so 
far. Most of these studies were performed in schoolchildren only. As yet, little is known 
about the effect of mixed infections on morbidity. Also, nothing is known about the 
immunological differences between single and mixed, or between S. mansoni and S. 
haematobium infections, and only one study investigated micro-geographical patterns 
in a co-endemic community (Farooq, 1966). 
Aims 
In co-endemic areas, S. mansoni and S. haematobium can interact, either directly, or 
indirectly via the host immune system. This may have important implications for 
infection and morbidity levels in such populations. In this thesis, we investigate the 
differences and interactions between these two Schistosoma species, as well as their 
effects on host morbidity. More specifically, the aim of this thesis is to get a detailed 
insight into the epidemiological patterns of Schistosoma infection and associated 
morbidity on a micro-geographical scale in S. mansoni and S. haematobium co-endemic 
areas. The main research questions of this thesis are: 
 What are the differences between single and mixed infections in terms of: 
 Infection intensity?     (Chapter 2) 
 S. mansoni- and S. haematobium-specific morbidity? (Chapter 3) 
 How do demographic and geographic distribution patterns differ between 
 Single and mixed infection?    (Chapter 2 and 4) 
 S. mansoni and S. haematobium infection?  (Chapter 2 and 4) 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 How do adaptive cytokine responses differ between S. mansoni and S. 
haematobium infections, in terms of 
 Adult worm antigens (AWA)?   (Chapter 5) 
 Soluble Schistosoma egg antigens (SEA)?   (Chapter 5) 
 How do TLR-induced cytokine responses differ between S. haematobium-
infected and -uninfected subjects?   (Chapter 6) 
 
A co-endemic focus, Nouk Pomo, a peninsula in Lac de Guiers in the north of Senegal 
(see Figure 1.5), was selected as the study site. The small scale of this study allowed a 
detailed, multidisciplinary analysis of complex (co-)infection and morbidity patterns. 
Moreover, it enabled us to take the well-known focality of schistosomiasis into 
account. Chapters 2 to 5 describe the research conducted in this population. 
Demographic patterns and associations between (co-)infection and morbidity are 
described in Chapter 2 and 3, and geographic patterns in Chapter 4. In Chapter 5, 
cytokine responses to adult worm antigens (AWA) were used as a proxy for host 
responses to living adult worms. These responses may thus be related to 
immunological resistance in some individuals or conversely, to susceptibility to 
infection in others. Secondly, cytokine responses to soluble Schistosoma egg antigens 
(SEA), were used as a proxy for the egg-induced responses, and may as such be related 
to the observed morbidity patterns. Subsequently, Chapter 6 explores the innate 
immune responses that generally precede and shape these adaptive responses. To this 
extent, another population was studied, consisting of children from a S. haematobium-
mono-endemic area in Lambaréné, Gabon. 
Finally, Chapter 7 provides a general discussion of the epidemiological and immuno-
epidemiological findings described in Chapter 2 to 6. It points out the significance of 
our observations for our general understanding of the disease as well as the practical 
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Abstract 
Due to the large overlap of Schistosoma mansoni- and Schistosoma haematobium-
endemic regions in Africa, many people are at risk of co-infection, with potential 
adverse effects on schistosomiasis morbidity and control. Nonetheless, studies on the 
distribution and determinants of mixed Schistosoma infections have to date been rare. 
We conducted a cross-sectional survey in two communities in northern Senegal (n=857) 
to obtain further insight into the epidemiology of mixed infections and ectopic egg 
elimination. Overall prevalences of S. mansoni and S. haematobium infection were 61% 
and 50% respectively, in these communities. Among infected subjects, 53% had mixed 
infections and 8% demonstrated ectopic egg elimination. Risk factors for mixed 
infection - i.e. gender, community of residence and age - were not different from what 
is generally seen in Schistosoma-endemic areas. Similar to overall S. mansoni and S. 
haematobium infections, age-related patterns of mixed infections showed the 
characteristic convex-shaped curve for schistosomiasis, with a rapid increase in 
children, a peak in adolescents, and a decline in adults. Looking at the data in more 
detail however, the decline in overall S. haematobium infection prevalences and 
intensities appeared to be steeper than for S. mansoni, resulting in a decrease in mixed 
infections and a relative increase in single S. mansoni infection with age. Moreover, 
individuals with mixed infections had higher infection intensities of both S. mansoni and 
S. haematobium than those with single infections, especially those with ectopic egg 
elimination (p<0.05). High infection intensities in mixed infections, as well as age-
related differences in infection patterns between S. mansoni and S. haematobium, may 
influence disease epidemiology and control considerably, and merit further studies into 





Schistosomiasis is amongst the most common human parasitic diseases with an 
estimated 207 million people infected worldwide. More than 90% of them live in sub-
Saharan Africa (Hotez and Kamath, 2009). The global distribution map of Schistosoma 
shows a large overlap of Schistosoma mansoni- and Schistosoma haematobium-endemic 
areas in Africa (Doumenge et al., 1987; Gryseels et al., 2006; Montgomery, 2011), 
indicating that many people are at risk of co-infection with both species. Nevertheless, 
little is known about the distribution and determinants of such mixed infections in 
human populations (Dennis et al., 1983; Robert et al., 1989; Ahmed et al., 1996; Booth 
et al., 1998; Lwambo et al., 1999). Animal models have described that S. mansoni and S. 
haematobium interact in the host. The two species have been shown to form 
heterologous male-female pairs with the male determining the oviposition site and the 
female producing eggs characteristic of her species (Khalil and Mansour, 1995; 
Southgate et al., 1998; Webster et al., 1999). This phenomenon probably contributes to 
the occurrence of ectopic egg elimination, i.e. S. mansoni eggs in urine or S. 
haematobium eggs in feces, in mixed foci (Ratard et al., 1991; Cunin et al., 2003). 
Recently, differences have been observed between single and mixed infections 
regarding their association with bladder as well as liver pathology (Koukounari et al., 
2010). Also, unforeseen increases in S. mansoni infection have been observed after 
praziquantel treatment in co-endemic areas (Ernould et al., 1999a; Koukounari et al., 
2010). Moreover, mixed infections may lead to the hybridization of Schistosoma spp. or 
parthenogenesis (Jourdane et al., 1995; Khalil and Mansour, 1995), with as yet unclear 
consequences for disease and transmission (Wright and Ross, 1980; Webster and 
Southgate, 2003; Huyse et al., 2009). Understanding the epidemiology of mixed 
infections will help us to answer important standing questions on the underlying 
mechanisms towards morbidity and to develop effective strategies for the prevention 
and control of schistosomiasis in co-endemic areas.  
During the past decades, many communities in northern Senegal have become co-
endemic for S. mansoni and S. haematobium (De Clercq et al., 1999; Ernould et al., 
1999a; Southgate et al., 2001; Van der Werf et al., 2002; Ten Hove et al., 2008; Huyse et 
al., 2009). Schistosoma mansoni was introduced in Richard-Toll in 1988 upon 
construction of the Diama dam and rapidly spread throughout the region (Talla et al., 
1990; , 1992). By 1994, virtually the whole Lac de Guiers area had become exposed to 
this species (Picquet et al., 1996). Today, both S. mansoni and S. haematobium are 
widespread, resulting in a large number of people with mixed infections in the 
communities around the lake. 
Here, we report the results of a cross-sectional study investigating the epidemiology of 
mixed Schistosoma infections in two communities on the banks of Lac de Guiers in  
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Figure 2.1. Map of northern Senegal indicating the communities participating in this study, 
Ndieumeul and Diokhor Tack. 
 
northern Senegal. We studied the patterns of S. mansoni and S. haematobium infection 
in these mixed foci, and compared mixed with single infections. Possible underlying 
mechanisms and the impact of the reported findings are discussed. 
Material and methods 
Study area 
Ndieumeul (also known as Thiekène; 16°13’12”N 15°51’36”W) and Diokhor Tack 
(16°11’24”N 15°52’48”W), are the largest communities on the Nouk Pomo peninsula in 
Lac de Guiers, Senegal and are situated 4 km apart (Figure 2.1). These Wolof 
communities have a total estimated population size of 1,300 people. Cultivation is the 
main means of subsistence and the farmlands are irrigated with water from the lake. 
Although the water from Lac de Guiers is piped to the capital city of Dakar, 250 km 
away (Berger et al., 2006), the people living nearby do not have access to safe water. 
To our knowledge, there have been no periodic anthelminthic treatment programs in 
these villages prior to our study. 
The present study was conducted in 2009 as part of a larger investigation on the 





Figure 2.2. Schematic overview of Schistosoma infection groups. 
 
www.york.ac.uk/res/schistoinir) for which approval was obtained by the review board 
of the Institute of Tropical Medicine in Belgium, the ethical committee of the Antwerp 
University Hospital in Belgium and ‘Le Comité National d’Ethique de la Recherche en 
Santé’ in Senegal.  
Informed and written consent were obtained from all participants. After the study, 
praziquantel (40 mg/kg) and mebendazole (500 mg) treatment were offered to all 
community members to treat and prevent schistosomiasis and soil-transmitted 
helminthiasis, respectively, according to WHO guidelines (WHO, 2006). 
Parasitology 
Two feces and two urine samples were collected from each participant on consecutive 
days. For each feces sample, two Kato-Katz slides of 25 mg of fecal material each were 
prepared and microscopically examined for Schistosoma spp., Ascaris lumbricoides, 
Trichuris trichiura and hookworm (Katz et al., 1972; WHO, 1991). Schistosoma mansoni 
infection intensity was expressed as the number of eggs detected per gram of feces 
(epg). Urine filtration was performed using a filter of 12µm pore-size (Isopore, USA) 
according to standard procedures (WHO, 1991). Schistosoma haematobium infection 
intensity was expressed as the number of eggs detected per 10 ml of urine (ep10ml). 
World Health Organization (WHO) standards were used to categorize schistosomal 
infection intensity into light (1-99 epg for S. mansoni and 1-49 ep10ml for S. 
haematobium), moderate (100-399 epg for S. mansoni) and heavy infections (≥400 epg 
for S. mansoni and ≥50 ep10ml for S. haematobium) (Montresor et al., 1998). Ectopic 
eggs were measured qualitatively (positive/negative). 
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In this paper, the following definitions are used (see also Figure 2.2): single infection is 
defined as passing eggs of only one species, and mixed infection as passing eggs of 
both S. mansoni and S. haematobium. Ectopic egg elimination refers to the elimination 
of schistosomal eggs via the unusual route – i.e. S. haematobium eggs in feces or S. 
mansoni eggs in urine. Overall S. mansoni infection refers to both mixed and single S. 
mansoni infections. Overall S. haematobium infection includes both mixed and single S. 
haematobium infections. 
Statistical analyses 
IBM SPSS 19.0 (SPSS, Inc.) was used for statistical analyses. Results were considered 
significant when the p-value was <0.05. Data were characterized by percentages, 
geometric means, and 95% confidence intervals (CIs). As egg output showed skewed 
distributions, data were normalized by 10log-transformation. Geometric means of egg 
counts (GM epg or ep10ml) were calculated for microscopically positive individuals to 
analyze the intensity of infection. The Mann-Whitney U test was used to determine age 
differences between the communities. The Pearson Chi-square test was used to 
determine the association between community and gender as well as between S. 
mansoni and S. haematobium infection status. The independent-samples T-test was 
used to compare GM infection intensities between single and mixed infections. 
Multivariable logistic regression models were used to identify independent risk factors 
for overall S. mansoni and overall S. haematobium infection, respectively. In the first 
model, S. mansoni-positive subjects were compared with S. mansoni-negative subjects. 
In the second model, S. haematobium-positive subjects were compared with S. 
haematobium-negative subjects. Age, gender and community of residence were 
included as potential risk factors. Similarly, the association between mixed infection 
and these risk factors was assessed, with single S. mansoni and single S. haematobium 
infection as reference groups, respectively. 
To assess the association between infection intensity (S. mansoni or S. haematobium 
infection) and mixed infection, multivariable linear regression was performed, using a 
dummy variable for mixed infection (1=mixed, 0=single), and age, gender and 
community of residence as other risk factors. 
The association between ectopic egg elimination and intensity of infection in mixed 
infections was assessed by multivariable logistic regression, with non-ectopic mixed 
infections as a reference group. Infection intensity of S. mansoni and S. haematobium, 
age, gender, and community of residence were included as risk factors. 
Due to the skewed trend of infection prevalences and intensities with age, the 
population was divided into seven age groups (0-4, 5-9, 10-14, 15-19, 20-29, 30-39 and ≥ 






Complete data (based on ≥1 feces sample and ≥10 ml of urine) were obtained from 857 
individuals. This group consisted of 428 males and 429 females, 253 subjects from 
Ndieumeul and 604 from Diokhor Tack, with a median age of 16 (range 0-85) years. 
There were no significant differences regarding age or gender between the two 
communities (p>0.8). 
Seventy-three per cent of the study population was infected with at least one 
Schistosoma spp. (Table 2.1). The overall prevalence of S. mansoni infection was 61% 
(520/857) and that of S. haematobium 50% (431/857), with 15% (129/857) and 9% (76/857) 
of heavy infections, respectively. Among infected subjects, 53% (328/623) had mixed 
infections: 8% (49/623) had mixed infections with ectopic egg elimination and 45% 
(279/623) without ectopic egg elimination.  
 
Table 2.1. Schistosomal infection prevalences and intensities. 
GM: geometric mean; 95% CI: 95% confidence interval; epg: number of Schistosoma mansoni eggs 













feces urine feces urine  GM epg (95%CI) GM ep10ml (95%CI) 
Positive subjects 623 (72.7)     
Single infections 295 (34.4)     
+ - - - 191 (22.3) 76.6 (62.0-94.4)   
- - - + 102 (11.9)   2.3 (1.8-3.0) 
- - + - 1 (0.1)     
- + - - 1 (0.1)     
Mixed infections  328 (38.3) 167.4 (142.0-197.2) 9.9 (8.0-12.1) 
without ectopic eggs 279 (32.6)     
+ - - + 279 (32.6) 148.9 (124.7-177.7) 7.6 (6.1-9.5) 
with ectopic S. haematobium eggs 2 (0.2)     
+ - + + 1 (0.1) 420.0  25.0  
+ - + - 1 (0.1) 60.0    
with ectopic S. mansoni eggs 47 (5.5)     
+ + - + 39 (4.6) 383.1 (264.2-554.5) 58.3 (36.2-93.9) 
- + - + 8 (0.9)   9.5 (1.7-48.7) 
Negative subjects 234 (27.3)     
- - - - 234 (27.3)     
Overall S. mansoni infections 520 (60.7) 125.3 (109.7-143.1)   
Overall S. haematobium infections 431 (50.3)   7.1 (5.9-8.4) 
Total  857 (100%)     
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Figure 2.3. Age-prevalence and -intensity curves for schistosomal infection in the communities 
studied. 
The bars indicate overall infection prevalences per age group. Dark grey stacks indicate infections 
with ectopic egg elimination. Grey stacks in the middle indicate mixed infections, and lighter grey 
stacks designate single Schistosoma mansoni and single Schistosoma haematobium infections (all 
without ectopic egg elimination). Lines indicate mean 10log-transformed infection intensities 
among positive subjects with 95% confidence intervals (whiskers). Epg: number of S. mansoni 
eggs detected per gram of feces; ep10 ml: number of S. haematobium eggs detected per 10 ml of 
urine. 
 
Individuals who were positive for S mansoni were more likely to be infected with S. 
haematobium and vice versa (p<0.001). Among positive subjects, S. mansoni and S. 
haematobium infection intensities were significantly higher in mixed compared with 
single infections (p<0.001). 
Furthermore, 2.5% (21/857) of the study population harbored one or more intestinal 
helminths. Ascaris lumbricoides was found in 17 and T. trichiura in six individuals. No 
hookworm infections were detected. 
Mixed Schistosoma infections 
Figure 2.3 indicates that overall S. mansoni infection prevalences were higher than 
those for S. haematobium in all age groups, except in children under five years. 
Accordingly, single S. haematobium infection was the most dominant infection in the 
youngest subjects (< 5 years). The prevalences and intensities of overall S. mansoni and 
S. haematobium infection, as well as mixed infections, increased up to the second 
decade of life, with a subsequent decrease in adults (Figure 2.3). The decline in 
prevalence and intensity was sharper and occurred at an earlier age for S. haematobium 
than for S. mansoni. As a result, single S. mansoni infection was the most dominant 
infection in the oldest age group (≥40 years). These patterns were similar in the two 
communities. Table 2.2 summarizes the risk factors for overall S. mansoni and S. 
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associated with both infections. For S. haematobium infection, gender differences were 
more pronounced in adults than in children (p=0.008 for the age*gender interaction 
term); age-stratified analysis indicated that adult women (≥20 years of age) were more 
at risk of being infected with S. haematobium compared with their male counterparts 
(odds ratio (OR) 2.5; 95% CI: 1.6-4.0). A similar trend was found for S. mansoni infection, 
although it was not significant. The risk factors for mixed infection are summarized in 
Table 2.2, and reflect those of overall S. mansoni and S. haematobium infection. Again, 
gender differences were more pronounced in adults than in children. Age-stratified 
analysis showed that adult women were more at risk of being infected with mixed 
infections than their male counterparts (OR=2.7; 95% CI: 1.5-4.9 for mixed infection 
versus single S. mansoni, and OR=1.6; 95% CI: 0.7-3.7 for mixed infection versus single S. 
haematobium). 
Similar risk factors were identified for infection intensities as for infection prevalences 
(data not shown). In addition, S. mansoni infection intensity was associated with the 
presence of S. haematobium infection and vice versa (standardized β=0.21 and 0.22 for 
S. mansoni and S. haematobium infection intensity, respectively (p<0.001)). These 
associations were similar in both communities. 
Ectopic Schistosoma egg elimination 
Ectopic S. mansoni egg elimination was found in 48 subjects and ectopic S. 
haematobium egg elimination in three subjects. Within the first group, most individuals 
also had S. mansoni eggs in feces and S. haematobium eggs in urine (n = 39, Table 2.1). 
This combination was restricted to 5-29-year-old individuals. Within this age range, 
ectopic elimination of S. mansoni eggs was significantly associated with schistosomal 
infection intensities: the OR for ectopic S. mansoni elimination was 3.5 (95%CI: 2.0-6.2) 
for a 10-fold increase in S. haematobium and 2.2 (95%CI: 1.1-4.4) for a 10-fold increase in 
S. mansoni infection intensity. Similarly, the average S. haematobium infection intensity 
was four times lower in those with single S. haematobium infection (GM=2.3 eggs/10 ml) 
than in those with additional ectopic S. mansoni eggs (GM=9.5 eggs/10 ml), suggesting 
a positive association between ectopic S. mansoni egg elimination and S. haematobium 
infection intensity in the other groups as well (Table 2.1). 
Discussion 
Due to the large overlap of S. mansoni- and S. haematobium-endemic regions in Africa, 
many people are at risk of co-infection, with potential adverse effects on 
schistosomiasis morbidity and control (Cheever et al., 1977; Friis et al., 1996; Koukounari 
et al., 2010). Nonetheless, studies on the distribution and determinants of mixed 




mansoni and S. haematobium infections as well as ectopic egg elimination in two mixed 
foci in northern Senegal. 
The age-related patterns of overall S. mansoni and S. haematobium infection 
corresponded to the characteristic convex-shaped curve for schistosomiasis, with a 
peak in adolescence (Woolhouse, 1998; Cook and Zumla, 2009). Mixed infections 
followed the same pattern. However, a more detailed analysis revealed that the decline 
in overall S. haematobium infection prevalences and intensities after adolescence 
appeared to be steeper than for S. mansoni. Previous studies in either S. mansoni- or S. 
haematobium-endemic foci (summarized by Agnew et al. (1993)), as well as in mixed 
foci (Hairston, 1965; Clarke, 1966; Farooq et al., 1966a; Dennis et al., 1983; Kvalsvig and 
Schutte, 1986; Robert et al., 1989; De Clercq et al., 1999; Lwambo et al., 1999; El Khoby 
et al., 2000) have shown similar trends, but only Agnew et al. (1993) explicitly 
mentioned this. In an early autopsy study, Cheever et al. (1977) reported a more 
pronounced reduction of S. haematobium than S. mansoni worm loads with age, which 
is also in line with our results. The underlying mechanism for this apparently rather 
common phenomenon is unknown and merits further investigation. Different 
mechanisms could play a role and are discussed below. 
Cheever et al. (1977) showed that S. haematobium eggs have a higher tendency to 
accumulate at the oviposition site than S. mansoni eggs. Accumulating S. haematobium 
eggs lead to progressive bladder wall pathology which may subsequently obstruct egg 
passage into the lumen of the bladder and lead to a reduction of S. haematobium egg 
excretion. Furthermore, differences between Schistosoma spp. in age-dependent 
reduction of fecundity have been suggested, possibly mediated by the host’s immune 
system (Agnew et al., 1996). 
Differences in vulnerability to the host’s immune response between the two species 
may also explain the more pronounced reduction of S. haematobium compared with S. 
mansoni worm load with age as observed by Cheever et al. One human study indicated 
that the two species induce different types of humoral immune responses (van 
Remoortere et al., 2001). The authors showed that S. haematobium-infected subjects 
produced IgM as well as IgG antibodies against specific carbohydrate epitopes, while 
IgM – which is thought to inhibit protective host immune responses (Butterworth et 
al., 1987) – dominated in S. mansoni infections. Also, animal studies reported 
vaccination with cercariae to convey a higher degree of protection against S. 
haematobium than against S. mansoni infection (Taylor et al., 1973; Webbe et al., 1976; 
Agnew et al., 1993; Dean et al., 1996). Similarly, animal models provided evidence for 
differences in ‘concomitant immunity’: adult S. mansoni worms appear to have a 
greater capacity than S. haematobium to elicit an immune response which prevents 
infection with new worms, while they themselves remain invulnerable to the host’s 
immune defense (Agnew et al., 1993; Terry, 1994). 
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Omer and Teesdale (1978) suggested that the apparent increased vulnerability of S. 
haematobium compared with S. mansoni may be related to the location of the worms in 
the human blood circulation. The authors suggested that treatment-induced damage 
to, and dislodgement of, adult S. haematobium would result in displacement of the 
worms within the blood stream from the vesical plexus via the heart to the lungs. 
Trapped in the capillary beds of the lung alveoli, they would not be able to recover 
from this damage (i.e. so-called ‘irreversible lung-shift’). Damaged adult S. mansoni 
worms, on the other hand, would be carried away from the mesenteric plexus via the 
portal vein to the liver where they can recover and then return to their oviposition site. 
Although speculative, similar mechanisms may play a role upon immune damage to 
adult worms. 
The observed differences between age-related S. mansoni and S. haematobium patterns 
may also be related to differences in exposure to the two species; a lower cumulative 
exposure to S. mansoni compared with S. haematobium could have resulted in a lower 
protective immune response against the first species (Woolhouse, 1998; Mitchell et al., 
2008). However, this scenario is unlikely in this specific area because S. mansoni was 
introduced before S. haematobium (Picquet et al., 1996), and current exposure to the 
first appeared more intense; peak and overall (heavy) infection prevalences were 
higher for S. mansoni at the time of this current study. 
This suggests that differences in host-parasite interactions play a more important role 
than parasite exposure in the observed, more pronounced decline of S. haematobium 
than of S. mansoni infection with age. It should be noted however, that most evidence 
relies on animal models and/or old data. Caution should be used when extrapolating 
observations from animal models to the human host, particularly with regard to S. 
haematobium for which humans are assumed to be the only natural final host (Cook 
and Zumla, 2009). More recent human studies are needed to corroborate our age-
related observations on mixed Schistosoma infections as well as on the proposed 
underlying mechanisms. 
Not only age, but also other risk factors for mixed infection observed in this study were 
similar to those generally observed for schistosomiasis. Schistosomiasis is 
characterized by a focal epidemiology (Anderson and May, 1985a). It is therefore not 
surprising that also for mixed infections, community of residence was identified as an 
important risk factor. This could be due to differences in water contact behavior, snail 
distribution, genetic differences and other factors (Robert et al., 1989; Pinot de Moira 
et al., 2007). Furthermore, women were more at risk of infection than men. Gender 
differences have been previously observed (Dennis et al., 1983; Robert et al., 1989; El 
Khoby et al., 2000; Cunin et al., 2003), and have been attributed to hormonal 




water contact between males and females (Fulford et al., 1996; Mahmoud, 2001; Scott 
et al., 2003; Sow et al., 2011). 
Understanding the exact relation between mixed infection and infection intensity is 
crucial, as increased egg loads can have important repercussions on the development 
of morbidity (Gryseels et al., 2006). We found higher S. mansoni and S. haematobium 
infection intensities in mixed than in single infections and a positive association 
between S. mansoni and S. haematobium infections in these mixed foci. Robert et al. 
also found higher infection intensities in mixed infections (1989). However, other 
studies on a larger scale (at county, provincial or district level) reported inconsistent 
results (Dennis et al., 1983; Ahmed et al., 1996; Booth et al., 1998; Lwambo et al., 1999). 
Possibly, the relationship between mixed infection and infection intensity varies 
according to local differences in S. mansoni and S. haematobium transmission, which 
may be diluted on a larger scale. As such differences can even occur at a community 
level (Pinot de Moira et al., 2007), it is important to further investigate the relationship 
between mixed infection, infection intensity and morbidity in small-scale studies and 
different endemic settings. 
Ectopic eggs were found in 15% of mixed infections, and most of those were S. mansoni 
eggs. Single infection with ectopic egg elimination was uncommon. Ectopic S. mansoni 
egg elimination was associated with S. mansoni and S. haematobium infection intensity. 
A ‘spilling over’ of S. mansoni worms and/or eggs towards the urinary bladder may have 
partly contributed to the elimination of S. mansoni eggs via the urine in heavily infected 
children (Husting, 1965). It has also been proposed that increased portal pressure – due 
to severe S. mansoni-associated hepatic fibrosis – might contribute to this phenomenon 
(Cook and Jordan, 1970; Cheever et al., 1977). Nevertheless, ectopic S. mansoni egg 
elimination was more strongly associated with S. haematobium than with S. mansoni 
infection intensity. Previous studies have consistently found this association (Blair, 
1965; Husting, 1965; Ratard et al., 1991; Cunin et al., 2003) which has been attributed to 
sexual interactions between the two species (Webster et al., 1999). Experimental 
models have shown that S. mansoni and S. haematobium can form heterologous male-
female pairs. This results in S. haematobium males carrying S. mansoni females to the 
vesical plexus. These females will then lay eggs with a S. mansoni-like morphology that 
are passed into the urine (Southgate et al., 1998). In addition, single males can remove 
homo- or heterologous females from other male worms (Tchuem Tchuente et al., 1995; 
Pica-Mattoccia et al., 2000; Steinauer, 2009). Male S. haematobium appear to be 
competitively stronger in taking heterologous females away from their male partner 
than S. mansoni (Webster et al., 1999; Cunin et al., 2003). This might explain why S. 
mansoni eggs are more commonly found to be eliminated via the unusual route than S. 
haematobium eggs (Ratard et al., 1991; Ernould et al., 1999a; Cunin et al., 2003); 
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prevalences of ectopic S. mansoni elimination of up to 31% have been reported (Ernould 
et al., 1999a). 
In the present study, ectopically eliminated eggs were categorized as either S. mansoni 
or S. haematobium. However, we cannot exclude that some of these may have been 
genetic hybrids (Huyse et al., 2009), or parthenogenetic eggs, which could not be 
distinguished from regular Schistosoma eggs by microscopy. Experimental studies 
suggest that ectopic S. mansoni-like eggs are likely to be of parthenogenetic origin 
(Taylor, 1970; Basch and Basch, 1984; Imbert-Establet et al., 1994; Tchuem Tchuente et 
al., 1994; Jourdane et al., 1995; Khalil et al., 1995; Southgate et al., 1998). To date 
however, the possibility that S. mansoni x S. haematobium hybrids exist in nature has 
not been excluded. It is essential to determine the exact genetic nature and viability of 
ectopic Schistosoma eggs since hybrid species are assumed to be more infective and 
pathogenic than their parental species (Wright and Ross, 1980; Webster and 
Southgate, 2003; Huyse et al., 2009). 
Initially, the distributions and risk factors for mixed infections did not appear to differ 
much from those of overall S. mansoni or S. haematobium infections in these mixed 
foci. Looking at the data in more detail, however, the decline in infection prevalences 
and intensities in adults was steeper for S. haematobium than for S. mansoni, resulting 
in a decrease in mixed infections and a relative increase in single S. mansoni infections 
over age. These observations are in line with previous studies in humans. Also, animal 
studies suggested S. mansoni to be less vulnerable to the host’s age-dependent 
immune response than S. haematobium. Furthermore, a positive association was found 
between mixed infection, ectopic S. mansoni egg elimination and infection intensity of 
both species, with potentially important consequences for the development of 
morbidity in co-endemic areas. The significance of these findings should be confirmed 
by further epidemiological studies at a micro-geographical level, taking host- and 
parasite-related as well as environmental factors into account. 
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Abstract 
Background: The global distribution map of schistosomiasis shows a large overlap of 
Schistosoma haematobium- and S. mansoni-endemic areas in Africa. Yet, little is known 
about the consequences of mixed Schistosoma infections for the human host. A recent 
study in two neighboring co-endemic communities in Senegal indicated that infection 
intensities of both species were higher in mixed than in single infections. Here, we 
investigated the relationship between mixed Schistosoma infections and morbidity in 
the same population. So far, this has only been studied in children. 
Methods: Schistosoma infection was assessed by microscopy. Schistosoma-specific 
morbidity was assessed by ultrasound according to WHO guidelines. Multivariable 
logistic regression models were used to identify independent risk factors for morbidity. 
Principal findings: Complete parasitological and morbidity data were obtained from 403 
individuals. Schistosoma haematobium-specific bladder morbidity was observed in 83% 
and S. mansoni-specific hepatic fibrosis in 27% of the participants. Bladder morbidity was 
positively associated with S. haematobium infection intensity (OR=1.9 (95% CI 1.3-2.9) for 
a 10-fold increase in intensity). Moreover, people with mixed infections tended to have 
less bladder morbidity than those with single S. haematobium infections (OR=0.3 (95% 
CI 0.1-1.1)). This effect appeared to be related to ectopic S. mansoni egg elimination in 
urine. Hepatic fibrosis on the other hand was not related to S. mansoni infection 
intensity (OR=0.9 (95% CI 0.6-1.3)), nor to mixed infections (OR=1.0 (95% CI 0.7-1.7)). 
Conclusions: This is the first population-wide study on the relationship between mixed 
Schistosoma infections and morbidity. Mixed infections did not increase the risk of S. 
mansoni-associated morbidity. They even tended to reduce the risk of S. haematobium-
associated morbidity, suggesting a protective effect of S. mansoni infection on bladder 
morbidity. These unexpected results may have important consequences for 






Worldwide more than 207 million people are infected with Schistosoma, 85% of whom 
live in Africa (WHO, 2010). Due to the large overlap in Schistosoma haematobium- and S. 
mansoni-endemic areas (Doumenge et al., 1987; Gryseels et al., 2006; Montgomery, 
2011) many people are at risk of co-infection. Yet, little is known about mixed 
Schistosoma infections and their impact on host morbidity. 
Clinical manifestations of schistosomiasis are associated with the species-specific 
oviposition sites (Gryseels et al., 2006). Both S. haematobium and S. mansoni mature in 
the portal vein of the human host and form male-female pairs. Subsequently, the S. 
mansoni male carries the female to the mesenteric plexus whereas the S. haematobium 
couple continues its way to the veins of the pelvis. In these respective sites, they lay 
eggs, which are eventually eliminated from the body via the urine (S. haematobium) or 
feces (S. mansoni). About half of the eggs, however, are carried away with the blood 
stream and/or trapped in the tissues. These retained eggs provoke inflammatory and 
granulomatous immune responses (Gryseels et al., 2006). For S. haematobium, this can 
lead to inflammation, ulceration and pseudopolyposis of bladder and ureteral walls, 
and in children this is often accompanied by hematuria. Chronic lesions may evolve to 
fibrotic and sandy patches with severe sequelae such as hydroureter, hydronephrosis, 
and squamous cell bladder cancer (Smith and Christie, 1986; King, 2002; Gryseels et al., 
2006). For S. mansoni, egg deposition can lead to inflammatory hepatic schistosomiasis 
and hepatosplenomegaly in children and adolescents (Wilson et al., 2011). Trapped 
schistosomal eggs are gradually replaced by fibrotic deposits, and give rise to chronic 
hepatic schistosomiasis (Gryseels et al., 2006). 
In mixed S. mansoni and S. haematobium infections, the above-described processes act 
in parallel, which may result in more severe or other abnormalities than in single 
infections. So far, only two studies have investigated the relationship between mixed 
infections and host morbidity. In Zimbabwe, a positive association between S. mansoni 
egg output and liver size was found in the presence but not in the absence of S. 
haematobium. Yet, this effect was very little (Friis et al., 1996). In a study in Mali, mixed 
infection was associated with reduced hepatic morbidity on one hand and increased 
bladder morbidity on the other (Koukounari et al., 2010). Both studies were performed 
in schoolchildren, in whom severe hepatic schistosomiasis is unlikely to have developed 
already (Richter et al., 1996; Gryseels et al., 2006; Wilson et al., 2011). Community-wide 
studies would therefore be more appropriate to investigate mixed infections and 
morbidity. 
In northern Senegal, many communities have in the past decades become co-endemic 
for S. mansoni and S. haematobium (De Clercq et al., 1999; Ernould et al., 1999a; 
Southgate et al., 2001; Van der Werf et al., 2002; Ten Hove et al., 2008; Huyse et al., 
2009). Schistosoma mansoni was introduced in Richard-Toll in 1988 upon construction 
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of the Diama dam and rapidly spread throughout the region (Talla et al., 1990; Talla et 
al., 1992). By 1994, virtually the entire Lac de Guiers area had become exposed to this 
species (Picquet et al., 1996). Today, both S. mansoni and S. haematobium are widely 
spread, resulting in a large number of people with mixed infections in the communities 
around the lake. 
Recently, we reported on the distribution of and risk factors for mixed Schistosoma 
infections in two communities on the banks of Lac de Guiers. Individuals with mixed 
infections were found to have higher infection intensities than those with single 
infections (Chapter 2). In the present study, we set out to investigate the relationship 
between mixed Schistosoma infections and morbidity in the same communities. We 
studied the patterns of S. haematobium-specific bladder morbidity and S. mansoni-
specific hepatic morbidity in this co-endemic focus, and compared morbidity in people 
with mixed Schistosoma infections to those with single infections. 
Methods 
Ethics statement 
This study was part of a larger investigation on the epidemiology of schistosomiasis 
and innate immune responses (SCHISTOINIR: www.york.ac.uk/res/schistoinir) for which 
approval was obtained from the review board of the Institute of Tropical Medicine, the 
ethical committee of the Antwerp University Hospital and ‘Le Comité National 
d’Ethique de la Recherche en Santé’ in Dakar. Informed and written consent was 
obtained from all participants prior to inclusion into the study. 
Study area 
This study was conducted from July until November 2009 in Ndieumeul (also known as 
Thiekène) and Diokhor Tack, two neighboring communities on the Nouk Pomo 
peninsula in Lac de Guiers. Details on the study area have been described elsewhere 
(Chapter 2). 
Parasitology and urine dipstick 
Two urine and two feces samples were collected from each participant on consecutive 
days for microscopic analysis (Katz et al., 1972; WHO, 1991). Per feces sample, two Kato-
Katz slides of 25 mg fecal material each were prepared and microscopically examined 
for Schistosoma species (Katz et al., 1972). Schistosoma mansoni infection intensity was 
expressed as the number of eggs detected per gram of feces (epg). Urine filtration was 
performed using a filter of 12µm pore-size (Isopore) according to standard procedures 
(WHO, 1991). Schistosoma haematobium infection intensity was expressed as the 




qualitatively (positive/negative). Ectopic egg elimination refers to elimination of 
schistosomal eggs via the unusual route – i.e. S. mansoni eggs in urine or S. 
haematobium eggs in feces. Single infection was defined as passing eggs of only one 
species, and mixed infection as passing eggs of both S. mansoni and S. haematobium, 
regardless of the route of egg elimination (Chapter 2). Microhematuria was determined 
in a subsample using Combur 7 dipsticks (Roche) on the first urine sample. All 
community members were offered praziquantel (one dose of 40 mg/kg body weight) 
and mebendazole (one dose of 500 mg) treatment after the study according to WHO 
guidelines (WHO, 2006). 
Ultrasound 
Participants were examined using a portable ultrasonography device with convex 
transducer. Pathologic lesions associated with S. haematobium or S. mansoni infection 
were recorded according to the Niamey guidelines (Richter et al., 1996). All 
examinations were performed by the same clinician who was blind to the participant’s 
infection status. Participants with severe pathology that needed further treatment 
were referred to the appropriate health authority. For S. haematobium-specific 
morbidity, the urinary bladder score was determined (Richter et al., 1996). A score of ≥1 
was considered as S. haematobium-specific urinary bladder morbidity in accordance 
with previous studies (Hatz et al., 1990; Medhat et al., 1997; Leutscher et al., 2000; King 
et al., 2001; Kouriba et al., 2005; Koukounari et al., 2006; Shiff et al., 2006; Koukounari 
et al., 2010). Individuals with a score of 0 were categorized as controls. For S. mansoni-
specific morbidity, the liver image pattern was determined (Richter et al., 1996). 
Additional measurement of periportal thickening was not included as this approach has 
been shown to be not reproducible (King et al., 2003). Liver image patterns of C to F 
were categorized as S. mansoni-specific hepatic morbidity (Boisier et al., 2001; King et 
al., 2003; Booth et al., 2004a; Booth et al., 2004b; Malenganisho et al., 2008). 
Individuals with liver image pattern A or B are not likely to have periportal fibrosis 
(Richter et al., 1996) and were therefore categorized as controls. Individuals with signs 
of hepatic morbidity that were not specific for S. mansoni (e.g. hepatitis, cirrhosis or 
fatty liver) were excluded (Richter et al., 1996) (Table 3.2). 
Statistical analysis 
IBM SPSS 19.0 (SPSS, Inc.) was used for statistical analysis. Results were considered 
significant when the p-value was <0.05. As egg outputs showed skewed distributions, 
data were normalized by log (base 10)-transformation after adding half of the 
detection limit to allow for zeroes. 
Differences between groups were determined by the Pearson Chi-square test for 
community and gender, and by the Mann-Whitney U test for age. Furthermore, the 
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Pearson Chi-square test was used to determine the association between bladder 
morbidity and microhematuria, as well as between bladder and liver morbidity. 
Because of the non-linear trend of morbidity over age, the population was divided into 
four age groups (0-9, 10-19, 20-39 and ≥40 years) for multivariable regression analysis. 
Multivariable logistic regression models were used to identify independent risk factors 
for S. haematobium-specific bladder morbidity and S. mansoni-specific hepatic fibrosis, 
respectively. Age, gender, community of residence, S. haematobium infection intensity 
and S. mansoni infection intensity were included as potential risk factors. Moreover, 
significant interaction terms with age (p<0.05) were added. 
Similar models were used to assess the independent effect of mixed infection (as 
compared to single infection) on S. haematobium-specific bladder morbidity and S. 
mansoni-specific hepatic fibrosis, respectively. Among S. haematobium-positive 
subjects, the association between bladder morbidity and mixed infection was 
investigated using a dummy variable for mixed infection (1=mixed, 0=single), and age, 
gender, community of residence and S. haematobium infection intensity as other 
determinants. Likewise, the association between hepatic fibrosis and mixed infection 
was investigated in S. mansoni-positive subjects with a dummy variable for mixed 
infection and upon correction for age, gender, community of residence and S. mansoni 
infection intensity.  
Results 
Complete parasitological data were obtained from 857 individuals (Chapter 2). 
Ultrasound data were collected from a random subsample of 403 individuals. The latter 
group consisted of 207 males and 196 females with a median age of 16 (range 3-85) 
years. There were no significant dissimilarities between those who participated in the 
ultrasound examination and those who did not, except for a slightly lower percentage 
of individuals participating from the community of Ndieumeul as compared to Diokhor 
Tack (p=0.005), and from the youngest as compared to the older age groups (p=0.030). 
No significant differences in age or gender were observed between the two 
communities. 
Morbidity prevalences 
Schistosoma haematobium-specific bladder morbidity was observed in 83% of the study 
population (334/403; Table 3.1). Most common lesions concerned multifocal or diffuse 
bladder wall thickening (n=189), irregularities (n=94) or a single mass (n=19). 
Microhematuria was twice as prevalent among those with bladder morbidity as 





Table 3.1. Schistosoma haematobium-associated bladder morbidity, hematuria and S. 
haematobium infection in the two co-endemic communities studied. 
GM: Geometric Mean, calculated for microscopically S. haematobium-positive individuals only. 
 
Table 3.2. Schistosoma mansoni-associated hepatic fibrosis and S. mansoni infection in the two 
co-endemic communities studied. 
Morbidity Liver image pattern n (%) S. mansoni infection 
% GM (95%CI)  
Negative A-B 282 (70) 72 123 (99-153) epg 
 A 142 (35) 75 131 (98-175) epg 
 B 140 (35) 69 115 (83-160) epg 
Positive C-F 109 (27) 61 113 (76-168) epg 
 C 89 (22) 63 125 (81-193) epg 
 D 10 (2) 40 113 (29-400) epg 
 E 9 (2) 67 45 (10-160) epg 
 F 1 (0.2) 0 N/A 
Excluded  12 (3)   
Total  403 (100) 69 120 (99-145) epg 
GM: Geometric Mean, calculated for microscopically S. mansoni-positive individuals only; N/A: Not 
Applicable. 
 
Table 3.3. Liver and bladder co-morbidity in the two co-endemic communities studied. a 
Bladder morbidity Hepatic fibrosis  
 Negative Positive Total 
Negative  51 16 67 
Positive 231 93 324 
Total 282 109 391 
a Number of cases. 
 
S. mansoni-specific fibrosis was present in 27% (109/403) of the population (Table 3.2). 




n (%) Microhematuria 
(%) 
S. haematobium infection 
% GM (95%CI)  
Negative 0 69 (17) 21 33 3.9 (1.8-8.1) ep10ml 
Positive ≥1 334 (83) 44 58 8.8 (6.7-11.5) ep10ml 
 1 15 (4) 62 73 8.5 (2.2-31.5) ep10ml 
 2 301 (75) 42 56 8.5 (6.4-11.3) ep10ml 
 ≥3 18 (4) 71 78 13.1 (4.2-39.5) ep10ml 
Total  403 (100) 40 54 8.1 (6.2-10.4) ep10ml 
MIXED SCHISTOSOMA INFECTION AND MORBIDITY 
42  
 
Figure 3.1. Age distribution of schistosomiasis morbidity in the two co-endemic communities 
studied. 
Colored stacks indicate morbidity prevalences and continuous black lines indicate mean 10log-
transformed infection intensities among positive subjects with the standard error of the mean 
(whiskers). Panel A: Different forms of S. haematobium-specific bladder morbidity are denoted by 
a color gradient: light yellow stacks designate a urinary bladder score of 1, bright yellow a score 
of 2 and orange (3 and 4), red (5) and violet (6) indicate higher morbidity scores. The dotted red 
line indicates hematuria prevalence in a subsample (n=317). Panel B: The severity of S. mansoni-
specific fibrosis is denoted by a color gradient. Yellow stacks designate liver image pattern C, 
orange pattern D, red pattern E, and violet stacks indicate pattern F. Striped stacks designate 
those with borderline liver morbidity (pattern B, not classified as morbidity). 
 
Morbidity of both liver and bladder was observed in 24% (93/391) of the study 
participants (Table 3.3). Those who had bladder morbidity tended to be more at risk for 
hepatic fibrosis and vice versa (odds ratio (OR)=1.3 (95% confidence interval (CI) 0.7-
2.4)). 
Age-related patterns 
Figure 3.1 shows that bladder morbidity was mainly observed in children (<20 years), 
with a peak in 10-to-19-year-olds. The age-related distribution of bladder morbidity 
coincided with that of S. haematobium infection intensity and microhematuria, 
although the peak was slightly later in adolescence, and the subsequent decline in 
adults less pronounced.  
The prevalence of hepatic fibrosis increased from 6% in 0-to-9-year-olds to 44% in those 
≥20 years old. The more severe forms of hepatic fibrosis (liver image patterns D, E and 
F) only became apparent in adults (≥20 years old). The peak in the age-related 
distribution of hepatic fibrosis occurred more than 10 years later in life than the S. 






Multivariable analysis showed age to be a significant risk factor for bladder morbidity 
as well as hepatic fibrosis (Table 3.4). However, age-related patterns of hepatic fibrosis 
differed between the two communities (p=0.033): while the ORs for hepatic fibrosis 
increased with age in Diokhor Tack (p<0.001), they did not vary with age in Ndieumeul 
(data not shown). Individuals from Diokhor Tack were significantly more at risk for 
hepatic fibrosis but tended to be less at risk for bladder morbidity than their 
counterparts from Ndieumeul (Table 3.4). Furthermore, females were less at risk for 
both forms of morbidity than males. Neither S. mansoni intensity nor S. haematobium 
intensity was identified as an independent risk factor for hepatic fibrosis. On the other 
hand, S. haematobium (but not S. mansoni) infection intensity was a strong risk factor 
for bladder morbidity. 
Effect of mixed infection 
After including mixed infection to the multivariable model, the above-described trends 
remained the same (Table 3.5). The risk of hepatic fibrosis did not differ between 
subjects with single S. mansoni and those with mixed infections. Interestingly however, 
mixed infection tended to be negatively associated with S. haematobium-specific 
bladder morbidity, suggesting a protective effect of current S. mansoni infection 
(p=0.068). 
Ectopic egg elimination and bladder morbidity 
Ectopic S. haematobium eggs were found in one (0.6%) and ectopic S. mansoni eggs in 
23 (13%) out of 176 individuals with mixed infections. Table 3.6 illustrates the 
importance of the route of S. mansoni egg elimination in the development of bladder 
morbidity. Those who eliminated S. mansoni via both urine and feces (n=17) had highest 
S. haematobium infection intensities and prevalences of bladder morbidity. Lowest 
prevalences of morbidity were observed in those who exclusively eliminated S. mansoni 
eggs via the urine (and not via the feces; n=6), despite relatively high S. haematobium 
infection intensities. 
Discussion 
The global distribution map of schistosomiasis shows a large overlap of Schistosoma 
mansoni- and S. haematobium-endemic areas in Africa (Doumenge et al., 1987; Gryseels 
et al., 2006; Montgomery, 2011). Yet, little is known about the consequences of mixed 
Schistosoma infections for the human host. Here, we report on the relationship of 
mixed Schistosoma infections with S. haematobium-specific bladder morbidity and S. 
mansoni-specific hepatic morbidity in two co-endemic communities. 
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Table 3.6. S. mansoni egg elimination, infection intensity and bladder morbidity in subjects 
passing S. haematobium eggs in urine. 
Route of S. mansoni egg elimination n S. haematobium infection 
intensity (GM (95% CI))  
Bladder 
morbidity (%) 
No elimination (single S. haematobium 
infection) 
39 3.1 (2.0-4.7) ep10ml 92 
Exclusively via feces (mixed infection) 153 8.0 (6.0-10.8) ep10ml 89 
Via feces & urine (mixed infection) 17 60.1 (27.2-132.3) ep10ml 100 
Exclusively via urine (mixed infection) 6 12.0 (1.5-86.5) ep10ml 50 
Total  215 8.1 (6.2-10.4) ep10ml 89 
GM: Geometric Mean; 95%CI: 95% Confidence Interval. 
 
Risk factors for schistosomal morbidity in this co-endemic area – i.e. age, gender, 
community of residence – were similar to those generally observed in Schistosoma-
endemic areas. In line with other studies in mono-endemic areas, we observed that 
children are more at risk of bladder morbidity (King et al., 2004; Garba et al., 2010), 
while adults are more at risk for hepatic fibrosis (Gryseels et al., 2006; Berhe et al., 
2007). Participants from one community tended to be less at risk for bladder morbidity 
but were significantly more at risk for hepatic fibrosis than participants from the other. 
Micro-geographical differences (i.e. between neighboring communities) have been 
reported before (Butterworth et al., 1994; Boisier et al., 2001; Booth et al., 2004b; 
Malenganisho et al., 2008), and are probably due to geographical heterogeneities in 
Schistosoma exposure (history) (Anderson and May, 1985a; Robert et al., 1989; Pinot de 
Moira et al., 2007, and Chapter 2 of this thesis), although other factors (e.g. genetic or 
environmental factors) may also be involved (Butterworth et al., 1994). Males were 
more at risk for bladder morbidity and hepatic fibrosis than females. Previous studies in 
either S. mansoni- or S. haematobium-endemic areas have found similar associations for 
both forms of morbidity (Heurtier et al., 1986; Hatz et al., 1990; Serieye et al., 1996; 
Medhat et al., 1997; Traore et al., 1998; Mohamed-Ali et al., 1999; Wagatsuma et al., 
1999; El Khoby et al., 2000; Boisier et al., 2001; King et al., 2003; Brouwer et al., 2003; 
Booth et al., 2004b; Berhe et al., 2007; Malenganisho et al., 2008; Garba et al., 2010). 
Possibly, males are more prone to Schistosoma-associated pathology because of 
hormonal and immunological differences. It has been proposed that hepatic fibrosis 
might be more pronounced in men because androgens can reduce interferon (IFN)-γ 
levels while estrogens have the opposite effect on this antifibrogenic cytokine 
(Mohamed-Ali et al., 1999). Similarly, a study in Uganda showed that the risk of hepatic 







Recently, we found infection intensities of both S. mansoni and S. haematobium to be 
elevated in mixed as compared to single infections (Chapter 2). In the present study, S. 
haematobium infection intensity was identified as an independent risk factor for 
bladder morbidity, in accordance with previous studies from mono-endemic areas 
(Heurtier et al., 1986; Serieye et al., 1996; Medhat et al., 1997; Traore et al., 1998; El 
Khoby et al., 2000; Leutscher et al., 2000; Brouwer et al., 2003; Brouwer et al., 2004; 
Garba et al., 2010). However, subjects with mixed infections tended to have less 
bladder morbidity than those with single S. haematobium infections, independently of 
infection intensity. This would suggest a protective effect of S. mansoni on bladder 
morbidity. 
The observed reduction in bladder morbidity in mixed infections appeared to be related 
to ectopic S. mansoni egg elimination. Lowest prevalences of bladder morbidity were 
observed in S. haematobium-positive individuals who also eliminated S. mansoni eggs in 
urine (but not in feces), despite the relatively high S. haematobium infection intensities 
in this group. Experimental models have shown that S. mansoni and S. haematobium 
can form heterologous male-female pairs. As the S. haematobium male is assumed to 
be competitively stronger than S. mansoni (Webster et al., 1999; Cunin et al., 2003), this 
would result in more heterologous pairs in the vesical than in the mesenteric plexus 
and thus in more ectopic S. mansoni than ectopic S. haematobium egg elimination in 
mixed foci (Ratard et al., 1991; Khalil and Mansour, 1995; Southgate et al., 1998; 
Webster et al., 1999; Ernould et al., 1999a; Cunin et al., 2003; and Chapter 2 of this 
thesis). Nothing is known yet about the pathogenicity of eggs from heterologous pairs 
(Jourdane et al., 1995; Khalil and Mansour, 1995). It could be speculated however, that 
these heterologous pairs would produce less (pathogenic) eggs than homologous S. 
haematobium worm pairs, or that their eggs would deviate to other sites (Mansour et 
al., 1984; Soliman et al., 1986). Competition between S. mansoni and S. haematobium 
females for S. haematobium males would then lead to a reduction of bladder morbidity 
in mixed as opposed to single infections. Other factors may also underlie the potential 
protective effect of S. mansoni infection. As our study population has been exposed to 
S. mansoni for a longer period of time than to S. haematobium (Picquet et al., 1996), 
one could argue that S. mansoni-induced cross-resistance to S. haematobium might 
have played a role as well (Webbe et al., 1979). Obviously, more research is needed to 
confirm the observed relation between mixed Schistosoma infection and bladder 
morbidity, and to understand the underlying mechanisms. 
Only one epidemiological study has looked into mixed infections and bladder morbidity 
before. In contrast to our study, the authors reported a positive association between 
mixed infection and bladder morbidity in Malian subjects (Koukounari et al., 2010). 
However, they studied only schoolchildren (7-14 years) and did not take ectopic egg 
elimination into account. Restricting our analysis to children between 5 and 14 years 
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(the limited sample size did not allow us to perform the analysis on a smaller age 
range), the association between mixed infection and bladder morbidity still tended to 
be negative (OR=0.5 (95%CI 0.1-3.4)). Disregarding ectopic eggs as well, the association 
became positive (OR=1.7 (95%CI 0.4-7.6)), which is in line with the Malian study (data 
not shown). These discrepancies clearly demonstrate the importance of considering 
ectopic egg elimination in mixed Schistosoma infections and morbidity. 
In contrast to our findings for bladder morbidity, hepatic fibrosis was neither 
associated with current S. mansoni infection intensity nor with mixed infections. 
Hepatic fibrosis only develops after 5-15 years of exposure to S. mansoni (Gryseels et al., 
2006). This was illustrated by the >10 years’ time lag between the S. mansoni infection 
and S. mansoni-associated hepatic fibrosis peaks in the respective age-related curves 
(Figure 3.1). While inflammatory hepatic morbidity is generally positively associated 
with current S. mansoni infection (Guyatt et al., 1995; Kardorff et al., 1996; Gryseels et 
al., 2006), the progression of morbidity into chronic schistosomiasis is driven by 
cumulative exposure to S. mansoni eggs rather than current infection (Chan et al., 1996; 
Mahmoud, 2001; Wilson et al., 2011). 
So far, only two other studies have investigated the relationship between mixed 
infections and liver morbidity, with contrasting results. A Zimbabwean study found a 
slight positive association between mixed infections and liver size (Friis et al., 1996). 
The afore-mentioned Malian study observed a negative association between mixed 
infections and hepatic fibrosis (Koukounari et al., 2010). However, the latter classified 
liver image pattern B as abnormal (Koukounari et al., 2006), which is not according to 
the Niamey guidelines (Richter et al., 1996; Boisier et al., 2001; King et al., 2003; Booth 
et al., 2004a; Booth et al., 2004b; Malenganisho et al., 2008), and hampers an adequate 
comparison with our findings. Adopting the criteria of the Malian study, we still found a 
positive association between mixed infections and liver fibrosis in children (7-14 years), 
although not significant (data not shown). The divergences between the Malian study 
and our study – for bladder as well as liver morbidity – could furthermore be due to 
differences in the distribution of S. haematobium and S. mansoni infection status and 
intensity between the three Malian study areas, which were not accounted for 
(Koukounari et al., 2010). Also other differences in e.g. transmission dynamics 
(Butterworth et al., 1994), between the Malian and present study cannot be excluded. 
Conclusion 
Up to now, the relationship between mixed Schistosoma infection and morbidity has 
only been studied in schoolchildren. This population-wide study is the first to include 
adults. Mixed infections were not associated with an increased risk of S. mansoni-
associated morbidity and even tended to reduce the risk of bladder morbidity. These 




mansoni on bladder morbidity. Especially the role of interspecies interactions and 
ectopic S. mansoni egg elimination should be studied in more detail, as these 
phenomena may have important consequences for schistosomiasis morbidity and 
control in co-endemic areas. 
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Abstract 
Background: Schistosoma mansoni and S. haematobium are co-endemic in many areas in 
Africa. Yet, little is known about the micro-geographical distribution of these two 
infections or associated disease within such foci. Such knowledge could give important 
insights into the drivers of infection and disease and as such better tailor 
schistosomiasis control and elimination efforts.  
Methodology: In a co-endemic farming community in northern Senegal (346 children 
(0-19y) and 253 adults (20-85y); n=599 in total), we studied the spatial distribution of S. 
mansoni and S. haematobium single and mixed infections (by microscopy), S. mansoni-
specific hepatic fibrosis, S. haematobium-specific urinary tract morbidity (by 
ultrasound) and water contact behavior (by questionnaire). The Kulldorff’s scan 
statistic was used to detect spatial clusters of infection and morbidity, adjusted for the 
spatial distribution of gender and age. 
Principal findings: Schistosoma mansoni and S. haematobium infection densities 
clustered in different sections of the community (p=0.002 and p=0.023, respectively), 
possibly related to heterogeneities in the use of different water contact sites. While the 
distribution of urinary tract morbidity was homogeneous, a strong geospatial cluster 
was found for severe hepatic fibrosis (p=0.001). Particularly those people living 
adjacent to the most frequently used water contact site were more at risk for more 
advanced morbidity (RR=6.3; p=0.043). 
Conclusions: Schistosoma infection and associated disease showed important micro-
geographical heterogeneities with divergent patterns for S. mansoni and S. 
haematobium in this Senegalese community. Further in depth investigations are 
needed to confirm and explain our observations. The present study indicates that local 
geospatial patterns should be taken into account in both research and control 
of schistosomiasis. The observed extreme focality of schistosomiasis even at 
community level, suggests that current strategies may not suffice to move from 
morbidity control to elimination of schistosomiasis, and calls for less uniform measures 






Schistosomiasis is amongst the most common human parasitic diseases with over 230 
million people affected worldwide (WHO, 2010). More than 90% of them live in sub-
Saharan Africa (Hotez and Kamath, 2009). The two major species are Schistosoma 
mansoni and S. haematobium, which are co-endemic  in many regions (Gryseels et al., 
2006). However, little is known about the geographical distribution of both species 
within such co-endemic regions. Knowledge on micro-geographical variations of single 
and mixed Schistosoma infections and associated disease could provide important 
insights into the drivers of infection and disease and as such better tailor 
schistosomiasis control and elimination efforts.  
Recent progress in geographic information systems (GIS) has facilitated a better 
understanding of geospatial dimensions of schistosomiasis on the large scale. On 
continental and national scales, climatic (e.g. temperature and rainfall) and physical 
factors (e.g. vegetation, large water bodies, altitude) have been identified as major 
determinants of the heterogeneous geographical distribution of Schistosoma infection 
(either S. mansoni or S. haematobium (Dennis et al., 1983; Kloos et al., 1988; Ahmed et 
al., 1996; Tsang et al., 1997; Brooker et al., 2001; Handzel et al., 2003; Raso et al., 2005; 
Simoonga et al., 2008; Brooker and Clements, 2009; Clements et al., 2009)). On 
subnational levels, distance to water contact sites, land use and the distribution of 
infected snails have been reported to contribute to these heterogeneities (Gryseels 
and Nkulikyinka, 1988; Chandiwana et al., 1988; Gryseels and Nkulikyinka, 1990; 
Coutinho et al., 1997; Gazzinelli, 2006; Kapito-Tembo et al., 2009; Odiere et al., 2011). 
Few studies have however exploited these techniques to address the geospatial 
dimensions of schistosomiasis on the micro-scale, i.e. within communities or among 
households (Utzinger et al., 2003; Clennon et al., 2004; Clennon et al., 2006; Brooker et 
al., 2006; Matthys et al., 2007; Pullan et al., 2008; Yiannakoulias et al., 2010; Mutuku et 
al., 2011; Stothard et al., 2011). Most of these considered spatial patterns of only one 
Schistosoma species even though S. mansoni and S. haematobium often occur together 
(Gryseels et al., 2006). Moreover, micro-geographical clustering of Schistosoma 
infection has never been studied in relation to Schistosoma-specific morbidity. 
In the present study, we set out to investigate the spatial patterns of S. mansoni and S. 
haematobium infection and morbidity in a co-endemic community on the bank of Lac de 
Guiers in the north of Senegal (Chapter 2 and 3). During the past decades, many 
communities around Lac de Guiers in the north of Senegal have become co-endemic for 
S. mansoni and S. haematobium (De Clercq et al., 1999; Southgate et al., 2001; Ten Hove 
et al., 2008; Huyse et al., 2009). Schistosoma mansoni was introduced in Richard-Toll in 
1988 upon construction of the Diama dam and rapidly spread throughout the region 
(Talla et al., 1990; , 1992). By 1994, virtually the whole Lac de Guiers area had become 
exposed to this species (Picquet et al., 1996). Today, both S. mansoni and S. 
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This study was part of a larger investigation on the epidemiology of schistosomiasis 
and innate immune responses (SCHISTOINIR: www.york.ac.uk/res/schistoinir) for which 
approval was obtained from the review board of the Institute of Tropical Medicine, the 
ethical committee of the Antwerp University Hospital and ‘Le Comité National 
d’Ethique de la Recherche en Santé’ in Dakar. Informed and written consent was 
obtained from all participants prior to inclusion into the study. For minors, informed 
and written consent was obtained from the legal guardian. 
Participants with severe pathology that needed further treatment were referred to the 
appropriate health authority. After the study, all community members were offered 
praziquantel (40 mg/kg) and mebendazole (500 mg) to treat and prevent 
schistosomiasis and soil-transmitted helminthiasis, respectively (Chapter 2), according 
to WHO guidelines (WHO, 2006). 
 
Figure 4.1. General map of the study village.  
The inset shows that Diokhor Tack is located in the south-west of the Nouk Pomo peninsula in 
Lac de Guiers. The main figure indicates the locations of the 68 households that participated in 
the study (white dots). Black dots with Roman numerals refer to the sites where people come 
into direct contact with water from the lake. Water contact site III and IV are open spaces 
enclosed by dense vegetation. Site IV is the largest water contact site. The more remote water 
contact sites (I, II, and V) are located along irrigation canals in which vegetation was sparser at 





This cross-sectional study was conducted from July until November 2009 in Diokhor 
Tack (16°11’24’’N 15°52’48’’W), the largest community on the Nouk Pomo peninsula in 
Lac de Guiers. Details on the study area have been described elsewhere (Chapter 2). In 
short, it is an isolated, compact and homogeneous Wolof community of Muslim faith 
with a surface of ~0.25 km². Cultivation is the main means of subsistence and the 
farmlands that surround the village are irrigated with water from the lake. Although 
the water from Lac de Guiers is piped to the capital city of Dakar, 250 km away (Berger 
et al., 2006), the people living nearby do not have access to safe water. Water contact 
takes place in the lake or in specific sites in canals that are connected to the lake in the 
west (Figure 4.1). There were no periodic anthelminthic treatment programs prior to 
our study and the community does not have a health facility. The nearest ‘health post’ 
is ~12 km away. All community members that gave informed consent (or their legal 
guardians) were included in the study. Participants were registered and recruited from 
door to door for the parasitological and ultrasound surveys. The community consisted 
of 71 households, 68 of which participated in this study (Figure 4.1). This corresponded 
to a total study population of 599 individuals.  
Data collection and definitions 
For microscopic diagnosis of Schistosoma infection, two feces and two urine samples 
were collected from each participant on consecutive days. For each feces sample, two 
Kato-Katz slides of 25 mg fecal material each were prepared, and urine samples were 
filtered and processed according to standard procedures, as previously described 
(Chapter 2 and 3). In analogy with earlier micro-geographic studies (Clennon et al., 
2004; Clennon et al., 2006; Mutuku et al., 2011), S. mansoni and S. haematobium 
infection densities were expressed as the number of eggs detected per gram of feces 
(epg) or per 10 ml of urine (ep10ml), respectively, including both negative (0 epg or 0 
ep10ml) and positive individuals (Kitron and Higashi, 1985). Single infection was defined 
as passing eggs of only one species, and mixed infection as passing eggs of both S. 
mansoni and S. haematobium, irrespective of the route of egg elimination (Chapter 2). 
Schistosoma-specific morbidity was determined by ultrasound, as previously described 
(Chapter 3). Pathologic lesions associated with S. haematobium or S. mansoni infection 
were recorded according to the Niamey guidelines (Richter et al., 1996). Individuals 
with signs of hepatic morbidity that were not specific to S. mansoni (e.g. hepatitis, 
cirrhosis or fatty liver) were excluded (Richter et al., 1996). To assess the presence or 
absence of S. mansoni-specific hepatic fibrosis, the liver image pattern was determined 
(Richter et al., 1996). Liver image patterns of C (“periportal fibrosis possible”) to F 
(“very advanced periportal fibrosis”) were categorized as S. mansoni-specific hepatic 
fibrosis (Chapter 3). Individuals with liver image pattern A (“no sign of periportal 
fibrosis”) or B (“incipient periportal fibrosis not excluded”) were categorized as 
MICRO-GEOGRAPHICAL VARIATIONS IN SCHISTOSOMIASIS 
56  
controls (Richter et al., 1996). To assess the presence or absence of S. haematobium-
specific urinary tract morbidity, the urinary bladder score was determined (Richter et 
al., 1996). A score of ≥1 was considered as S. haematobium-specific bladder morbidity in 
accordance with previous studies (Medhat et al., 1997; Leutscher et al., 2000; and 
Chapter 3 of this thesis). The severity of morbidity was represented by the liver image 
pattern score for S. mansoni- and by the upper urinary tract score for S. haematobium-
specific morbidity (Richter et al., 1996). Finally, individual questionnaires were used to 
explore water contact behavior in a random subsample of people older than 5 years of 
age. 
Mapping and geospatial processing 
Water contact sites as well as the center of each household were located using a hand-
held differential global positioning system with an accuracy of 3m (Garmin Etrex H). 
Household locations in latitude and longitude were then linked to the collected 
individual infection, morbidity and questionnaire data (multiple observations per 
location). These data were imported into SaTScan 9.1.1 (Software for the spatial and 
space-time scan statistics, developed by M. Kulldorff, Harvard Medical School, Boston 
and Information Management Services Inc., Silver Spring, Maryland, USA. Available at 
www.satscan.org) according to the software’s user guide (Kulldorff, 2010). ArcMap 9.3 
(ESRI, Redlands, California, USA) was used to project the geographic coordinates and 
statistically significant clusters (see below) on to the Universal Transverse Mercator 
zone 28N (1984 datum). 
Spatial statistics 
The widely used Kulldorff’s scan statistic in SaTScan™ tests whether events such as 
disease cases are distributed randomly in space and, if not, identifies the approximate 
location of significant geospatial clusters (Kulldorff, 1997). The test uses a moving 
circular window that varies up to a predefined size. Each window is a potential cluster. 
For each window, a likelihood ratio test is applied based on the observed and expected 
number of cases inside and outside the window to test the null hypothesis of absolute 
spatial randomness against the alternative hypothesis that there is an elevated risk 
within the window as compared to outside. The window with the maximum likelihood 
is the ‘most likely cluster’. The p-value of the maximum likelihood ratio test statistic was 
obtained after 999 Monte Carlo replications. A maximum window size of 50% of the 
study population was chosen upon sensitivity analysis using maximum sizes from 10 to 
50%. Only statistically significant (p<0.05) most likely clusters were reported, and 
standard settings (i.e. non-overlapping secondary clusters) were used throughout all 
analyses. In case the most likely (significant) cluster contained only one household, an 
additional check was performed to increase the robustness of cluster detection. The 




(using the “criteria for reporting secondary clusters” option “no restriction = most 
likely cluster for each grid point” (Kulldorff, 2010)), and the secondary cluster (including 
the first household) was reported, if it remained significant. Additionally, clusters with 
p<0.06 were displayed to indicate households that tended to have increased risks. 
Infection densities of S. mansoni and S. haematobium showed skewed distributions, and 
were therefore normalized by log (base 10)-transformation after adding half of the 
detection limit to allow for zeroes. The detection limit for S. mansoni infection was 10 
epg and that for S. haematobium infection 0.5 ep10ml. The spatial distribution of log-
transformed infection densities was assessed using normal models (Kulldorff et al., 
2009). Geometric mean (GM) infection densities in- and outside spatial clusters were 
computed to quantify significant spatial heterogeneities. Subsequently, Bernoulli 
models (Kulldorff, 1997) were run to investigate the distribution of single S. mansoni, 
single S. haematobium and mixed infections, comparing spatial distributions of people 
with: 
 single S. mansoni (1) versus those without single S. mansoni infections (0); 
 single S. haematobium (1) versus those without single S. haematobium 
infections (0); 
 mixed (1) versus those without mixed infections (0). 
The spatial distribution of the prevalence of hepatic fibrosis and urinary tract morbidity 
was tested using binary variables in separate Bernoulli models. Ordinal models were 
used to assess the distribution of the severity of S. mansoni- and S. haematobium-
specific morbidity (Jung et al., 2007). Relative risks (RR) comparing people in- and 
outside clusters, as well as prevalences in- and outside clusters were calculated to 
quantify significant spatial heterogeneities based on Bernoulli and ordinal models.  
Gender and age are important risk factors for both Schistosoma infection (Chapter 2), 
and morbidity (Chapter 3). To investigate whether these demographic factors 1) caused 
clustering of infection and morbidity, and/or 2) impacted on the size and exact 
locations of statistically significant clusters, the abovementioned analyses were 
adjusted using multiple datasets (Kulldorff et al., 2007). Six datasets were prepared, 
containing either males or females from 0 to 9, 10 to 19, or ≥20 years old (Table 4.1). 
SaTScan™ incorporated all datasets into a single log likelihood function. This function is 
defined as the sum of the individual log likelihoods for those data sets for which the 
observed case count is more than the expected. Since this adjustment was only 
possible for the Bernoulli and normal models, separate Bernoulli models were run for 
the ordinal morbidity model showing significant spatial heterogeneities in the 
unadjusted analysis. 
Finally, Bernoulli models were used to compare the geospatial distribution of people 
reporting to frequent a particular water contact site versus the distribution of people 
who did not report to frequent that site. 
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Male 0 – 9 109 15 17 27 49 3 41 
Female 0 – 9 79 9 16 17 28 2 18 
Male 10 – 19 90 21 10 49 49 12 48 
Female 10 – 19 68 11 6 42 34 6 26 
Male ≥ 20 103 39 3 15 49 33 44 
Female ≥ 20 150 44 20 39 82 34 56 
Total  599 139 72 189 291 90 233 




Characteristics of the study population 
Complete parasitological data were obtained from a total of 599 individuals from 68 
households. The median household size was 8 people (range 1-20). The total study 
population consisted of 302 males and 297 females with a median age of 15 (range 0-
85) years. Ultrasound and questionnaire data were obtained from random subsamples 
of 291 individuals (64 households), and 277 individuals (63 households), respectively. 
The prevalence of overall S. mansoni infection was 55% (328/599) and that of S. 
haematobium 44% (261/599). Mixed infections were observed in 32% of the population 
(189/599). The prevalence of S. mansoni-specific hepatic fibrosis was 31% (90/291). Most 
cases had liver image pattern C (71/90), 9/90 had pattern D, while advanced periportal 
fibrosis was observed in 10/90 cases (nine with liver image pattern E and one with F). 
The prevalence of S. haematobium-specific urinary tract morbidity was 80% (233/291). 
Positive upper urinary tract scores (range 3-12) were observed in 6% of the study 
population (18/291). Distributions of single and mixed Schistosoma infections, S. 
mansoni-associated hepatic fibrosis and S. haematobium-associated bladder morbidity 
according to gender and age are summarized in Table 4.1. 
Spatial distribution of Schistosoma infection 
Figure 4.2A depicts the heterogeneous geospatial distribution of S. mansoni and S. 
haematobium infection densities (p=0.001 for both unadjusted analyses). While the size 
of the S. haematobium infection density cluster increased upon correction for the 
spatial distribution of gender and age, both S. mansoni and S. haematobium clusters 





Figure 4.2. Spatial distribution of S. mansoni and S. haematobium infection densities.  
Black circles and crosses indicate households that were included in and excluded from the 
analysis, respectively. Roman numerals indicate water contact sites. Panel A depicts the 
unadjusted clusters (p=0.001 for both S. mansoni and S. haematobium). The geometric mean 
(GM) S. mansoni infection density was 33 epg for those living in the northern S. mansoni cluster 
(n=285) compared to 12 epg in the rest of the community (n=314). The GM S. haematobium 
infection density was 4.7 ep10ml inside the southern S. haematobium cluster (n=34) and 0.7 
ep10ml outside (n=565). Panel B depicts the gender- and age-adjusted clusters (p=0.002 for S. 
mansoni (north), and p=0.023 for S. haematobium (south). 
 
Participants with mixed and those with single S. haematobium infections were 
randomly distributed (p=0.16 and p=0.080, respectively), while those with single S. 
mansoni infections tended to cluster geographically (Figure 4.3A; RR=1.7; p=0.053). 
Figure 4.3B indicates that the clustering of single S. mansoni was independent of the 
spatial distribution of gender and age (p≤0.050), although the cluster size and exact 
location were slightly altered upon adjustment. 
Spatial distribution of Schistosoma-specific morbidity 
Figure 4.4A indicates that people with hepatic fibrosis (RR=1.9; p=0.054) and urinary 
tract morbidity (RR=1.2; p=0.053) tended to cluster in the same area. Adjusted analysis 
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Figure 4.3. Spatial distribution of single S. mansoni infections.  
Black circles and crosses indicate households that were included in and excluded from the 
analysis, respectively. Blue Roman numerals indicate water contact sites. Continuous pink circles 
are statistically significant clusters (p<0.05) and dotted circles are borderline significant (p<0.06). 
Panel A depicts the unadjusted cluster (RR=1.7; p=0.053). The prevalence of single S. mansoni 
infection was 30% (83/278) inside and 17% (56/321) outside the cluster. Panel B shows the gender- 
and age-adjusted clusters (p=0.045 for the most likely cluster (center) and p=0.050 for the 
secondary cluster (north). 
 
distribution of gender and age (p=0.087 for hepatic fibrosis and p=0.071 for urinary 
tract morbidity in the adjusted analysis). In order to assess the distribution of morbidity 
by severity, ordinal analyses were performed for liver image pattern and upper urinary 
tract scores. Figure 4.4B shows that this resulted in one significant cluster (p=0.001) in 
which the RR increased with the severity of hepatic fibrosis: the RR for a healthy liver 
image pattern A was 0.3, that for B 1.3, for C 1.4, for D 2.7 and for E 4.3. Moreover, the 
only person with pattern F in the community lived in this cluster. Bernoulli models were 
used to investigate whether this cluster of severe hepatic fibrosis was independent of 
the distribution of gender and age. Since more severe hepatic fibrosis was only 
observed in adults, these analyses were restricted to ≥20-year-olds. Unadjusted 
Bernoulli models revealed that image patterns D-F (as opposed to A-C) clustered in the 
































































































































































































































































Figure 4.4. Spatial distribution of S. mansoni- and S. haematobium-specific morbidity.  
Black circles and crosses indicate households that were included and excluded from the analysis, 
respectively. Continuous colored circles are statistically significant clusters (p<0.05) and dotted 
circles are borderline significant (p<0.06). Roman numerals indicate water contact sites. Panel A 
depicts the unadjusted clusters for the prevalence of morbidity. Both S. mansoni-specific hepatic 
fibrosis (pink dotted circle; RR=1.9) and S. haematobium-specific urinary tract morbidity clusters 
(green dotted circle; RR=1.2) were borderline significant (p=0.054 and p=0.053, respectively). The 
prevalence of hepatic fibrosis was 41% (59/145) in- and 21% (31/146) outside, and that of urinary 
tract morbidity was 89% (117/131) in- and 73% (116/160) outside the cluster. Gender- and age-
adjusted analysis revealed no (borderline) significant clusters for the prevalence of morbidity. 
Panel B depicts the clusters of morbidity by severity. The risk of severe hepatic fibrosis was 
elevated in the circle with a RR of 0.3 for liver image pattern A, 1.3 for B, 1.4 for C, 2.7 for D and 
4.3 for E, and the only person with pattern F lived here (p=0.001; unadjusted ordinal model). The 
gender- and age-adjusted cluster for patterns D-F (as opposed to A-C) in adults constituted of the 
households indicated in pink (p=0.031; Bernoulli model). 
 
(RR=6.3; p=0.043; data not shown). The combined distribution of patterns E and F (as 
opposed to A-D) was homogeneous (p=0.20). In the adjusted model, the cluster of 
pattern D-F remained statistically significant (Figure 4.4B; p=0.031). 
The risk of severe urinary tract morbidity was homogeneously distributed (p=0.38 in 
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Figure 4.5. Spatial distribution of self-
reported use of the different water contact 
sites. 
Black circles and crosses indicate households 
that were included and excluded from the 
analysis, respectively. Roman numerals 
indicate water contact sites. Gray circles 
indicate clusters of people that reported to 
frequent a given water contact site indicated 
by an arrow. Participants in the northeastern 
cluster were more likely to frequent site II 
(3/4 versus 5/273; p=0.005), participants in the 
middle cluster to frequent site III (4/17 versus 
2/260; p=0.022), and those from the 
southwestern cluster to frequent site V (8/53 
versus 1/224; p=0.001) than those living 
outside the respective clusters. 
 
Water contact behavior 
Water contact activities were concentrated at site IV with 62% of the interviewees 
(172/277) reporting to frequent this site. Numbers of observations in the other sites 
were limited. Nonetheless, spatial analysis of the questionnaire data revealed 
significant heterogeneities in the self-reported use of the different water contact sites 
(Figure 4.5). People from two adjacent households in the northeast were more likely to 
frequent site II than those from the rest of the community (3/4 in- versus 5/273 outside 
the cluster; p=0.005). People living in the center of the community were more likely to 
frequent site III than others (4/17 versus 2/260; p=0.022). Those from the southwest 
were more likely to frequent site V (8/53 versus 1/224; p=0.001). Use of site I and IV did 
not appear to be linked to a particular group of households (p=0.31 and p=0.16 
respectively). 
Discussion 
The present micro-geographical study revealed significant clusters of S. mansoni and S. 
haematobium infection density in different sections of one community in a co-endemic 
area, possibly related to heterogeneities in the use of different water contact sites. 
While the distribution of urinary tract morbidity was homogeneous, a strong geospatial 
cluster was found for severe hepatic fibrosis. Particularly those people living adjacent 
to the most frequently used water contact site were more at risk for advanced 




These findings confirm the well-known focality of schistosomiasis (Cook and Zumla, 
2009). Even within one community, one cannot assume the risk of schistosomiasis to 
be homogenous. More remarkably even, the two Schistosoma species clustered in 
different sections of the community; Schistosoma mansoni infections clustered in the 
north while S. haematobium clustered in the south. A series of recent GIS studies 
showed significant micro-geographical heterogeneities in S. haematobium infection 
within a mono-endemic Kenyan community (Clennon et al., 2004; Clennon et al., 2006). 
Those in S. mansoni mono-endemic communities showed conflicting results with 
heterogeneous spatial patterns in some studies and homogeneous patterns in others 
(Utzinger et al., 2003; Brooker et al., 2006; Matthys et al., 2007; Pullan et al., 2008; 
Yiannakoulias et al., 2010; Stothard et al., 2011). To our knowledge, only Farooq et al. 
have so far investigated the spatial distribution of both infections in a co-endemic 
community in Egypt in the 1960s. They reported higher infection levels of S. mansoni in 
small children in one section of the community and higher levels of S. haematobium in 
another section (Farooq, 1966). This is in agreement with the divergent distributions of 
S. mansoni and S. haematobium infection densities observed in the present study. 
Several interrelated factors may underlie these observations, and are discussed below. 
First of all, the micro-geographic distributions of the intermediate snail host of S. 
mansoni and S. haematobium, which belong to the genus Biomphalaria and Bulinus, 
respectively, may be divergent as well. Unfortunately, it was logistically impossible to 
collect snails in the present study. Yet, it is known that these snail species prefer 
different niches and that their distribution is influenced by chemical, physical, and 
biological factors (Polderman et al., 1985; Woolhouse and Chandiwana, 1989; Amankwa 
et al., 1994; Ernould et al., 1999b; Johnson et al., 2009; Al-Sheikh and Dagal, 2011). 
Indeed, Woolhouse and Chandiwana demonstrated that the snail hosts of S. mansoni 
and S. haematobium occupy different locations in one single habitat in a co-endemic 
focus (Woolhouse and Chandiwana, 1989). Ecological factors may thus have favored S. 
mansoni transmission in the north and S. haematobium transmission in the south. 
At the human host level, behavioral factors may have played a role in the observed 
spatial pattern of infection. Although based on a small number of observations, our 
questionnaire data indeed indicated that people from the north and center were more 
likely to frequent the northern sites than other community members, whereas those 
from the southwest were more likely to use the southernmost site. It thus seems that 
the first group maintained S. mansoni transmission in the north and the second S. 
haematobium transmission in the south. This corresponds to the study of Woolhouse 
and Chandiwana reporting 1) a similar geospatial segregation of S. mansoni and S. 
haematobium infection in the snail host population between transmission sites, and 2) a 
very focal man-to-snail transmission, within a distance of 40m. Interestingly, they 
proposed that these divergent patterns most likely reflected differences in the 
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distribution of defecation from that of urination, favoring S. mansoni and S. 
haematobium transmission, respectively (Woolhouse and Chandiwana, 1989). In 
contrast to water contact behavior, age and gender of the human host were shown to 
have a negligible impact on the divergent pattern of S. mansoni and S. haematobium 
infection. Spatial clustering in the different sections of the community remained 
significant upon correction for age and gender. Other factors that may have 
contributed to the spatial pattern include genetic differences in susceptibility to 
infection (Bethony et al., 2002; Grant et al., 2011; Grant et al., 2012). Indeed, extended 
families tended to live together in this community (L. Meurs, personal observation). 
Also, people from the same section/extended family are more likely to have similar 
behavioral patterns (Farooq, 1966; Farooq et al., 1966a; Lima e Costa MF et al., 1987; 
Kloos et al., 1998). 
In contrast to the spatial distribution of S. haematobium infection, the distribution of S. 
haematobium-associated urinary tract morbidity was homogeneous. This was 
unexpected as S. haematobium infection has consistently been reported as an 
independent risk factor for urinary tract morbidity (Heurtier et al., 1986; King et al., 
1988; Serieye et al., 1996; Medhat et al., 1997; Traore et al., 1998; El Khoby et al., 2000; 
Leutscher et al., 2000; Brouwer et al., 2003; Brouwer et al., 2004; Garba et al., 2010). 
The fact that S. haematobium was only introduced in this region approximately 6 years 
prior to this study (Southgate et al., 2000), may explain the relatively low severity of 
urinary tract morbidity in this community and the consequent absence of a spatial 
pattern. The severity of urinary tract morbidity is expected to progress over time with 
cumulative exposure to S. haematobium eggs (King et al., 1992). 
On the other hand, a strong geospatial cluster was found for severe S. mansoni-specific 
hepatic fibrosis which overlapped with that of S. mansoni infection density. At first 
sight, this seems to be in contrast with previous studies by this group showing that 
current S. mansoni infection is not associated with hepatic fibrosis (Chapter 3), which 
usually develops after 5-15 years of exposure (Gryseels et al., 2006). However, a closer 
look at the overlapping clusters showed that teenagers had the highest infection 
densities and contributed most to the S. mansoni infection density cluster (data not 
shown). Adults on the other hand had more advanced morbidity, and contributed most 
to the severe hepatic fibrosis cluster. This suggests that these adults were in fact the 
teenagers with the highest S. mansoni infection densities earlier in life. 
Moreover, the clustering of severe hepatic fibrosis in adults seemed to be associated 
with the distance to the water. Those living within ~100 m of the major water contact 
site (Figure 4.4B) were at least six times more likely to develop advanced hepatic 
fibrosis (liver image pattern D-F) than those living farther away. However, other factors 
cannot be excluded such as genetic predisposition (Bethony and Quinnell, 2008), diet 




living in close vicinity of the water at a higher risk of developing hepatic morbidity than 
the rest of the community. 
To our knowledge, only Booth et al. have so far investigated micro-geographical 
variations in Schistosoma-associated morbidity. They found an association between 
splenomegaly and the combined exposure to S. mansoni and Plasmodium falciparum 
but did not explicitly investigate spatial clustering (Booth et al., 2004c). 
To our knowledge this is the first study to quantify micro-geographical infection 
patterns of S. mansoni and S. haematobium in a co-endemic community, and the first to 
relate these to patterns of Schistosoma-specific morbidity. Apart from the strengths, it 
is also important to address some limitations of our study. First, the study was cross-
sectional and the results were merely descriptive in nature. The present study was a 
first attempt to describe patterns of schistosome infection and morbidity on a micro-
scale, and it was not designed to explain the underlying mechanisms of potential micro-
geographical clustering. Based on the limited data that were available, we generated a 
number of hypotheses, but other risk factors, including environmental, malacological, 
genetic, immunological and socio-economic factors, should be included in future 
studies. In addition, more spatial as well as spatio-temporal studies (Clennon et al., 
2004; Clennon et al., 2006; Mutuku et al., 2011) are necessary to confirm our 
observations in other geographical areas and to explain them. Another limitation was 
that there is as yet no standard technique available to investigate spatial patterns. The 
emergence of various statistical methods has greatly boosted geospatial studies on 
schistosomiasis and increased our understanding of this disease. On the other hand, 
the large variety of methods has also hampered the comparison between the different 
micro-geographical studies that have been conducted so far and standardization is 
recommended. 
Current WHO schistosomiasis control strategies aim to prevent morbidity in later life 
through regular mass drug administration (MDA) to at risk populations in so-called 
homogeneous ecological zones (WHO, 2011; WHO, 2013). However, the strong micro-
geographical clustering of infection and morbidity observed in the present study 
suggests that less uniform strategies should be developed to better tailor control 
efforts at the local level. A more targeted approach will be even more relevant in view 
of resolution WHA65.21 on the elimination of schistosomiasis, recently adopted by the 
WHO (WHO, 2013). It is expected that MDA alone cannot break the Schistosoma life 
cycle and that complementary interventions will have to be put in place (Sturrock, 
1989). Micro-geographical studies will help to get much needed insights into local 
transmission dynamics of S. mansoni and S. haematobium and hence to develop 
sustainable control and elimination strategies (Peng et al., 2010).  
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Abstract 
Background: In Africa, many areas are co-endemic for the two major Schistosoma 
species, S. mansoni and S. haematobium. Epidemiological studies have suggested that 
host immunological factors may play an important role in co-endemic areas. As yet, 
little is known about differences in host immune responses and possible immunological 
interactions between S. mansoni and S. haematobium in humans. The aim of this study 
was to analyze host cytokine responses to antigens from either species in a population 
from a co-endemic focus, and relate these to S. mansoni and S. haematobium infection. 
Methodology: Whole blood cytokine responses were investigated in a population in the 
north of Senegal (n=200). Blood was stimulated for 72 h with schistosomal egg and 
adult worm antigens of either Schistosoma species. IL-10, IL-5, IFN-γ, TNF-α, and IL-2 
production was determined in culture supernatants. A multivariate (i.e. multi-response) 
approach was used to allow a joint analysis of all cytokines in relation to Schistosoma 
infection. 
Principal findings: Schistosoma haematobium egg and worm antigens induced higher 
cytokine production, suggesting that S. haematobium may be more immunogenic than 
S. mansoni. However, both infections were strongly associated with similar, modified 
Th2 cytokine profiles.  
Conclusions: This study is the first to compare S. mansoni and S. haematobium cytokine 
responses in one population residing in a co-endemic area. These findings are in line 
with previous epidemiological studies that also suggested S. haematobium egg and 
worm stages to be more immunogenic than those of S. mansoni.  
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Introduction 
Schistosomiasis is a parasitic disease of major public health importance. Schistosoma 
mansoni and S. haematobium are the main human species. Both species are endemic in 
Africa, where their distributions show a great overlap (Gryseels et al., 2006). 
Schistosomes are known to down-regulate host immune responses and to induce so-
called modified Th2 responses. The exact phenotype of the induced response depends 
on a complex immunological ‘dialogue' that involves cytokines and immune cells of 
Th2, but also Th1, Th17 and regulatory components of the immune system (Allen and 
Maizels, 2011). 
So far, little is known about differences in host immune responses to schistosomes and 
possible immunological interactions between S. mansoni and S. haematobium in 
humans. Yet, epidemiological studies have suggested that host immunological factors 
may play an important role in co-endemic areas. Interspecies differences in 
immunogenicity for example, may explain why infection-age curves and morbidity 
patterns differ between S. mansoni and S. haematobium. Also, immunological 
interspecies differences and/or immunological interactions between S. mansoni and S. 
haematobium may explain differences in morbidity levels between single and mixed 
Schistosoma infections. Cheever et al. reported a more pronounced reduction of S. 
haematobium than S. mansoni worm loads with age (1977). Similarly, in a mixed focus in 
northern Senegal, we found the age-infection curve of S. haematobium to decline more 
steeply after adolescence than that of S. mansoni (Chapter 2), indicating that protective 
immunity against S. haematobium may develop more rapidly. In addition, we found that 
mixed S. mansoni and S. haematobium infection as compared with single S. 
haematobium infection tended to decrease the risk of S. haematobium-specific urinary 
tract pathology (Chapter 3). This appeared mainly due to ectopically excreted, possible 
hybrid eggs (Huyse et al., 2013). Others also found S. mansoni to affect S. haematobium-
specific morbidity and vice versa (Koukounari et al., 2010; Gouvras et al., 2013), 
indicating that the two infections may have different effects on the egg-induced 
immune responses that provoke morbidity. 
The present study set out to compare Schistosoma-specific cytokine responses induced 
by S. mansoni and S. haematobium antigens, and to relate these to Schistosoma 
infection in a S. mansoni and S. haematobium co-endemic area. Schistosoma infection 
status (single and mixed) and infection intensities as well as Schistosoma-specific 
cytokine responses were determined in residents from a co-endemic focus in northern 
Senegal. A multivariate (i.e. multi-response) approach was used to allow a joint analysis 
of multiple cytokine responses (interleukin (IL)-10, IL-5, interferon (IFN)-γ, tumor 
necrosis factor (TNF)-α, and IL-2) (Bourke et al., 2013).  
  
CYTOKINE RESPONSES IN CO-ENDEMIC SCHISTOSOMIASIS 
70  
Materials and methods 
Ethics statement 
This study was part of a larger investigation on the epidemiology of schistosomiasis 
and innate immune responses (SCHISTOINIR) for which approval was obtained from 
the review board of the Institute of Tropical Medicine, the ethical committee of the 
Antwerp University Hospital and ‘Le Comité National d’Ethique de la Recherche en 
Santé’ in Dakar. Informed and written consent was obtained from all participants prior 
to inclusion into the study. For minors, informed and written consent was obtained 
from their legal guardians. 
All community members were offered praziquantel (40 mg/kg) and mebendazole (500 
mg) treatment after the study according to WHO guidelines (WHO, 2006). 
Study area 
This study was conducted in Ndieumeul and Diokhor Tack, two neighboring 
communities on the Nouk Pomo peninsula in Lake Guiers. Details on the study area 
have been described elsewhere (Chapter 2 and 3). Between July 2009 and March 2010, 
parasitological data were collected from 857 individuals (Chapter 2). A random 
subsample of 200 subjects was followed up immunologically. These subjects were 
between 5 and 53 years of age. Individuals who had lived in an urban area in the 5 years 
preceding the study (n=7), had taken praziquantel within the last year (n=2), or had 
clinical signs of malaria (recruited upon recovery), and pregnant women (n=18) were 
excluded from the immunological study.  
Parasitology 
Two feces and two urine samples were collected from each participant on consecutive 
days. Infection with Schistosoma spp. was determined quantitatively (by Kato-Katz and 
urine filtration), and infection with soil-transmitted helminths (STHs) Ascaris 
lumbricoides, Trichuris trichiura and hookworm, was assessed qualitatively (by Kato-
Katz), as described elsewhere (Chapter 2). Aliquots of the first fecal samples were 
preserved in ethanol to confirm microscopy results by multiplex PCR (A. lumbricoides, 
hookworm and Strongyloides stercoralis) (n=198) (Wiria et al., 2010). Infection with 
Plasmodium was determined by Giemsa-stained thick blood smears. 
Whole blood culture 
Five hours after venipuncture, heparinized blood was diluted 1:4 in RPMI 1640 
(Invitrogen) supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 1 mM 
pyruvate and 2 mM glutamate (all from Sigma). This mixture (200 µl sample volume) 
was incubated in 96-well round bottom plates (Nunc) at 37 ºC under 5% CO2 atmosphere 
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for 72 h, together with one of four schistosomal water-soluble antigen preparations at 
a final concentration of 10 µg protein/ml: 
 Schistosoma egg antigen (SEA) derived from S. mansoni (SEAm); 
 SEA from S. haematobium (SEAh); 
 Adult worm antigen (AWA) from S. mansoni (AWAm); or 
 AWA from S. haematobium (AWAh). 
Medium (see above) without stimulus was used as a negative control. After harvesting, 
supernatants were stored at -80 °C. Schistosoma eggs and adult worms were isolated 
from either S. mansoni- or S. haematobium-infected golden hamsters. SEAm, SEAh, 
AWAm and AWAh were prepared from this material using identical procedures. In brief, 
eggs or worms were freeze-dried and then homogenized in phosphate-buffered saline 
(PBS) with 10% n-octyl-β-D-glucopyranoside. Subsequently, this mixture was sonicated, 
frozen, thawed and washed with PBS. The resulting pellet was dialyzed and filter-
sterilized.  While AWAm and AWAh batches were lipopolysaccharide (LPS)-free, SEAm 
and SEAh antigens contained equivalent amounts of LPS (final concentrations of 1-5 
ng/ml). 
Cytokine measurement 
IL-10, IL-5, IFN-γ, TNF-α, and IL-2 in culture supernatants were analyzed simultaneously 
using custom Luminex cytokine kits (Invitrogen) according to the manufacturer’s 
instructions. Samples with concentrations below the detection limit were assigned 
values corresponding to half of the lowest value detected. Lowest values detected 
were 0.063 pg/ml for IL-10, 0.044 pg/ml for IL-5, 0.090 pg/ml for IFN-γ, 0.051 pg/ml for 
TNF-α, and 0.063 pg/ml for IL-2. 
Statistical analysis 
Results were considered significant when the p-value was <0.05. The Pearson Chi-
square test was used to determine the association between infection status on the one 
hand, and age and gender on the other. Nonparametric techniques were chosen 
because cytokine concentrations were not normally distributed. Univariate statistics 
were used to compare single antigen-induced responses within individuals (IBM SPSS 
21.0). McNemar’s tests were used to compare cytokine response frequencies between 
S. mansoni and S. haematobium antigen-induced responses within individuals (e.g. 
SEAm- versus SEAh-induced responses). Similarly, Wilcoxon Signed Rank tests were 
used to compare cytokine response levels between S. mansoni and S. haematobium 
antigen-induced responses within individuals. Multivariate (i.e. multi-response) 
statistics were used to collectively analyze multiple cytokine responses – i.e. cytokine 
profiles - in the study population, and to investigate interrelationships between these 
responses (Bourke et al., 2013). We chose the nonparametric technique nonmetric 
CYTOKINE RESPONSES IN CO-ENDEMIC SCHISTOSOMIASIS 
72  
multidimensional scaling (nMDS; in R with the ‘Vegan’ package (R Core Team, 2012; 
Oksanen et al., 2013)). This is a variant of the parametric principal component analysis 
(PCA), but with fewer assumptions about the nature of the data and the 
interrelationship of the variables (Clarke and Warwick, 2001). This is important because 
cytokine response levels were not normally distributed, even after log-transformation. 
Also, levels of different cytokines typically correlate with one another. Upon 
computation of the cytokine profiles, associations between these cytokine profiles and 
Schistosoma infection were assessed. The approach is illustrated in the Supporting 
information, page 84. Before nMDS, cytokine concentrations in the negative control 
were subtracted from those in antigen-stimulated samples to obtain net cytokine 
responses. Negative values were set to zero. Net cytokine responses were normalized 
by log(base 10)-transformation after adding 1 pg/ml to allow for zeroes. Schistosoma 
infection intensities were normalized after adding half of the detection limit (i.e. 5 eggs 
per gram of feces and 0.25 eggs per 10ml of urine for S. mansoni and S. haematobium, 
respectively). One nMDS was performed for each of the four Schistosoma-specific 
whole blood stimulations (either SEAm, SEAh, AWAm or AWAh) using the ‘metaMDS’ 
function (Oksanen et al., 2013). Each nMDS was repeated several times to assess the 
robustness of the resulting pattern (Clarke and Warwick, 2001). The Euclidean 
dissimilarity index was used (Oksanen et al., 2013), and cytokine profiles - i.e. the matrix 
of IL-10, IL-5, IFN-γ, TNF-α, and IL-2 - were plotted in three dimensions (3D) to 
adequately represent the variation in the data (Clarke and Warwick, 2001). Afterwards, 
gradients of the separate cytokine responses, on which the nMDS was based, were 
fitted using the ‘envfit’ function (Oksanen et al., 2013). The same function was used to 
fit infection intensities onto each 3D nMDS, and to statistically test associations of 
antigen-induced cytokine profiles with Schistosoma infection intensity or infection 
status, i.e. uninfected, single S. mansoni, single S. haematobium, versus mixed S. 
mansoni and S. haematobium infection. The ‘ordiellipse’ function was used to fit 
average group scores - with their 95% confidence intervals (CIs) - for different infection 
statuses (Oksanen et al., 2013). In contrast to individual S. mansoni- and S. 
haematobium-induced cytokine responses which can be compared quantitatively within 
individuals as described above (univariate statistics), qualitative differences between S. 
mansoni- and S. haematobium-induced cytokine profiles could only be assessed visually 
by nMDS, not by formal statistical testing. 
Results 
Characteristics of the study population 
The study population consisted of 88 males and 112 females with a median age of 16 
(range 5-53) years. Malaria and STHs T. trichiura and hookworm were absent in this 
population, and A. lumbricoides and S. stercoralis rare (n=3 and 2, respectively, with   
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Table 5.1. Schistosoma infections in the study population. 




Prevalence (n) Code for Infection Status 
in Figure 5.2 
 Feces Urine a Feces Urine   
Positive     158  
Single infections     63  
 + - - - 42 M (dark blue) 
 - - - + 21 H (light blue) 
Mixed infections     95 MH 
 + - - + 81 MH (pink) 
 + + - + 13 MH (yellow) 
 - + - + 1 MH (red) 
Negative - - - - 42 N (green) 
Total 136 14 0 116 200  
a Schistosoma mansoni eggs that were ectopically excreted in the urine had a S. mansoni-
like morphology but may have had a genetically hybrid constitution (Chapter 2; Huyse et 
al., 2013). 
 
100% concordance between microscopy and PCR). In contrast, 137 (69%) subjects were 
infected with S. mansoni, and 116 (58%) with S. haematobium. Sixty percent (95/158) of 
all Schistosoma infections were mixed S. mansoni and S. haematobium infections (Table 
5.1). The distributions of S. mansoni and S. haematobium infections in the study 
population according to age and gender are shown in Table 5.2. Both Schistosoma 
infections peaked in adolescents (10 to 19 year-olds), but gender differences were not 
statistically significant. Epidemiological patterns of infection have been described in 
more detail elsewhere (Chapter 2). 
General cytokine profiles 
Insight into the different antigen-induced cytokine responses relative to one another 
was obtained by nMDS. Figure 5.1 and 5.2 show the variation in multivariate cytokine 
responses in the study population, with dots representing individuals. Distances 
between dots approximate inter-individual dissimilarities in cytokine responses with 
stress values (i.e. discrepancies) of 0.051 for SEAm, 0.041 for SEAh, 0.058 for AWAm, 
and 0.061 for AWAh. Red arrows indicate increasing gradients of IL-10, IL-5, IFN-γ, TNF-α 
and IL-2 responses, respectively. The level of a cytokine response increases in the 
direction of the corresponding arrow (see also Supporting information, page 84). The 
length of a cytokine arrow indicates the goodness of fit of that arrow (or cytokine 
gradient).  
The nMDS outcomes for the first axis (nMDS1) show that for each of the four antigen 
stimulations, all cytokine responses point to the left. Individuals plotted on the left 
produced consistently higher levels of all cytokines measured than those on the right. 
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Table 5.2. Distribution of Schistosoma infection in the study population. 
  n S. mansoni infection S. haematobium infection 
   Percentage of 
positives (%) 
p-value Percentage of 
positives (%) 
p-value 
Age (in years)    0.001  0.001 
 5-9 51 58.8  66.7  
 10-19 59 88.1  72.9  
 20-39 55 58.2  49.1  
 ≥40 35 65.7  34.3  
Gender    0.32  0.20 
 Male 88 72.7  63.6  
 Female 112 65.2  53.6  
 
In other words, nMDS1 indicates a gradient of high (left) to low (right) cytokine 
responses. In analogy, the second axis (nMDS2), indicates a gradient of Th1-like (IFN-γ 
and TNF-α, top) to Th2-like (IL-5, bottom) phenotypes for each of the antigen 
stimulations. In contrast to SEA-induced IL-5, AWA-induced IL-5 was not accompanied 
by production of IL-10. IL-2 levels increased with Th1 cytokines, except for SEAm. The 
third axis (nMDS3) indicates a gradient of TNF-α and IL-2 (left) to IFN-γ and IL-10 (right). 
In contrast to antigen-induced cytokines, spontaneously induced levels of cytokines in 
the control (medium only), did not show significant gradients, except for IL-5 on the 
third nMDS axis (stress=0.11, data not shown). 
Comparison between S. mansoni- and S. haematobium-induced 
cytokine responses and cytokine profiles 
Figure 5.1 and 5.2 indicate that S. mansoni and S. haematobium antigens induced very 
similar cytokine profiles; cytokine profiles differed more between adult (AWA) and egg 
(SEA) life stages of the parasite than between the two Schistosoma species. Within 
individuals, S. haematobium-induced cytokine response levels were higher than those 
induced by S. mansoni (Table 5.3). This was statistically significant for all SEA- and AWA-
induced cytokine responses that were measured, except for SEA-induced IFN-γ and IL-
10. 
Relation between cytokine profiles and Schistosoma infection 
intensity  
Subsequently, we related the above-described variation in cytokine responses in the 
study population (i.e. plotted cytokine profiles) to infection intensity. Table 5.4 shows 
that all associations between Schistosoma antigen-induced cytokine profiles and 
infection intensity were statistically significant. In Figure 5.1, the direction of the black 
arrows represents the increasing gradients of S. mansoni and S. haematobium infection   
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Table 5.3. Levels of Schistosoma-induced cytokine responses in 72h whole blood cultures 
(n=200). 
Antigen Species Cytokine Response (%) Median Concentration in pg/ml 
(IQR) a 
p-value b 
SEA c S. mansoni      
  IL-10 92.0 12.7 (5.2 - 32.4) 0.874 
  IL-5 78.5 3.7 (1.0 - 19.0) <0.001 
  IFN-γ 67.5 3.4 (0.05 - 7.8) 0.729 
  TNF-α 64.5 0.7 (0.03 - 2.2) 0.046 
  IL-2 80.0 6.3 (2.0 - 18.8) <0.001 
 S. haematobium      
  IL-10 90.5 13.1 (4.7 - 32.2)  
  IL-5 77.0 5.2 (0.9 - 47.4)  
  IFN-γ 63.0 4.2 (0.05 - 7.8)  
  TNF-α 67.5 1.0 (0.03 - 4.3)  
  IL-2 80.5 8.2 (2.1 - 54.7)  
AWA d S. mansoni      
  IL-10 98.5 25.7 (13.2 - 48.2) 0.008 
  IL-5 94.5 69.3 (11.8 - 201.2) <0.001 
  IFN-γ 74.5 5.4 (0.05 - 9.4) 0.002 
  TNF-α 90.5 4.6 (1.2 - 10.9) <0.001 
  IL-2 98.0 60.3 (22.4 - 152.1) <0.001 
 S. haematobium      
  IL-10 99.0 30.0 (17.0 - 50.4)  
  IL-5 96.0 108.6 (25.9 - 237.9)  
  IFN-γ 78.5 6.3 (1.7 - 12.1)  
  TNF-α 96.5 6.0 (2.7 - 15.1)  
  IL-2 98.0 99.5 (42.4- 224.5)  
None       
  IL-10 59.5 1.7 (0.03 - 4.9)  
  IL-5 57.0 0.9 (0.02 - 2.6)  
  IFN-γ 58.0 2.2 (0.05 - 5.8)  
  TNF-α 63.5 0.4 (0.03 - 1.5)  
  IL-2 45.5 0.03 (0.03 - 2.9)  
Blood samples from one individual were divided into five and stimulated with Schistosoma 
antigens (SEAm, SEAh, AWAm, or AWAh), and with medium only (negative control; see Materials 
and methods).  
a Crude cytokine levels are reported. IQR: Interquartile range (Tukey’s hinges) 
b Wilcoxon Signed Rank test comparing S. mansoni- and S. haematobium-induced cytokine 
levels within individuals (either for SEA or AWA) 
c Schistosoma egg antigen 
d Adult worm antigen 
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Figure 5.1. Variation in Schistosoma antigen-induced cytokine responses in relation to 
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Each three-dimensional (3D) nMDS ordination is represented in two 2D planes (Supporting 
information, page 84). Left and right panels represent the 1st and 2nd, and 2nd and 3rd dimensions, 
respectively. Panels A and B show the S. mansoni egg antigen (SEAm)-induced cytokine profile, 
Panels C and D that of S. haematobium SEA(h), Panels E and F that of S. mansoni adult worm 
antigens (AWAm), and Panels G and H show S. haematobium AWA(h)-induced cytokine profiles. 
Green dots represent individuals. Distances between dots approximate the rank order of 
dissimilarities in cytokine profiles between the respective individuals with stress values (i.e. 
discrepancies) of 0.051 for SEAm, 0.041 for SEAh, 0.058 for AWAm, and 0.061 for AWAh. Red 
arrows indicate linear gradients of normalized net cytokine responses on which the nMDS is 
based. Green dot sizes are proportional to individual values of normalized infection intensity of S. 
mansoni (for simplicity dots were only labelled with S. mansoni (not S. haematobium) infection 
intensity). Black arrows indicate linear gradients of post hoc fitted normalized infection intensity 
of S. mansoni (‘Sm’) and S. haematobium (‘Sh’). The length of the arrows is proportional to the 
goodness of fit onto the cytokine profile within one 2D plane, but lengths cannot be compared 
between cytokine and infection intensity arrows. Arrows are only depicted if their fit was 
significant at the level of p=0.05 in 3D ordinations (see Table 5.4), as well as in the respective 2D 
planes. In Panel H, the arrows of IL-5 response and S. mansoni infection intensity are overlapping 
and their labels are therefore illegible.  
a The biological a posteriori interpretation of nMDS1 (left x-axis) and nMDS2 (y-axis) were 
added between brackets on the axis labels, but nMDS3 (right x-axis) could not be 
interpreted. 
 
Table 5.4. Association between Schistosoma infection and Schistosoma antigen-induced 
cytokine profiles. 
Infection Antigen-induced cytokine profile 
  SEAm SEAh AWAm AWAh 
S. mansoni infection intensity      
 R² 0.14 0.17 0.10 0.13 
 p-value 0.001 0.001 0.001 0.001 
S. haematobium infection intensity      
 R² 0.05 0.18 0.07 0.15 
 p-value 0.02 0.001 0.003 0.001 
Infection status      
 R² 0.09 0.18 0.02 0.04 
 p-value 0.001 0.001 0.2 0.01 
Figure 5.1 shows the fit of infection intensity and Figure 5.2 that of infection status (uninfected, 
single S. mansoni, single S. haematobium, versus mixed infections) onto each of the four 
Schistosoma antigen-induced cytokine profiles (either SEAm, SEAh, AWAm or AWAh), obtained 
by the ‘metaMDS’ and ‘envfit’ functions (see also Supporting information, page 84) (R Core 
Team, 2012; Oksanen et al., 2013). Here, the goodness of these fits, i.e. squared correlation 
coefficients (R²), is shown. The statistical significance was assessed using permutation tests 
(n=999), and presented p-values are approximations. 
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Figure 5.2. Variation in Schistosoma antigen-induced cytokine responses in relation to 
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Each three-dimensional (3D) nMDS ordination is represented in two 2D planes (Supporting 
information, page 84) as in Figure 5.1: Left and right panels represent the 1st and 2nd, and 2nd and 
3rd dimensions, respectively. Panels A and B show the S. mansoni egg antigen (SEAm)-induced 
cytokine profile, Panels C and D that of S. haematobium SEA(h), Panels E and F that of S. mansoni 
adult worm antigens (AWAm), and Panels G and H show S. haematobium AWA(h)-induced 
cytokine profiles. Dots represent individuals and distances between dots approximate the rank 
order of dissimilarities in cytokine profiles between the respective individuals with stress values 
(i.e. discrepancies) of 0.051 for SEAm, 0.041 for SEAh, 0.058 for AWAm, and 0.061 for AWAh. Red 
arrows indicate linear gradients of normalized net cytokine responses on which the nMDS is 
based. The length of the arrows is proportional to the goodness of fit onto the cytokine profile 
within one 2D plane, and arrows are only depicted if their fit was significant at the level of p=0.05 
in 3D ordinations (see Table 5.4), as well as in the respective 2D planes. Green dots represent 
uninfected individuals, dark blue those with single S. mansoni infections, light blue single S. 
haematobium, and the other colors indicate people with mixed infections: pink indicates mixed 
infections without ectopic egg elimination, yellow mixed infections with S. mansoni in feces as 
well as in urine and S. haematobium in urine, and red dots represent one individual with both S. 
mansoni and S. haematobium eggs in urine (possibly a hybrid species (Huyse et al., 2013; Chapter 2 
and 3); see also Table 5.1). Ellipsoids represent 95% confidence intervals for average group scores, 
for different infection statuses: uninfected (‘N’), single S. mansoni (‘M’), single S. haematobium 
(‘H’), versus mixed infection (‘MH’). Ellipsoids are drawn using the function ‘ordiellipse’, and only 
depicted if the fit of infection status onto the cytokine profile was significant at the level of 
p=0.05 in 3D ordinations (see Table 5.4), as well as in the respective 2D planes. In Panel A and G, 
the labels for single S. mansoni (‘M’) and mixed infection (‘MH’) are overlapping.  
a The biological a posteriori interpretation of nMDS1 (left x-axis) and nMDS2 (y-axis) were 
added between brackets on the axis labels, but nMDS3 (right x-axis) could not be 
interpreted. 
 
intensity, respectively (see also Supporting information, page 84). On the first axis, 
which indicates cytokine response levels (see above), these arrows generally point into 
the opposite direction of cytokine responses. This indicates that people with elevated 
Schistosoma infection intensities are more likely to have lower cytokine responses, and 
vice versa. On the second axis, which indicates the Th1 versus Th2 response phenotype 
(see above), infection intensity generally increases with IL-5 and decreases with Th1 
cytokines TNF-α, IFN-γ, and IL-2 (except for SEAm-induced IL-5 which decreases with 
increasing infection intensity). Briefly, as infection intensity increased, cytokine 
response levels decreased and the Th2 phenotype became more pronounced. The 
association between infection intensity and reduced cytokine responsiveness was more 
pronounced for SEA than for AWA stimulation. Schistosoma infection intensity 
increased with AWA-induced IL-5, but decreased with SEA-induced IL-5 levels, indicating 
that  people with higher infection intensities produced more of a Th2-like response 
against AWA and more of a suppressive response (i.e. with low cytokine response 
levels) against SEA than people with lower infection intensities, and vice versa. 
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We did not observe differences in induced cytokine profiles between the two 
Schistosoma infections. Associations between cytokine profiles and infection intensity 
were comparable for S. mansoni and S. haematobium infections (Figure 5.1). Table 5.4 
shows significant correlations between cytokine profiles and Schistosoma infection 
intensity for homologous combinations (i.e. infection intensity and antigen stimulation 
of the same species) as well as for heterologous combinations (i.e. infection intensity 
of one and antigen stimulation of the other species). 
Relation between cytokine profiles and infection status (mixed 
versus single infections) 
Schistosoma antigen-induced cytokine profiles were significantly associated with 
Schistosoma infection status, except upon stimulation with AWAm (Table 5.4). Figure 
5.2 shows how antigen-induced cytokine profiles differed according to infection status 
(except for AWAm, which was not significantly associated with infection status), with 
95% CI ellipsoids indicating the average nMDS scores per infection group: uninfected 
(‘N’), single S. mansoni (‘M’), single S. haematobium (‘H’), versus mixed (‘MH’) 
Schistosoma infection group. In analogy with Figure 5.1, uninfected individuals had 
higher cytokine responses than Schistosoma-infected subjects, and their cytokine 
profiles were skewed more towards the Th1 phenotype. On the whole, there was a 
gradient in cytokine profiles from uninfected individuals, to people with single and then 
mixed Schistosoma infections (Figure 5.2) and these profiles were in the same direction 
as the gradient of infection intensity (Figure 5.1). In other words, people with low 
cytokine responses of the Th2 phenotype tended to have both mixed and heavier 
infections, people with strong Th1 responses tended to be uninfected, and those with 
an intermediate cytokine profile tended to have both single and lighter Schistosoma 
infections. 
For the SEAm-induced cytokine profile, there was a clear difference (i.e. separation 
between ellipsoids) between S. mansoni-infected individuals (with either single or 
mixed S. mansoni), and those without S. mansoni (no Schistosoma infection, or single S. 
haematobium infection; Figure 5.2A). There were no significant differences in this 
cytokine profile between single and mixed S. mansoni infections, or between 
uninfected individuals and those with single S. haematobium infections. This indicates 
that, in contrast to S. mansoni, S. haematobium infection status was not associated with 
SEAm-induced cytokine profiles. Schistosoma haematobium-induced cytokine profiles 
on the other hand, showed similar relationships with S. mansoni as well as with S. 
haematobium infection status. Cytokine profiles of people with single and mixed 
infections differed significantly from those of uninfected people, and cytokine profiles 
did not appear to differ between single S. mansoni and single S. haematobium 
infections. 
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Discussion 
The objective of this study was to compare cytokine responses induced by S. mansoni 
and S. haematobium antigens, and to relate these to Schistosoma infection in a S. 
mansoni and S. haematobium co-endemic area. We showed that Schistosoma infection 
intensity was significantly associated with Schistosoma antigen-induced cytokine 
profiles and that it may explain up to 18% of the variation in cytokine responses 
observed in this population. As Schistosoma infection intensity increased, cytokine 
responses decreased and the Th2 phenotype became more pronounced. This was 
exemplified by relatively higher IL-5 (and IL-10) and relatively lower IFN-γ, TNF-α and IL-
2 levels. Lightly infected and uninfected subjects on the other hand, had elevated 
cytokine responses, with a Th1 phenotype. These patterns are consistent with the 
modified Th2 response characteristic for schistosomiasis (Allen and Maizels, 2011). 
nMDS also indicated that the association between infection and the Th2 phenotype 
was more pronounced for AWA, while that between infection and (reduced) cytokine 
responsiveness was more pronounced for SEA. These observations fit with a previous 
study by Joseph et al. describing similar immunological differences between 
Schistosoma adult worm and egg life stages in a population from a S. mansoni mono-
endemic area, using more conventional analyses (Joseph et al., 2004).  
Secondly, we demonstrated that increased Schistosoma infection intensity and mixed 
(as compared to single) infections were associated with similar, modified Th2, cytokine 
profiles. This is probably due to the fact that subjects with mixed infections were more 
likely to have higher infection intensities than those with single infections (Chapter 2). 
Also, similar, modified Th2, cytokine profiles were observed for both S. mansoni and S. 
haematobium infection intensity, whether blood was stimulated with antigens from the 
homo- or heterologous species. This may be indicative of immunological cross-
reactivity between species. For S. mansoni-induced cytokine profiles however, this was 
unlikely, because profiles did not differ between single and mixed S. mansoni infection 
groups. While S. haematobium-induced cytokine profiles did differ between single and 
mixed S. haematobium infection groups, we could not determine whether these 
differences were due to mixed infection per se, or to higher S. haematobium infection 
intensity in mixed as compared to single infections. Other potentially confounding 
factors such as age may have been involved as well (Chapter 2), and future studies 
should be performed to assess their respective roles in determining cytokine 
responses. To obtain more evidence on the existence of cross-reactivity between the 
two major human Schistosoma species, it is important to compare immune responses 
between different co- and mono-endemic areas, using different immunological 
parameters (e.g. cytokine, humoral and cytological data). To our knowledge, only one 
human study reported on functional S. mansoni – S. haematobium cross-reactivity. This 
study from 1974 reported lethal in vitro activity of sera from subjects infected with one 
CYTOKINE RESPONSES IN CO-ENDEMIC SCHISTOSOMIASIS 
82  
species against schistosomula of the same but not of the other species (Smith and 
Webbe, 1974). Indeed, S. mansoni and S. haematobium may share few if any epitopes 
that are involved in protective immunity because they belong to genetically distinct 
groups. Potential cross-reactivity or the lack thereof merits further investigation as this 
may have important implications for our understanding of the epidemiology of 
schistosomiasis as well as for the development of an effective schistosomiasis vaccine. 
The present study demonstrated that nMDS can be used successfully to analyze host 
cytokine responses collectively. In this way, it was possible to analyze cytokine 
responses in relation to one another, and in relation to Schistosoma infection. nMDS is a 
nonparametric, multivariate and visual method. It is a robust and powerful tool 
because it avoids problems of multiple statistical tests and violations of data 
assumptions (Clarke and Warwick, 2001). Moreover, nMDS makes it easier to interpret 
complex data than traditional one-by-one graphs, tables, and tests. Here, we used this 
approach to study multivariate cytokine responses, but it can be used equally well to 
increase our understanding of other complex, multidimensional data, such as 
cytological and/or serological data (Durnez et al., unpublished data), as well as infection 
data on multiple co-endemic parasite species. 
Additional analyses showed that, within individuals, S. haematobium antigens induced 
higher cytokine responses in 72h whole blood cultures than those of S. mansoni. A very 
similar pattern was observed in parallel investigations in Ghana, in a population which 
was - in contrast to the Senegalese study population - first exposed to S. haematobium 
and then to both S. mansoni and S. haematobium, and with lower prevalences of S. 
mansoni and higher prevalences of S. haematobium (Amoah et al., unpublished data; 
and Chapter 2 of this thesis). This suggests that this finding does not depend on the 
level of transmission or on exposure history, and that the two Schistosoma species may 
differ in their immunogenicity. This hypothesis is in line with observations from Van 
Remoortere et al. (2001) who found S. mansoni to induce mainly IgM antibodies – which 
are thought to inhibit protective host immune responses (Butterworth et al., 1987) – 
while S. haematobium induced both IgM and IgG antibodies against shared 
carbohydrate epitopes. It is therefore tempting to speculate that lower cytokine 
response levels may prevent Ig class switching from IgM to IgG for these epitopes in S. 
mansoni infection, while stronger cytokine responses may promote class switching in S. 
haematobium infection. Alternatively, differences in their biochemical composition may 
underlie interspecies differences in both immunogenicity and humoral immune 
responses. These two immunological interspecies differences may also have 
contributed to earlier epidemiological findings. Several studies observed a steeper 
decline of the age-infection curve of S. haematobium as compared to S. mansoni after 
adolescence, indicating that protective immunity against S. haematobium might 
develop more rapidly (Cheever et al., 1977; Chapter 2). Secondly, higher levels of S. 
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haematobium- as compared to S. mansoni-specific morbidity have been observed in co-
endemic populations (Koukounari et al., 2010; Gouvras et al., 2013; Chapter 3), 
suggesting that the immune responses provoked by S. haematobium eggs might be 
more pathogenic. It should be noted however, that other factors may also explain 
these two epidemiological observations. For example, S. mansoni and S. haematobium 
eggs accumulate in different organs, i.e. the liver and the urinary tract, respectively, 
and these differences in anatomical context may also explain the differences in the 
extent of morbidity between the two species. More research is necessary to 
investigate the abovementioned immunological interspecies differences and their 
implications for epidemiological patterns of infection and morbidity in more detail. 
Conclusion 
In conclusion, this is the first study to comprehensively investigate S. mansoni- and S. 
haematobium-induced cytokine responses in a S. mansoni and S. haematobium co-
endemic area, and to relate these cytokine responses to Schistosoma infection. The 
present study demonstrates that nMDS can be used successfully as a tool for the joint 
analysis of multiple cytokine responses in relation to Schistosoma infection. We showed 
strong associations between Schistosoma infection and Schistosoma-induced cytokine 
profiles, and provided a first insight into potential differences and interactions between 
human S. mansoni and S. haematobium infections. This knowledge will contribute to an 
improved understanding of the mechanisms underlying Schistosoma infection and 
morbidity in co-endemic populations. 
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Supporting information 
Schematic representation of nonmetric multidimensional scaling 
The nonparametric data reduction technique nonmetric multidimensional scaling 
(nMDS) aims to plot the individuals (dots) in such a way that the inter-point distance in 
the plot approximates the same rank order as corresponding dissimilarities in 
multivariate cytokine profiles (i.e. matrix of net IL-10, IL-5, IFN-γ, TNF-α, and IL-2 
production) (Clarke and Warwick, 2001; R Core Team, 2012; Oksanen et al., 2013; Bourke 
et al., 2013). In other words: it aims to minimize the stress, i.e. discrepancy between 
inter-point distances and true dissimilarities. This is achieved in an iterative procedure. 
Subsequently, the plot (i.e. a 3D cloud of dots) is rotated in such a way that the first 
axis represents the largest variance, followed by gradually less variance in the 
consecutive axes. This method is analogous to principal component analysis which is, in 
fact, the parametric equivalent of nMDS. In order to obtain acceptable stress levels and 
robust patterns, it was necessary to plot individuals in three dimensions (3D) (Clarke 
and Warwick, 2001). One 3D nMDS (cube) was performed for each of the four 
Schistosoma-specific whole blood stimulations (either SEAm, SEAh, AWAm or AWAh) 
using the ‘metaMDS’ function (in R using the ‘Vegan’ package (R Core Team, 2012; 
Oksanen et al., 2013)). Afterwards, the ‘envfit’ function was used to test whether a 
gradient of infection intensity is present in the 3D cloud of dots. This is done by 
searching the vector (direction represented by an arrow) that shows a maximal 
correlation with the individual values of log-transformed infection intensity (Oksanen 
et al., 2013). Schistosoma mansoni as well as S. haematobium infection intensity were 
fitted onto each 3D cytokine profile. Table 5.4 presents the goodness of fit (R²) and 
statistical significance (p-value) for each of these combinations. Two 2D planes 
(squares) were produced from each 3D nMDS: A) nMDS axis 1 by 2; and B) axis 3 by 2. 
Significant 3D correlations were tested and fitted (pointers) in the two 2D planes 
(Figure 5.1). Similarly, ‘envfit’ was used to test whether people with different infection 
status (uninfected, single S. mansoni, single S. haematobium, versus mixed infections) 
differed in their cytokine profiles (not shown). The ‘ordiellipse’ function was used to 
visualize how cytokine responses varied with infection status (Figure 5.2). 
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Abstract 
Background: Schistosoma infection is thought to lead to down-regulation of the host's 
immune response. This has been shown for adaptive immune responses, but the effect 
on innate immunity, that initiates and shapes the adaptive response, has not been 
extensively studied. In a first study to characterize these responses, we investigated 
the effect of Schistosoma haematobium infection on cytokine responses of Gabonese 
schoolchildren to a number of Toll-like receptor (TLR) ligands. 
Methodology: Peripheral blood mononuclear cells (PBMCs) were collected from S. 
haematobium-infected and uninfected schoolchildren from the rural area of Zilé in 
Gabon. PBMCs were incubated for 24h and 72h with various TLR ligands, as well as 
schistosomal egg antigen (SEA) and adult worm antigen (AWA). Pro-inflammatory TNF-
α and anti-inflammatory/regulatory IL-10 cytokine concentrations were determined in 
culture supernatants. 
Principal findings: Infected children produced higher adaptive IL-10 responses than 
uninfected children against schistosomal antigens (72h incubation). On the other hand, 
infected children had higher TNF-α responses than uninfected children and significantly 
higher TNF-α to IL-10 ratios in response to FSL-1 and Pam3, ligands of TLR2/6 and TLR2/1 
respectively. A similar trend was observed for the TLR4 ligand LPS while Poly(I:C) 
(Mda5/TLR3 ligand) did not induce substantial cytokine responses (24h incubation). 
Conclusions: This pilot study shows that Schistosoma-infected children develop a more 
pro-inflammatory TLR2-mediated response in the face of a more anti-inflammatory 
adaptive immune response. This suggests that S. haematobium infection does not 
suppress the host's innate immune system in the context of single TLR ligation. 
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Introduction 
Schistosomiasis is a parasitic disease of major public health importance and is largely 
chronic in nature. The WHO estimates that more than 207 million people are infected 
worldwide (Chitsulo et al., 2000; WHO, 2010). Chronic helminth infections are generally 
assumed to cause down-regulation of immune responses allowing long-term survival of 
the parasite on the one hand and minimizing immunopathology on the other (Burke et 
al., 2009) with important consequences to the host’s health (Maizels and 
Yazdanbakhsh, 2003; Gryseels et al., 2006; Diaz and Allen, 2007; King and Dangerfield-
Cha, 2008). Effects of schistosomal infection on adaptive immunity are widely studied 
in this context and it has been shown that chronic schistosomiasis inhibits in vitro 
proliferation of human lymphocytes in response to schistosomal antigens (Rocklin et 
al., 1980; Grogan et al., 1998). The anti-inflammatory cytokine interleukin (IL)-10 plays 
an important role in this down-regulation (King et al., 1996; Mwatha et al., 1998; 
Montenegro et al., 1999; Wamachi et al., 2004; Booth et al., 2004a). Van den Biggelaar 
and colleagues (2000) have demonstrated that children chronically infected with 
schistosomes produce more IL-10 together with IL-5 and IL-13 in response to adult 
worm antigen (AWA), than those free of Schistosoma infection. Helminth-induced 
immunomodulation may also have an impact on other infections and vaccine 
effectiveness. For example, in filarial infections, IL-10 down-regulates responses to 
unrelated antigens such as tetanus toxoid (Cooper et al., 1998; Nookala et al., 2004). 
Similar mechanisms might explain the impaired reaction to tetanus toxoid observed in 
Schistosoma mansoni-infected individuals (Sabin et al., 1996). Another feature of IL-10 is 
that it might suppress atopy in Schistosoma haematobium-infected children (van den 
Biggelaar et al., 2000; Smits et al., 2007). 
Although it is becoming clearer how chronic schistosomiasis impacts on adaptive 
immune responses in terms of immunoregulation, the effects of schistosomal infection 
on innate immunity is a less studied area. In general, the innate immune system detects 
invading pathogens through a set of ‘pattern-recognition receptors’ (PRRs) which 
recognize ‘pathogen-associated molecular patterns’ (PAMPs) (Iwasaki and Medzhitov, 
2004; Lee and Kim, 2007). Engagement of PRRs, such as Toll-like receptors (TLRs) 
initiates early immune events prior to the full activation of adaptive immunity. TLRs act 
as homo- (e.g. TLR3 or TLR4) or heterodimers (e.g. TLR2/1 or TLR2/6), or in combination 
with other PRRs such as C-type lectins. Most TLRs induce IL-12p70 which in turn 
promotes differentiation of Th1 cells and inflammatory responses, characterized by 
production of tumor necrosis factor α (TNF-α) and interferon γ (IFN-γ). On the other 
hand, C-type lectins can be in part responsible for the induction of anti-inflammatory 
responses (Geijtenbeek and Gringhuis, 2009). The interplay between innate receptors is 
thought to form the signals that will determine the development of adaptive immune 
responses (Lee and Kim, 2007; Chang, 2010). 
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The present study is part of the SCHISTOINIR project that aims to explore innate 
immune responses in schistosomiasis (for further information: 
www.york.ac.uk/res/schistoinir). This pilot study was set out to investigate how chronic 
schistosomiasis affects the peripheral blood mononuclear cell (PBMC) response to 
various TLR ligands. Here, we report the results from children living in a S. 
haematobium-endemic rural area near Lambaréné, Gabon. 
Methods 
Ethics statement 
The study was approved by the “Comité d’Ethique Regional Independent de 
Lambaréné” (CERIL). Written informed consent was obtained from parents or legal 
guardians of all children participating prior to inclusion into the study. 
Study site and population 
This pilot study was performed in Zilé, a rural area situated 16 km from Lambaréné, 
Gabon (van der Kleij et al., 2004; Retra et al., 2008). This area is endemic for S. 
haematobium, but with important focal differences. Within Zilé there are two smaller 
communities, one with high (PK15) and one with low transmission (PK17), 2 km apart 
from each other. In June and July 2008, we recruited 17 S. haematobium-infected 
schoolchildren from PK15 and 13 uninfected from PK17, and compared their immune 
profiles. Study participants had no history of anti-helminthic treatment within the last 3 
months prior to this study. 
Parasitological examination 
S. haematobium infection was determined a maximum of seven days prior to blood 
collection by examining the residue of 10 ml of urine passed through a filter of 12-µm 
pore-size (Millipore). Children were classified as S. haematobium-infected if at least one 
S. haematobium egg was detected in the urine, or uninfected if three consecutive urine 
samples were negative. Geometric mean infection intensity was calculated for infected 
children using the first urine reading. Infections with intestinal helminths Ascaris 
lumbricoides and Trichuris trichiura were determined by analyzing one fresh stool 
sample using the Kato-Katz method 30-45 minutes after preparation (Katz et al., 1972). 
Necator americanus larvae were detected in a 7-day coproculture of the same stool 
sample. To this end the classical charcoal culture procedure was used (Polderman et al., 
1991; Krepel et al., 1992; Reiss et al., 2007). Infection with Plasmodium falciparum and 
microfilaria was determined by Giemsa-stained thick blood smears (Planche et al., 
2001). 
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After collection of blood samples, all S. haematobium-infected children were treated 
with a single dose of praziquantel (40 mg/kg), and those with intestinal helminths were 
given a single dose of albendazole (400 mg). Children with other infections or clinical 
complaints were provided with appropriate medical care. 
Hematology 
Hematological parameters were analyzed using the ADVIA® 120 Hematology System 
(Bayer Health Care) and erythrocyte sedimentation rate was determined manually. 
PBMC cultures 
PBMCs were isolated from heparinized venous blood by density centrifugation on Ficoll 
(AZL pharmacy, The Netherlands) and cultured in 200µl of IMDM supplemented with 5% 
fetal bovine serum (Greiner Bio-One), 100 U/ml penicillin (Astellas), 10 µg/ml 
streptomycin, 1 mM pyruvate and 2mM L-glutamine (Sigma) in 96-well round bottom 
plates (Nunc). PBMCs were seeded at 1 x 106 cells/well for stimulation with 
schistosomal egg antigen (SEA) or adult worm antigen (AWA), and at 5 x 105 cells/well 
for stimulation with specific TLR ligands and phyto-hemagglutinin (PHA; positive 
control). IMDM medium was used as a negative control. Supernatants were collected 
after 24h and 72h of incubation at 37°C in a 5% CO2 atmosphere and stored at -80°C until 
cytokine analysis. 
Innate and adaptive stimuli 
A panel of four TLR ligands was used:  
 TLR2/1 ligand, Pam3CSK4 (Pam3), a synthetic bacterial triacylated lipopeptide 
(final concentration of 100 ng/ml; EMC microcollections GmbH),  
 TLR2/6 ligand, FSL-1, a synthetic diacylated lipoprotein mimicking the N-
terminal part of LP44 from Mycoplasma salivarium (50 ng/ml; InvivoGen), 
 TLR3 ligand polyinosinic-polycytidylic acid (poly(I:C)), a synthetic analogue of 
viral double-stranded RNA (50µg/ml; InvivoGen), 
 TLR4 ligand, ultrapure lipopolysaccharide (LPS) derived from Escherichia coli 
(100 ng/ml; InvivoGen). 
In addition to the classical innate ligands, we used the schistosomal antigen-containing 
products SEA and AWA from S. haematobium at a final concentration of 10 µg 
protein/ml. Purified PHA (Remel) was used as a positive control at a final concentration 
of 2 µg/ml. 
Cytokine analysis 
Two cytokines were measured in this pilot study; one key pro-inflammatory cytokine, 
TNF-α (Martich et al., 1993; Feldmann et al., 1996; Abraham et al., 1998), and the anti-
TLR LIGATION AND S. HAEMATOBIUM INFECTION 
92  
inflammatory/regulatory cytokine IL-10 (Spits and De Waal, 1992; De Vries, 1995; 
Papadakis and Targan, 2000; Booth et al., 2004a; Grant et al., 2011). Cytokine 
concentrations were measured in supernatants from single PBMC cultures by ELISA 
according to the manufacturer’s instructions, using half of the reaction volume 
(PeliKine CompactTM, Human TNF-α and IL-10 ELISA kit, Sanquin). 
A pro-inflammatory index was computed as the TNF-α : IL-10 ratio upon stimulation 
relative to the spontaneously produced TNF-α : IL-10 ratio (i.e. in medium): 
 
   






Table 6.1. General characteristics of the study population. 
 Uninfected Infected 
n 13 17 
Age (mean (range)) 10.2 y (7-16) 11.4 y (7-16) 
Sex (boys / girls) 8 / 5 9 / 8 
BMI (median (interquartile range)) 15.5 kg/m² (2.83) 15.7 kg/m² (1.64) 
S. haematobium infection intensity (geometric 
mean (range)) 
Not applicable 9.8 eggs/10ml (1-1002) 
Intestinal helminth infection (n/total) 5/12 5/11 
N. americanus infection(n/total) 1a/12 2/12 
A. lumbricoides infection (n/total) 2b/12 2 b/11 
T. trichiura infection (n/total) 4c/12 2 b/11 
Malaria (n/total) 1/12 0/17 
Microfilariasis (n/total) 0/12 1/17 
Erythrocyte sedimentation rate (median (range))  15 mm/h (6-50) 15 mm/h (10-88) 
Level of white blood cells (median (range)) 8.70∙10³/µl (3.80-10.30) 7.20∙10³/µl (5.00-12.40) 
Level of lymphocytes (median (range)) 3.22∙10³/µl (1.68-5.00) 3.33∙10³/µl (1.26-4.60) 
Level of monocytes (median (range)) 0.68∙10³/µl (0.36-1.00) 0.64∙10³/µl (0.49-1.04) 
Level of neutrophils (median (range)) 2.99∙10³/µl (1.06-6.08) 2.14∙10³/µl (1.05-5.79) 
Level of eosinophils (median (range)) 0.79∙10³/µl (0.20-1.93) 1.53∙10³/µl (0.50-2.49) 
Level of basophils (median (range)) 0.09∙10³/µl (0.04-0.27) 0.07∙10³/µl (0.04-0.12) 
Level of hemoglobin (median (range)) 12.2 g/dl (11.4-13.2) 11.3 g/dl (9.1-13.6) 
Thick smears (n=1) for the diagnosis of blood parasites as well as stool samples (n=6 for Kato-
Katz and n=5 for coproculture) for the diagnosis of intestinal helminths were missing at random. 
a Including one child with a T. trichiura - N. americanus co-infection. 
b Including one child with a T. trichiura - A. lumbricoides co-infection. 
c Including one child with a T. trichiura - N. americanus co-infection and another one with 
a T. trichiura - A. lumbricoides co-infection. 
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Statistical analysis 
Differences between schistosome-infected and uninfected groups were determined by 
the Fisher’s exact test for sex and intestinal helminth infections and by the Mann-
Whitney U test for helminth infection intensity, body mass index (BMI) and 
hematological parameters. Age was normally distributed and differences between 
infection groups were tested using the independent student’s T test. As cytokine 
concentrations were not normally distributed, nonparametric tests were used. 
Differences in an individual’s cytokine response to different stimuli (e.g. medium versus 
stimulus-induced cytokine concentration, or ratio) were tested by the Wilcoxon 
matched-pair signed-rank test. 
Differences between infection groups in cytokine concentrations and pro-inflammatory 
indices were tested by the Mann-Whitney U test. Cytokine concentrations were 
corrected for spontaneous cytokine production. This was done by subtracting the 
spontaneously induced cytokine concentration (i.e. in medium) from the stimulus-
induced cytokine concentration. For the pro-inflammatory index, this was done by 
dividing the stimulus-induced ratio by the spontaneously induced ratio (see formula 
above). Similarly, Spearman’s ρ was calculated to estimate the correlation between 
cytokine responses and infection intensity. 
SPSS 18.0 (SPSS Inc.) and GraphPad Prism 5 (GraphPad Software, Inc.) were used for 
statistical analysis. Results were considered significant when the p-value was <0.05. 
Results 
Characteristics of the study population 
Table 6.1 shows that the demographic, parasitological and hematological 
characteristics of the infected and uninfected groups of schoolchildren were 
comparable. Although S. haematobium-infected children tended to be more anemic 
and to have higher eosinophil levels, there were no significant differences between the 
groups for any of the parameters. In addition, the prevalence and infection intensity of 
A. lumbricoides, T. trichiura or N. americanus did not significantly differ between S. 
haematobium-positive and -negative children (data not shown for infection intensity). 
Schistosoma haematobium infection intensities were low (<50 ep10ml) in 14/17 infected 
children (Montresor et al., 1998). Malaria and filariasis are endemic in this area (Wildling 
et al., 1995). However, only one study participant was infected with P. falciparum and 
one with microfilariae. 
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Figure 6.1. Cytokine production in response to TLR ligands in PBMC cultures. 
White and grey boxes correspond to S. haematobium-free and infected children respectively with 
the whiskers indicating minimal and maximal concentrations. * p<0.05; ** p<0.01. Panel A: At 
24h, the ‘innate’ time-point, infected children produced significantly more TNF-α in response to 
the TLR2/1 ligand Pam3CSK4 (Pam3) compared with uninfected children. TLR-mediated IL-10 
production did not significantly deviate between infection groups. When innate cytokine 
responses faded at 72h, similar trends were observed. These plots were not adjusted for 
spontaneous cytokine production. Panel B: At both time points, pro-inflammatory indices (i.e. 
cytokine ratio induced by one of the stimuli relative to the spontaneously produced ratio) 
induced by the TLR2 ligands, Pam3 and FSL-1, were significantly higher in infected versus 
uninfected children. 
 
Cytokine responses to TLR-ligands 
TLR-induced cytokine production by PBMC cultures from infected and uninfected 
groups was measured at 24h (Figure 6.1A, upper panel). While Pam3, FSL-1 and LPS led 
to substantial and significant cytokine production in both groups compared to the 
medium control, the TLR3 ligand poly(I:C) did not stimulate significant levels of TNF-α 
or IL-10. Pam3, FSL-1 and LPS tended to induce the production of greater quantities of 
the pro-inflammatory cytokine TNF-α in infected compared to uninfected children 
(Pam3; p<0.01), while the production of IL-10 was comparable between the two groups. 
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Figure 6.2. Cytokine production in response to schistosomal products in PBMC cultures. 
PBMCs were stimulated with schistosomal egg antigen (SEA) or adult worm antigen (AWA). 
White and grey boxes correspond to S. haematobium-free and infected children respectively with 
the whiskers indicating minimal and maximal concentrations. * p < 0.05; ** p < 0.01. Panel A: 
Cytokine production did not differ between groups at 24h (mainly innate response) but the 
adaptive IL-10 response after 72h of incubation to both schistosomal products was significantly 
higher in infected children than in S. haematobium-free children. Furthermore, only infected 
children produced a significant innate TNF-α response to schistosomal products at 24h. These 
plots are not adjusted for spontaneous cytokine production. Panel B: After 24h (predominantly 
innate), most cytokine ratios induced by schistosomal products were more anti-inflammatory 
than the ratios induced by medium alone. When the adaptive response had developed after 72h 
however, only infected children produced significant anti-inflammatory cytokine balances while 
pro-inflammatory indices were lower in infected children than in uninfected children (AWA; p < 
0.05). 
 
There was a stronger pro-inflammatory index for PBMC responses of infected children 
(Figure 6.1B, upper panel) upon TLR-stimulation (except poly(I:C)) than those from 
uninfected children. These differences were significant for both Pam3 and FSL-1 
(p<0.05) which are ligands for TLR2. 
Furthermore, S. haematobium infection intensity was positively associated with TLR2- 
and TLR4-mediated TNF-α but not with IL-10 responses. This was significant for Pam3 
TLR LIGATION AND S. HAEMATOBIUM INFECTION 
96  
(ρ=0.80) and FSL-1 (ρ=0.66). Also, pro-inflammatory indices tended to be positively 
associated with infection intensity (significant for Pam3 with ρ=0.60).  
In order to get an idea of the dynamics of the innate response, TLR responses were 
also measured after 72h. Cytokine responses to TLR ligands decreased over time, being 
less pronounced after 72h. Nevertheless, the difference between infected and 
uninfected subjects was similar to that observed in 24h cultures with a largely pro-
inflammatory TLR response in infected subjects (Figure 6.1, lower panels). 
Cytokine responses to schistosomal products 
We examined adaptive immune responses by analyzing cytokine production by PBMCs 
after 72h of incubation with schistosomal antigens (Figure 6.2, lower panels). Since 
these products not only contain antigenic components but also innate ligands (Van der 
Kleij et al., 2002; Thomas, 2003; Van Die, 2003; Van Vliet, 2005; Aksoy et al., 2005; Van 
Liempt et al., 2007; Caldas et al., 2008; Ritter et al., 2010), cytokine production was 
assessed at both 24h (innate) and at 72h (adaptive response). 
SEA- and AWA-induced IL-10 was detected in PBMC culture supernatants after 24h and 
increased further in 72h cultures. IL-10 production in infected children was consistently 
higher than in uninfected children at 24h but this difference was only significant at 72h: 
both SEA- and AWA-induced IL-10 responses were significantly higher in infected 
children at 72h (Figure 6.2A). 
After 24h, AWA-stimulated cultures from infected children secreted significant levels of 
TNF-α (p<0.05 cf. medium), while in uninfected children, antigen-induced TNF-α was 
only detected after 72h. 
After 24h, the cytokine ratios following stimulation with schistosomal products seemed 
more anti-inflammatory than pro-inflammatory (i.e. increased IL-10 : TNF-α; Figure 6.2B, 
upper panel). After 72h, the pro-inflammatory index tended to increase in uninfected 
children, and was significantly higher than in infected children upon stimulation with 
AWA (Figure 6.2B, lower panel). 
Discussion 
In this pilot study we investigated the effects of chronic Schistosoma infection on TLR-
mediated cytokine production. We showed that innate TNF-α responses and TNF-α : IL-
10 ratios upon TLR2 stimulation of PBMCs were significantly higher in S. haematobium-
infected children compared with those without infection, in the face of enhanced 
regulatory adaptive responses to schistosomal antigens. This suggests that 
schistosomal infection is associated with elevated pro-inflammatory TLR2 responses. 
While cytokine responses upon TLR stimulation tended to decrease over time, the 
reverse was seen after stimulation with schistosomal products. Although at 24h, TNF-α 
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levels tended to be more pronounced in infected than in uninfected children, 
analogous with the observed TLR-mediated cytokine responses, after 72h of 
stimulation, PMBCs from S. haematobium-infected children produced significantly more 
IL-10 than uninfected children, as has been described elsewhere (van den Biggelaar et 
al., 2000). Schistosomal products are more complex than single TLR stimuli. SEA and 
AWA stimulate the innate immune system through TLRs, C-type lectins and other 
innate receptors (Van der Kleij et al., 2002; Thomas, 2003; Van Die, 2003; Van Vliet, 
2005; Aksoy et al., 2005; Van Liempt et al., 2007; Caldas et al., 2008; Ritter et al., 2010) 
but in addition, they contain antigens which can be processed and presented to the T 
cell receptor forming the basis of acquired immune responses. Schistosomal products 
are thus able to activate both innate and adaptive pathways. This may explain the 
observed trend of an initial pro-inflammatory-like immune response. Concurrent with a 
fading innate cytokine response, a clear anti-inflammatory adaptive response 
comprising elevated IL-10 was detected in infected children at 72h. 
To our knowledge there are only two other human studies on TLR-mediated cytokine 
profiles in schistosomiasis. Van der Kleij et al. reported reduced TLR responses in 
Gabonese S. haematobium-infected as compared to uninfected children (Van der Kleij 
et al., 2004). These results seem to contradict the current findings, but can be 
explained by differences in the selection of the uninfected control groups. While in the 
present study both infected and uninfected children were from the same S. 
haematobium-endemic rural area (Zilé), Van der Kleij et al. recruited the uninfected 
control group from a non-endemic neighboring semi-urban area to ensure that the 
negative subjects were truly negative with no history of exposure. However, when we 
examined the dataset of the Van der Kleij study to compare the infected (n=5) and 
uninfected (n=10) groups from the same rural area of Zilé, infected children tended to 
produce higher TNF-α levels as well as higher pro-inflammatory indices in response to 
LPS than their uninfected counterparts, which is in line with our results. 
The second study of TLR-mediated cytokine profiles was carried out in Brazil and also 
corresponds with our results. Although they did not highlight it, Montenegro et al. 
showed that 48h whole blood cultures from S. mansoni-infected adults produced more 
TNF-α than those of uninfected adults in response to LPS (Montenegro et al., 2002). 
In addition, a mouse model of infection pointed towards a similar association between 
TLR function and schistosomal infection and suggests that schistosomal infection 
induces elevated pro-inflammatory TLR responses (Joshi et al., 2008). 
Few field studies on TLR responses in other helminth infections than schistosomiasis 
have been published and show varying results. In contrast to S. haematobium infection, 
a negative association has been found between infection with the filarial nematode 
Wuchereria bancrofti and intracellular pro-inflammatory cytokine expression upon TLR 
stimulation in lymphocytes and monocytes in a population in South India (Babu et al., 
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2005; Babu et al., 2006). In addition, W. bancrofti was associated with reduced pro-
inflammatory cytokine responses upon TLR stimulation of PBMCs in a population from 
the same area with latent tuberculosis (Babu et al., 2009). On the other hand, Jackson 
et al. showed infections with intestinal nematodes, i.e. hookworm and Trichuris 
trichiura, to be associated with pro-inflammatory cytokine production, but not with 
regulatory cytokine production, upon TLR2 and TLR4 stimulation of monocytes from 
children from Pemba Island (Jackson et al., 2006). Apparently, the effect of helminth 
infections on the innate immune responses is species specific; some helminth species 
may be associated with more pro-inflammatory TLR responses while other helminths 
are associated with more anti-inflammatory TLR responses. In the present study, S. 
haematobium-infected and uninfected children did not significantly differ with respect 
to the number and species of other helminth infections. However, information on soil-
transmitted helminth infections was not available for some of the participants and we 
cannot entirely rule out that these infections may have altered the observed innate 
cytokine responses. In addition, other parasites such as malaria may influence immune 
balances (Hartgers and Yazdanbakhsh, 2006). The duration as well as the intensity of 
infection might further influence innate immune responses. It is therefore important to 
confirm our findings in a larger study population and in varying epidemiological 
settings.  
In conclusion, this pilot study on innate immune responses in schistosomiasis shows a 
more pro-inflammatory response to single TLR2 ligands in the face of an anti-
inflammatory adaptive immune response in S. haematobium-infected children. Whilst 
the precise biological mechanisms for these observations remain to be ascertained, it 
seems that the commonly accepted view that schistosomal infection suppresses the 
host's immune system does not hold for ligation of single TLRs. Many receptors – TLRs 
as well as non-TLRs such as C-type lectins – are involved in innate signaling and their 
interactions as well as down-stream pathways are at the basis of the immune response 
to invading pathogens (Lee and Kim, 2007; Carvalho et al., 2009). Given the fact that a 
Schistosoma worm is a complex mix of ligands stimulating the innate immune system, 
further research into this innate cross-talk is necessary. 
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Schistosomiasis is one of the most common human parasitic diseases with over 230 
million people affected worldwide. The two major species are Schistosoma mansoni and 
S. haematobium, which occur together in many African regions (Gryseels et al., 2006). 
In such co-endemic areas, the two species can interact, either directly or indirectly via 
the host immune system. This may have important implications for infection and 
morbidity levels in the communities involved. However, few studies have investigated 
this. This thesis is one of the first investigations into differences and interactions 
between the two major human Schistosoma species, and their effects on host 
morbidity. 
In the previous chapters, patterns of infection and morbidity were investigated in a 
detailed way by zooming in into one co-endemic focus in the north of Senegal, Nouk 
Pomo, and by adopting a multidisciplinary approach including epidemiological, 
parasitological, clinical, geographical, and immunological investigations. We compared 
demographic determinants of S. mansoni and S. haematobium, single and mixed 
infections, S. mansoni and S. haematobium morbidity, as well as the effect of mixed and 
single infections on morbidity (Chapter 2 and 3). The micro-geographical distribution of 
S. mansoni and S. haematobium infection and morbidity, and that of single and mixed 
infections were studied (Chapter 4), and immunological patterns of S. mansoni and S. 
haematobium infection were compared in order to gain more insight into the 
mechanisms that may underlie epidemiological observations (Chapter 5 and 6). 
In this chapter, we will integrate the findings of the different chapters and take them 
one step further. We present a comprehensive analysis of factors related to mixed 
infections and morbidity, and provide an in-depth analysis of age-related infection 
patterns and immune responses in (co-)endemic situations. The relevance of the 
findings in this thesis for schistosomiasis control and elimination will be highlighted, 
and we will conclude with directions for further research. 
Mixed infections and morbidity 
In Africa, many people are at risk of infection with both S. mansoni and S. haematobium 
(Gryseels et al., 2006). It is therefore important to understand, whether and how such 
mixed Schistosoma infections may alter the risk of developing chronic morbidity. This is 
a challenging research question because chronic morbidity due to schistosome 
infection generally develops over the course of many years, and it is difficult to follow a 
population for such a long period of time, if only for ethical reasons. The transversal, 
multidisciplinary studies in this thesis nonetheless provide some important insights into 
the possible determinants of morbidity in populations co-endemic for S. mansoni and S. 




            
heterologous worm pairing, infection intensity, and egg-induced immune responses on 
host morbidity in mixed infections. 
Heterologous worm pairing  
We found that people with the heaviest infections often had ectopic S. mansoni eggs in 
urine. A ‘spilling over’ of the surplus of S. mansoni worms and/or eggs towards the 
urinary bladder may have contributed to this phenomenon. However, ectopic S. 
mansoni eggs were also observed in a minority of people without S. mansoni eggs in 
feces, and in whom ‘spilling over’ was therefore less likely. In Chapter 3, this specific 
subgroup of people with both S. haematobium and ectopic S. mansoni eggs in urine, but 
without S. mansoni eggs in feces (n=6), tended to be less at risk of S. haematobium-
specific urinary tract morbidity than those with other S. haematobium infections. It was 
argued that this may have been due to direct interactions between the two 
Schistosoma species. Schistosoma haematobium males probably outnumber and/or 
outcompete S. mansoni males, and are able to pair with heterologous S. mansoni 
females. In such heterologous male-female pairs, the S. haematobium male determines 
the oviposition site (region of the urinary tract) and the S. mansoni female the egg 
morphology (lateral spine). Perhaps, less (pathogenic) eggs are produced upon 
heterologous pairing, or these eggs may be more likely to deviate to other sites. While 
this thesis was in preparation, a study in Kenyan school children observed very similar 
patterns, which may also be explained by heterologous worm pairing. Although that 
study did not take ectopic egg elimination into account, children with mixed infections 
were less at risk for urinary tract morbidity than those with single S. haematobium 
infections (Gouvras et al., 2013). Moreover, Huyse et al. (2013) discovered S. mansoni x 
S. haematobium hybrid eggs in children living in the same area as our study population. 
Like ectopic eggs, these hybrids were observed more frequently in urine than in feces. 
It is therefore tempting to speculate that the ectopic S. mansoni eggs observed in this 
thesis may have included genetic hybrids.  
Heterologous worm pairing in the intestinal tract on the other hand, is less likely to 
occur as S. haematobium males have been shown to be competitively stronger than S. 
mansoni males (Webster et al., 1999; Cunin et al., 2003). Consistent with this, ectopic S. 
haematobium egg elimination in feces was rare in the present study (Chapter 2). 
Infection intensity 
In Chapter 2, we found higher infection intensities of S. mansoni as well as S. 
haematobium in mixed as opposed to single infections. As far as we are aware, this is 
the only study that has been performed on such a small geographical scale. Studies 
that were performed on a larger geographical scale reported inconsistent results, 
which could have been due to local variations in transmission dynamics of the two 
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species. Robert et al. (1989) for example, reported comparable infection intensities in 
mixed and single S. mansoni infections but elevated intensities in mixed as compared 
with single S. haematobium infections in one population living in different communities 
on the banks of the Lagdo Lake in northern Cameroon. Preliminary results from our 
group in another village - Pakh - in the Lac de Guiers area, indicated significantly 
elevated levels of S. haematobium but reduced levels of S. mansoni in mixed as 
compared with single infections. As it is unknown which factors underlie these 
differences, it remains unclear to which extent the association between mixed 
infection and infection intensity observed in this thesis can be extrapolated to other 
populations.  
The association between S. haematobium infection intensity and S. haematobium-
specific urinary tract morbidity appeared stronger than that between S. mansoni 
infection intensity and S. mansoni-specific hepatic fibrosis. In Chapter 3, a direct 
association was found between active infection and urinary tract morbidity, but not 
hepatic fibrosis. Similar patterns were found in a S. mansoni and S. haematobium co-
endemic focus in Egypt (Farooq et al., 1966b). The micro-geographical patterns in 
Chapter 4 strongly suggested an association between the level of S. mansoni infection 
intensity earlier in life and the severity of hepatic fibrosis later on in adult life. The 
difference in the delay between infection and the onset of morbidity may be due to 
interspecies differences in egg pathogenicity (see ‘Egg-induced immune responses’ 
below), or to differences between the anatomical context of the liver and urinary tract. 
The same micro-geographical analyses showed that severe hepatic fibrosis clustered 
close to the central water contact site, in the same area where children showed the 
heaviest infections of the community. Preliminary analyses did not indicate any 
evidence of spatial heterogeneity in egg-induced cytokine responses, nor in any of the 
other adaptive or innate cytokine responses measured (data not shown). This strongly 
suggests that, on the community level, (cumulative) exposure to Schistosoma eggs may 
be more important in determining the risk of developing morbidity than individual host 
immune responses. Yet, it remains to be investigated whether there may be more 
subtle effects of cytokine responses on host morbidity, or whether immune 
parameters other than the cytokine responses measured here may provide a better 
indicator for who is likely to develop morbidity and who not, and how this relates to 
mixed infections. 
Egg-induced immune responses 
As explained above, people who excreted both S. haematobium and ectopic S. mansoni 
eggs in urine, but no S. mansoni eggs in feces tended to be less at risk of bladder 
morbidity. Due to an insufficient number of people with this type of infection in the 




            
these subjects. Hence, it remains to be determined whether any protective effect of 
heterologous worm pairing might be immune-mediated. In general, people with mixed 
infections produced lower levels of cytokines than those with single infections, but 
with the approach used it was not possible to determine whether this was due to co-
infection per se or due to elevated infection intensity, or to other potential 
confounders. The similarity of S. mansoni- and S. haematobium-induced cytokine 
profiles rather suggested that co-infection with S. mansoni is unlikely to have skewed 
immune response against S. haematobium eggs towards a potentially more or less 
pathogenic phenotype, and vice versa. 
Nonetheless, it was shown that the magnitude of these responses were higher upon 
stimulation with S. haematobium as compared to S. mansoni (egg) antigens, suggesting 
that S. haematobium might induce stronger and therefore potentially more pathogenic 
immune responses than S. mansoni. Indeed, S. haematobium-specific morbidity was 
more common than S. mansoni-specific morbidity (Chapter 3), and age distributions 
indicated that the delay of onset of morbidity may be shorter for S. haematobium than 
for S. mansoni (Figure 3.1). Moreover, people without putative hybrid S. mansoni x S. 
haematobium eggs were more at risk for S. haematobium-specific morbidity than those 
with these ectopic S. mansoni(-like) eggs (Table 3.6). 
As discussed in Chapter 5, this hypothesis is in line with findings of Van Remoortere et 
al. (2001). These authors showed that S. mansoni induces mainly IgM – which is thought 
to inhibit protective host immune responses (Butterworth et al., 1987) – while S. 
haematobium induces both IgM and IgG antibodies against shared carbohydrate 
 
 
Figure 7.1. Hypothesized effects of S. mansoni and S. haematobium infection on host morbidity. 
Van Remoortere et al. (2001) demonstrated that the antibodies to specific glycan epitopes from 
S. mansoni life stages induce more IgM and less IgG than those from S. haematobium life stages. 
The inhibitory effect of IgM might reduce anti-egg responses of the host immune system and 
thereby the development of host morbidity in S. mansoni co-infections, while increased IgG levels 




Figure 7.2. Schistosoma infection intensity, cumulative egg exposure, egg-induced immune 
responses, and morbidity in schistosomiasis. 
Chronic hepatic schistosomiasis is used here as an example to demonstrate the relationship 
between Schistosoma infection intensity, cumulative exposure to Schistosoma eggs, and local 
immune responses to tissue-trapped eggs which may altogether lead to morbidity. The number 
of eggs in the liver indicates the number of trapped eggs or lesions with immuno-reactive 
remnants. Sizes of the black areas surrounding the eggs indicate the relative strength of the 
immune reactions in individual tissue lesions. We hypothesize that in the endemic setting, as 
people age, they will move from low to high cumulative egg exposure and from high to low 
infection intensities, and thus have enhanced immune responses against individual eggs (bottom 
right). After deworming, Schistosoma infection intensities decrease and immune responses 
against tissue-trapped eggs may become more pathogenic. 
 
epitopes. IgM responses against trapped eggs might protect S. mansoni-infected 
individuals from developing morbidity, while increased IgG levels might predispose S. 
haematobium-infected individuals to more severe morbidity. Interestingly, IgG levels 
against the same carbohydrate epitopes were shown to be even higher in S. japonicum 
infections (Van Remoortere et al., 2001), which are associated with a more rapid onset 
of chronic morbidity and with more severe morbidity than S. haematobium (Jordan et 
al., 1993). We therefore cautiously hypothesize that S. mansoni-induced glycan-specific 
IgM may inhibit anti-egg responses and contribute to reduced levels of urinary tract 




            
haematobium-induced IgG might be hypothesized to enhance anti-egg responses and 
lead to increased levels of hepatic morbidity in mixed as compared to single S. mansoni 
infection, as illustrated in Figure 7.1.  
It should be taken into account that the relationship between active infection and 
morbidity may not be as straightforward as is generally assumed. Chapter 5 suggested 
that heavily infected individuals have low immune responses to the eggs trapped in 
host tissues, while those with lighter infections have stronger immune responses to 
individual eggs. People with light infections are generally older, and are likely to have 
accumulated more Schistosoma eggs than younger individuals with heavy infections. 
This may imply that the pathogenicity of individual, trapped eggs might increase as the 
host ages. In other words, high cumulative exposure and reduced levels of infection 
might have synergistic effects on the development of chronic morbidity in 
schistosomiasis in older age. As explained in Figure 7.2, this may also imply that 
(temporary) worm elimination upon praziquantel treatment may lead to exacerbation 



















Figure 7.3. Overview of the factors that were studied and the relationships that were found 
with mixed infections and S. haematobium-specific urinary tract morbidity. 
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Net effect on morbidity 
Figure 7.3 summarizes how heterologous worm pairing, infection intensity, and egg-
induced immune responses may together (partly) determine the net effect of mixed 
infection on host morbidity, with S. haematobium-specific urinary tract morbidity as an 
example. Briefly, heterologous worm pairing might lead to less (pathogenic) 
Schistosoma eggs in the urinary tract, than pure S. haematobium infections. On the 
other hand, infection intensities were found to be higher in mixed Schistosoma 
infections, but it remains to be investigated whether a causal relationship exists 
between co-infection and infection intensity. Increased infection intensities lead to 
higher cumulative exposure of host tissues to Schistosoma eggs and thus to higher 
morbidity levels. We could not identify any interspecies differences in the induction of 
systemic cytokine profiles - i.e. regulatory, Th1, or Th2 phenotypes – but other immune 
parameters that were not measured (e.g. humoral immune responses) may still explain 
the observed differences in morbidity between single and mixed Schistosoma 
infections. 
Age, Schistosoma infection and Th1 immunity 
In Chapter 5, multiple cytokine responses to each of four Schistosoma antigens tested 
were visualized using nonmetric multidimensional scaling (nMDS). This resulted in four 
cytokine profiles. Associations between these cytokine profiles and Schistosoma 
infection were subsequently investigated. We found that both S. mansoni and S. 
haematobium infection were positively associated with antigen-induced Th2 and 
negatively with inflammatory/Th1 cytokines. This corresponds with results from earlier 
studies in either S. mansoni or S. haematobium mono-endemic areas (e.g. that of Joseph 
et al., 2004). These immuno-epidemiological patterns suggest that Th1 rather than Th2 
responses may protect against infection, and confirms previous observations in mouse 
models (Wilson and Coulson, 2009). Moreover, worm antigen-induced Th1 responses 
consistently showed a linear increase with age (data not shown), suggesting that such 
protective immunity may be acquired with age - building up over time through 
cumulative exposure to schistosomes.  
Besides Schistosoma antigen-induced cytokine profiles, we also studied cytokine 
profiles that are not specific for schistosomes, i.e. those induced by the T-cell mitogen 
phyto-hemagglutinin (PHA). Age as well as infection trends were very similar to those 
induced by Schistosoma worm antigen-induced cytokine profiles. nMDS furthermore 
showed that all PHA-induced cytokine responses were positively associated with 
Schistosoma worm antigen-induced Th1 cytokines (p<0.01; data not shown). 
To investigate whether age may have confounded the association between cytokine 
profiles and infection intensity and/or vice versa, we used redundancy analysis (RDA) 




            
 
 
Figure 7.4. Variation partitioning by multivariable redundancy analysis: worm and mitogen-
induced cytokine profiles, age and infection. 
Venn diagrams indicate the percentages variance in antigen-induced cytokine profiles that could 
be explained by different explanatory variables (represented by circles) in multivariable RDA 
models and the percentages of variance that remained unexplained (outside circles) (n=199). 
Prior to RDA (‘rda’ function of Vegan package in R), net cytokine responses were log-
transformed and standardized as for nMDS (see Chapter 5). Explanatory variables (age, S. 
mansoni and S. haematobium infection intensity, and for Schistosoma adult worm antigen (AWA)-
induced cytokine profiles: PHA-induced cytokine profiles) were included in RDA models if they 
were significantly associated with respective 3D nMDS cytokine profiles. Except for the 
association between age and S. mansoni AWA-induced profiles (dashed circle), all associations 
were confirmed in simple RDA (continuous circles). The diagrams show that the association 
between infection intensity and AWA-induced cytokine responses remained in multivariable RDA. 
Also, the association between PHA- and AWA-induced cytokine profiles remained statistically 
significant in multivariable RDA. On the other hand, PHA responses were only associated with 
age - not with Schistosoma infection - and the significant effect of age on AWA-induced 
responses, was lost when PHA-responses were taken into account in the multivariable model. 
Asterisks indicate significance levels of the independent effects in full RDA models: * p<0.05; ** 
p<0.01; *** p<0.001.  
 
ecology – but to our knowledge, never in biomedical sciences – and that combines 
linear regression with principal component analysis. Also, RDA was used to investigate 
the effect of unspecific, PHA-induced cytokine response profiles on Schistosoma worm-
specific responses.  
RDA showed a very specific and independent immunoregulatory/Th2-skewing effect of 
infection on Schistosoma worm-induced cytokine profiles. In addition, RDA indicated an 
infection-independent effect of age on general (i.e. nonspecific) adaptive immune 
responses as measured by PHA-induced cytokine profiles (Figure 7.4). Indeed, ageing 
itself is associated with dramatic changes in T cell function (Gardner and Murasko, 
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2002), and a Ghanaian study observed a similar age-associated increase in innate Th1 
responses (May et al., 2009). The fact that, under adverse living conditions, subjects 
with a pro-inflammatory genetic predisposition are more likely to survive up to old age 
than those without might contribute to these observations (Van Bodegom et al., 2007; 
Kuningas et al., 2009). However, age-related increases in inflammation, termed 
‘inflamm-ageing’, have also been described in more affluent populations (e.g. 
Franceschi et al., 2000).  
 
 
Figure 7.5. Conceptual framework of the 
hypothesized triangular relationship between 
age, Th1 responses, and Schistosoma 
infection. 
Age-related infection and immunological 
patterns, as well as observations in Chapter 5 
suggested that worm-specific Th1 responses 
might play a central role in immunological 
protection against infection. Arrowheads 




Disentangling the triangle 
As illustrated in Figure 7.5, we hypothesize three different effects of ageing on 
Schistosoma infection and Schistosoma–specific Th1 immune responses. These may 
underlie Schistosoma infection-age infection curves in endemic areas: 
 Due to differences in water contact behavior, adults are assumed to be less 
exposed to Schistosoma infection than children. This, or other factors that were 
not measured (e.g. age-related hormonal, metabolic, or dermatological changes) 
would lead to reduced infection levels across age groups, and the absence of 
worms would give rise to a relative decrease in Th2 and increase in Th1 responses 
(blue chain of events). 
 In an endemic setting, exposure to Schistosoma antigens builds up as people age. 
This may give rise to a gradual increase in protective immunity and our 
observations indicate that such adaptive responses are most likely of the Th1 
phenotype. These responses would in turn lead to a reduction of infection with 



















            
 Factors inherent to ageing itself may lead to a progressive increase in general pro-
inflammatory/Th1 responses, or there may be selective survival of people with a 
genetic predisposition to produce pro-inflammatory/Th1 responses. Consequently, 
worm-specific immune responses would be skewed towards the Th1 phenotype in 
older individuals (red chain). If such Th1-type responses are indeed protective, this 
may lead to reduction of infection levels over age.  
Relevance for schistosomiasis control strategies 
A thorough knowledge of transmission of infection and disease etiology is key for 
successful schistosomiasis control. This thesis described the epidemiological patterns 
of S. mansoni and S. haematobium (co-)infection and disease at the smallest scale, i.e. at 
the micro-geographical level where disease transmission actually occurs. Strong spatial 
clustering at this level once more confirmed that such a fine geospatial resolution is 
essential to understand this complex disease and hence to develop sustainable control 
and elimination strategies. Based on our micro-epidemiological approach, we identified 
some opportunities and recommendations that should be taken into account to 
improve current strategies. 
Mass drug administration 
Currently, control strategies are based on periodic mass drug administration (MDA) 
with praziquantel. MDA aims to reduce infection levels early in life with the aim of 
reducing the development of chronic morbidity later in life. As explained above, our 
cross-sectional findings indeed suggest that cumulative exposure to infection is the 
main driver of severe morbidity (see ‘Mixed infections and morbidity: Infection 
intensity’), and as such, support this basis. 
The WHO recommends national control programs for schistosomiasis to target 
(mainly) school-age children and other high-risk groups (Table 7.1). Observations from 
this thesis suggest that optimizing current treatment allocation strategies may improve 
the effectiveness of MDA. Recently, the WHO has recognized that preschool-age 
children may be at a similar risk of schistosome infection and morbidity as their school-
age siblings, and that they should be targeted as well (WHO, 2013). However, our 
results indicate that not only preschool-age but also children older than 14 years and 
young adults continue to be infected. For S. mansoni, infection prevalences and 
intensities only peaked after school-age, i.e. in 15-19-year olds (Chapter 2). These older 
age groups are thus likely to contaminate the environment, and to develop morbidity 
over time. Instead of school-(age-)based MDA, we thus recommend community-wide 
MDA, not only in high-risk areas, but also in areas that are at moderate and low risk (at 
least for S. mansoni). 
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Table 7.1. Treatment strategy for schistosomiasis recommended by the WHO (2013). 
Category Baseline prevalence among 
school-age children 
Action to be taken 
High-risk 
community 
≥50% by parasitological 
methods a (S. mansoni and S. 
haematobium) or ≥30% by 
questionnaire for history of 
hematuria 
Treat all school-age children 
(enrolled and not enrolled) 
once a year 
Also treat adults 
considered to be at risk b 
(from special groups to 
entire communities living 
in endemic areas) 
Moderate-risk 
community 
10-50% by parasitological 
methods (S. mansoni and S. 
haematobium) or <30% by 
questionnaire for history of 
hematuria 
Treat all school-age children 
(enrolled and not enrolled) 
once every 2 years 
Also treat adults 
considered to be at risk b  
(special groups only) 
Low-risk 
community 
<10% by parasitological 
methods (S. mansoni and S. 
haematobium) 
Treat all school-age children 
(enrolled and not enrolled) 
twice during their primary 
schooling age (e.g. once on 
entry and once on exit) 
Praziquantel should be 
available in dispensaries 
and clinics for treatment 
of suspected cases 
a For S. haematobium, detection of hematuria by dipstick tests gives results equivalent to 
those determined by urine filtration. 
b From special groups (pregnant and lactating women, groups with occupation involving 
contact with infested water such as fishermen, farmers, irrigation workers or women in 
their domestic tasks) to entire communities living in endemic areas 
 
Current MDA allocation strategies do not reflect the spatial epidemiology of 
schistosomiasis infection and morbidity. In Chapter 4, we observed a highly focal 
distribution of both infection and associated disease on the micro-geographical level. 
We found that people living within 100m of the major water contact site had a more 
than six-fold higher risk of developing severe hepatic fibrosis than those who lived 
farther away. Nevertheless, the WHO recommends collecting baseline infection data 
based on parasitological surveys in sentinel sites that are assumed to be representative 
for a large so-called ‘homogeneous ecological zone’ (WHO, 2011). The recommended 
treatment strategy for this entire zone, i.e. 200,000-300,000 targeted children 
subsequently depends on the observed prevalence in 50 children from one randomly 
selected sentinel school. Obviously, such a uniform approach is prone to fail in reaching 
(all) those individuals who are most in need of treatment, and will result in unnecessary 
treatment of uninfected people. A substantial increase in the number of sentinel sites 
may help to overcome this problem, but would be incompatible with the logistical and 
economic advantages underlying current MDA-based control strategies (Molyneux et 
al., 2005). Novel ways are therefore urgently needed to enable a more targeted 
allocation of control interventions in Schistosoma-endemic areas. Based on the results 
of this thesis, we propose to use environmental factors such as the presence of 




            
for treatment allocation, rather than parasitological data from randomly selected 
schoolchildren. 
Other findings in this thesis suggested that removal of the causative agent might not 
simply lead to a proportional reduction of morbidity, especially in co-endemic areas. An 
unexpected effect of mixed S. mansoni and S. haematobium infections on S. 
haematobium-specific urinary tract morbidity was observed. The presence of S. mansoni 
appeared to protect against this form of morbidity in some cases. Also, immune 
responses in individuals with low levels of infection appeared more pathogenic than in 
individuals with higher infection levels. In addition, other studies in S. mansoni and S. 
haematobium co-endemic areas have shown an increase rather than a decrease of S. 
mansoni infection after deworming (Omer and Teesdale, 1978; De Clercq et al., 1999; 
Ernould et al., 1999a; Koukounari et al., 2010; Webster et al., 2013; Gouvras et al., 2013). 
Hence, periodic MDA and subsequent changes in immunological and infection equilibria 
may (in some cases) exacerbate the development of chronic morbidity instead of 
reducing it (Daffalla and Fenwick, 1982). 
Elimination 
Gaining and sustaining control of schistosomiasis and possibly achieving local 
elimination are the year 2020 targets set by the WHO (Knopp et al., 2013). When 
moving from control to elimination, active surveillance and detection of increasingly 
low-transmission areas is needed, but proven very difficult. Today, it is increasingly 
being recognized that malaria transmission becomes more and more focal as malaria 
prevalences are reduced (Cotter et al., 2013). As similar phenomena may occur in a 
post-control setting for schistosomiasis, strategies need to be developed with a 
sufficiently high geospatial resolution to detect even the smallest schistosomiasis 
hotspots. Because it will not be cost-effective to routinely collect parasitological data 
from human populations in a post-control setting, new ways of detecting 
schistosomiasis should be sought, e.g. through environmental sampling (see also ‘Mass 
drug administration’). In addition, it is expected that MDA alone cannot break the 
Schistosoma life cycle and that complementary interventions will have to be put in 
place for schistosomiasis elimination, such as the provision of clean water and 
improved sanitation, snail control, and behaviour change (Sturrock, 1989; King, 2009; 
Gray et al., 2010; Rollinson et al., 2013; Freeman et al., 2013). Multidisciplinary studies on 
the micro-geographical level such as the ones described in this thesis will help to get 
much needed insights into local transmission dynamics of S. mansoni and S. 




Conclusions and directions for further research 
More studies are needed to investigate to which extent the observations in this thesis 
can be extrapolated over time and to other communities. Future studies may build on 
the findings of this thesis, on the hypotheses that were generated, and on the novel 
methodologies used. Here, we will discuss some main directions for further 
schistosomiasis research. 
Health impact of mixed Schistosoma infections 
Helminth co-infections and mixed Schistosoma infections are the rule rather than the 
exception. Nonetheless, co-infection and mixed infection remain an understudied 
element of human medicine. This thesis provides a significant addition to the limited 
number of studies on mixed Schistosoma infections in humans. We demonstrated that 
on the small scale, mixed Schistosoma infections are significantly associated with 
increased infection intensities. However, different relationships between mixed 
infection and infection intensity have been found in other study populations. It is 
important to understand which context-specific factors impact on the association 
between mixed infection and infection intensity, and which causal mechanisms 
underlie this association. For example, it remains to be investigated whether previous 
and/or concomitant infection with S. mansoni might alter host resistance to infection 
with S. haematobium, or whether it may alter S. haematobium egg production (or vice 
versa). Secondly, we found that mixed infections affect the host’s health differently 
than single infections (regardless of infection intensity). We hypothesized that this may 
be due to immunological differences between S. mansoni and S. haematobium, and also 
to heterologous worm pairing. Further studies are necessary to determine whether S. 
haematobium eggs are more immunogenic than those of S. mansoni, and to investigate 
the different features of anti-egg immune responses into more detail. Also, 
parasitological factors such as infection intensity, ectopic egg elimination, 
heterologous worm pairing, and hybridization between species should be studied in 
more detail to answer questions such as: What is the genetic nature of ectopically 
eliminated Schistosoma eggs? What are the morphological and immunological 
characteristics of S. mansoni x S. haematobium hybrid eggs? At the same time, 
confounding factors such as age and micro-geographical processes need to be taken 
into account. Only such a multidisciplinary approach can unravel the very complex 
mechanisms that determine the eventual effect of Schistosoma co-endemicity and 
mixed infections on the host’s health. 
Praziquantel treatment 
Mixed Schistosoma infections may not only impact on the host’s health, but also on the 




            
paid to the possibility that concomitant infections in co-endemic populations may 
reduce drug effectiveness and increase the risk of side effects (Buck et al., 1978). In 
addition, chemotherapeutical removal of one or more pathogens may clear the way for 
invasion of other pathogens that may lead to worse health outcomes (Daffalla and 
Fenwick, 1982). One major question that was not addressed in this thesis was how 
praziquantel treatment impacts on Schistosoma co-infection and morbidity levels. 
Nonetheless, some of our observations suggested that it might indeed have adverse 
health effects (e.g. S. mansoni infections appeared to protect against S. haematobium-
specific bladder morbidity, so elimination of S. mansoni might enhance this bladder 
morbidity). Given that praziquantel treatment may have unwanted effects in 
polyparasitism, and the recent scale-up of MDA programs, closer monitoring and 
investigations into both beneficial and adverse health effects of MDA with praziquantel 
are urgently warranted, especially in co-endemic areas (Humphries et al., 2012). Also, 
more evidence is needed from comprehensive, longitudinal studies to assess the 
effectiveness of MDA in terms of morbidity reduction, on the short as well as on the 
long term, and to improve WHO guidelines. 
Focal geographic distribution 
This thesis contains one of the few studies on the micro-geographical distribution of 
Schistosoma infection and the first on the micro-geographical distribution of associated 
morbidity. Significant spatial clustering of Schistosoma infection was observed even 
within one community, and S. mansoni and S. haematobium infection hotspots were 
found in different sections of the community. Future studies should investigate the 
drivers of this spatial clustering. It would be important to investigate whether similar 
divergent distributions of S. mansoni and S. haematobium also occur in other 
communities, and if so: what causes this divergence?  
In Chapter 2, we found that S. mansoni and S. haematobium clustered together in the 
same individuals, while in Chapter 4, geospatial analyses revealed that the two 
infections clustered in separate parts of the community. These contrasting patterns on 
the individual and micro-geographical level seem to point to human factors (e.g. 
individual water contact behavior and/or immunological factors) as an explanation for 
the co-occurrence of S. mansoni and S. haematobium on the individual level, rather than 
micro-geographical factors such as co-exposure to both species in the same water 
contact site. 
Not only Schistosoma infection but also associated chronic morbidity showed a very 
focal geographical distribution on the micro-geographical level, and people living within 
the close vicinity of the major water contact site of the community were 
disproportionally affected. This suggests that cumulative exposure to schistosomes 
may be the main driver of chronic morbidity on the community level, and warrants 
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further research into the role of this factor in the etiology of chronic Schistosoma-
specific disease. In order to estimate the effect of cumulative exposure relative to 
other etiologic factors such as co-infection, host immunology and host genetics, a 
multidisciplinary approach will be key in unravelling the complexities of disease 
etiology. 
Parasite immunology and vaccine development 
Immunological mechanisms undoubtedly underlie epidemiological patterns of infection 
and disease. Yet, it remains to be investigated to which extent they explain the 
notoriously heterogenic distribution of schistosomiasis. Further studies should also 
assess the role of innate immunity in schistosomiasis. Also, the role of host 
immunological processes in polyparasitism is still unclear. Moreover, longstanding 
questions remain: To which extent do we develop protective immunity against 
schistosomes? What is the immunological phenotype of a protective response? Do 
acquired immune responses drive the typically convex age-infection curve? Further 
studies are needed to confirm the age-related inflammatory/Th1 shift observed in this 
thesis, to elucidate the exact biological mechanisms that may drive this shift, and to 
assess whether it may confer immunological protection against schistosomes in older 
age. The eventual success of the candidate schistosomiasis vaccines that are currently 
being tested (Kupferschmidt, 2013), critically depends on the true balance between the 
different possible underlying mechanisms of the age-infection curve, and whether or 
not adaptive immune responses are able to reduce levels of infection. Hence, such 
studies will give crucial insights for vaccine development. 
Value of multidisciplinary research 
Adding a geospatial dimension to classical immuno-epidemiological investigations 
proved particularly valuable to increase our understanding of schistosomiasis on the 
small scale. We demonstrated for example, how spatial analyses may be used as a 
‘workaround’ to study longitudinal relationships, in a cross-sectional study (Chapter 4). 
This cannot be achieved through classical epidemiological methods. Also, the 
application of ecological techniques has proven very useful in studying the complexity 
of immunological responses (Chapter 5). In this way, this thesis provides a novel, more 
holistic approach to understanding schistosomiasis.  
Taking into account the occurrence of co-infections, and a wider adoption of 
multidisciplinary research is likely to lead to more novel insights and speed up the snail 
pace at which our knowledge of schistosomiasis is advancing today. Such knowledge is 
key to rationalizing and optimizing current schistosomiasis control (and possibly future 
elimination) strategies, particularly in co-endemic areas.  
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The aim of this thesis was to get a detailed insight into the epidemiological patterns of 
Schistosoma infection and associated morbidity on a micro-geographical scale in 
Schistosoma mansoni and S. haematobium co-endemic areas. A S. mansoni and S. 
haematobium co-endemic focus in the north of Senegal was selected as the primary 
study site. The small scale of this study allowed a detailed, multidisciplinary analysis of 
complex infection and morbidity patterns. Moreover, it enabled us to take the well-
known focality of schistosomiasis into account (Chapter 1). 
We observed prevalences of 61% and 50% for S. mansoni and S. haematobium infection, 
respectively. Most of these infections were mixed S. mansoni and S. haematobium 
infections (53%). In comparison to single infections, mixed infections were of higher 
intensity. Eight percent of the infected people also showed ectopic excretion of 
Schistosoma eggs (mainly S. mansoni in urine; Chapter 2).  
While elevated S. haematobium infection intensities predisposed for S. haematobium-
specific urinary tract morbidity, the presence of S. mansoni in co-infections tended to 
protect against this. The latter effect was most pronounced in people with ectopic S. 
mansoni egg excretion. On the other hand, no association was found between S. 
mansoni-specific hepatic fibrosis and Schistosoma infection. This is likely due to a slower 
disease onset in S. mansoni as compared to S. haematobium infection. Indeed, the delay 
between the age peak for S. mansoni infection and morbidity was >10 years, while such 
a delay could not be observed for S. haematobium (Chapter 3).  
We were the first to look into the micro-geographical distribution of chronic 
Schistosoma morbidity. In contrast to classical epidemiological analyses (see Chapter 3), 
spatial analysis did reveal a clear association between S. mansoni infection and 
morbidity. It was shown that adults living adjacent to the main Schistosoma 
transmission site were more than six times more likely to develop severe S. mansoni-
specific hepatic fibrosis than their counterparts living farther away. Children living in 
the same spot were also more at risk of heavy S. mansoni infection, indicating that 
cumulative exposure to Schistosoma eggs is likely to be the main driver of chronic 
morbidity in schistosomiasis (Chapter 4).  
We explored immune responses in the two Schistosoma infections in this population by 
means of whole blood cytokine responses. Cytokine responses to adult worm antigens 
were used as a proxy for host responses to living adult worms, and thus infection. 
Cytokine responses to soluble Schistosoma egg antigens were used as a proxy for the 
egg-induced responses that may have contributed to the observed morbidity patterns. 
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It was found that S. haematobium antigens induce higher cytokine levels than those of 
S. mansoni. This supports the idea that the first species may be more immunogenic. This 
hypothesis corresponds with our epidemiological findings: 1) in line with previous 
studies, we found the S. haematobium age curve to decline more steeply after 
adolescence than that of S. mansoni; and 2) we observed more S. haematobium- than S. 
mansoni-specific morbidity (83% versus 27%). Our investigations did not reveal any 
interspecies differences in the immunological phenotypes that were induced. Both 
Schistosoma species were associated with a modified Th2 response in a dose-
dependent manner. Such a response is characteristic for Schistosoma infection 
(Chapter 5).  
Subsequently, the innate immune responses that generally precede and shape these 
adaptive cytokine responses were investigated. This study was performed in children 
from a S. haematobium mono-endemic area in Lambaréné, Gabon. While children 
infected with S. haematobium produced more of the anti-inflammatory cytokine IL-10 
than uninfected children in response to adaptive stimuli (egg and worm antigens), their 
innate immune response to TLR ligands was more pro-inflammatory (TNF-α) than that 
of uninfected children. Hence, schistosomal infection suppresses the host’s adaptive 
immune system but does not appear to affect innate stimulation with single TLR 
ligands. This indicates that schistosomiasis does not induce a general suppression of 
the host immune system (Chapter 6). 
This thesis provides a novel, holistic approach to understanding schistosomiasis. It has 
led to important new insights into demographic and geographic patterns of S. mansoni 
and S. haematobium on a micro scale, and provides new leads for further research on 
disease etiology and underlying mechanisms. Further studies are necessary to 
investigate to which extent these results can be extrapolated over time and to other 
populations. Such knowledge is key to rationalizing and optimizing current 
schistosomiasis control strategies, particularly in co-endemic areas. An improved 
understanding of this complex disease would furthermore greatly aid in developing 





Hoofdstuk één biedt achtergrondinformatie over schistosomiasis. Dit is een chronische 
parasitaire worminfectie die wereldwijd bij meer dan tweehonderd miljoen mensen 
voorkomt, vooral in Afrika ten zuiden van de Sahara. Volwassen mannetjes- en 
vrouwtjeswormen kunnen jarenlang in innige omhelzing in de menselijke 
bloedcirculatie voortleven. Hier produceren zij ontelbare Schistosoma-eitjes die door de 
gastheer worden uitgescheiden. Als deze eitjes in zoetwater terechtkomen, komen ze 
uit en kunnen de larven een bepaalde slakkensoort infecteren. Via deze tussengastheer 
vermenigvuldigt de parasiet zich, komt hij weer in het water terecht, en kan hij 
vervolgens de mensen via de huid penetreren en infecteren als zij in contact komen 
met het besmette water. In de menselijke bloedstroom begint de parasitaire 
levenscyclus dan weer van voor af aan. In endemische gebieden leidt een Schistosoma-
infectie niet altijd tot direct zichtbare ziektesymptomen. Afhankelijk van factoren zoals 
het aantal herinfecties en de immuunstatus van de gastheer, kunnen er soms pas 
maanden tot jaren na een eerste infectie klinische symptomen optreden. Deze zijn het 
gevolg van de ophoping van (een deel van) de door de worm geproduceerde eitjes in 
de organen van de gastheer. De immuunreactie van de gastheer tegen deze eieren leidt 
op haar beurt tot een geleidelijke fibrotisering van het orgaanweefsel rondom de eitjes. 
In endemische gebieden ontstaat er zo sluipenderwijs het typische ziektebeeld van 
chronische schistosomiasis. Schistosomiasis kan door verschillende Schistosoma-
soorten veroorzaakt worden. Schistosoma mansoni en Schistosoma haematobium zijn 
de meest voorkomende. Volwassen S. mansoni-wormen leven in de venen van het 
mesenterium waar hun eitjes deels via de stoelgang worden uitgescheiden en zich 
deels in de lever ophopen. Volwassen S. haematobium-wormen daarentegen, leven 
voornamelijk in de venen van de urinewegen, waar hun eitjes via de urine worden 
uitgescheiden, of zich ophopen in de aangrenzende organen, bijvoorbeeld in de wand 
van de urineblaas. In die delen van Afrika waar mensen van het besmette water 
afhankelijk zijn omdat er geen alternatieve waterbronnen zijn, en onder slechte 
hygiënische omstandigheden leven, komt schistosomiasis vaak voor. Door de 
geografische overlap van S. mansoni en S. haematobium is de kans groot dat mensen 
beide soorten dragen (coinfectie) in plaats van één van de twee (monoinfectie). 
Paradoxaal genoeg weten we maar heel weinig over dit soort coinfecties, en dit is een 
groot hiaat in onze kennis van schistosomiasis. Het voornaamste doel van dit 
proefschrift was dan ook om meer over deze Schistosoma-coinfecties te weten te 
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komen. Hiertoe voerden we een uitgebreide transversale studie uit in twee 
aangrenzende Wolofdorpen op een schiereiland in Lac de Guiers. Dit gebied ligt in het 
noorden van Senegal en is co-endemisch voor S. mansoni en S. haematobium. 
Hoofdstuk twee beschrijft de epidemiologische infectiepatronen van de 
studiepopulatie in deze beide dorpen (n=857). Schistosoma mansoni- en S. 
haematobium infecties werden bepaald door middel van microscopische detectie van 
parasitaire eieren in de stoelgang en urine. Deze kwamen respectievelijk in 61% en 50% 
van de mensen voor. De meeste infecties waren coinfecties (53%). Deze infecties waren 
zwaarder (hogere eitellingen) dan de respectievelijke monoinfecties. Acht procent van 
de geïnfecteerde mensen had een afwijkend patroon van eiuitscheiding. Meestal werd 
bij hen S. mansoni in de urine teruggevonden in plaats van in de stoelgang, terwijl S. 
haematobium via de normale weg werd uitgescheiden. Dit kan deels verklaard worden 
door het feit dat vrouwelijke S. mansoni- en mannelijke S. haematobium wormen 
onderling kunnen paren (‘heterologe paring’). Dit komt vaker voor dan andersom (S. 
haematobium vrouwtjes met S. mansoni mannetjes). In zulke gevallen bepaalt het 
vrouwtje het eifenotype en het mannetje de locatie van de eiproductie. Globaal gezien 
vertoonden S. mansoni en S. haematobium infecties eenzelfde demografische verdeling 
(volgens leeftijd, geslacht en dorp). Uit een meer gedetailleerde analyse bleek wel dat 
de leeftijdscurve voor S. haematobium infectie scherper daalde na de puberteit dan die 
van S. mansoni. Dit zou er misschien op kunnen wijzen dat S. haematobium een sterkere 
immuunrespons uitlokt dan S. mansoni. 
Hoofdstuk drie gaat in op de epidemiologische patronen van S. mansoni-specifieke 
leverfibrose en S. haematobium-specifieke afwijkingen aan de urineblaas. Een deel van 
de studiepopulatie (n=403) werd onderzocht door middel van echografisch onderzoek 
met behulp van een gestandaardiseerd protocol. We observeerden meer blaas- dan 
leverafwijkingen (83% versus 27%). Waarschijnlijk heeft dit ermee te maken dat het 
langer duurt voordat S. mansoni-specifieke morbiditeit tot uiting komt. Dit zagen we 
ook terug in de infectie- en morbiditeitspatronen over de leeftijd. Deze toonden een 
verschil van >10 jaar tussen de leeftijd waarop S. mansoni-infectie en -morbiditeit pieken 
in deze populatie. Een dergelijk verschil kon voor S. haematobium niet waargenomen 
worden. Het zou er ook op kunnen wijzen dat S. haematobium immunogener is dan S. 
mansoni, zoals we al eerder suggereerden. Er kon geen statistische associatie 
aangetoond worden tussen Schistosoma-infectie en S. mansoni-specifieke leverfibrose 
op individueel niveau. Voor S. haematobium-specifieke morbiditeit werd een dergelijke 
associatie wel gevonden. Mensen met zwaardere S. haematobium infecties hadden een 
significant verhoogd risico op deze afwijkingen dan mensen met lichtere infecties. 
Daarbij leek de aanwezigheid van S. mansoni in coinfecties juist te beschermen tegen S. 
haematobium-specifieke blaasafwijkingen. Dit effect was het meest uitgesproken bij 
mensen met S. mansoni-eitjes in de urine in plaats van in de stoelgang, en dus mogelijk 
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het gevolg van de hierboven beschreven directe interacties tussen S. mansoni en S. 
haematobium in mensen met coinfecties in de vorm van heterologe wormparing. 
In hoofdstuk vier brengen we infectie- en ziektepatronen nog beter in kaart door de 
bovenstaande klassieke epidemiologische analyses met spatiële clusterdetectie te 
combineren, in één van de twee bovengenoemde dorpen (n=599). We stelden vast dat 
S. mansoni- en S. haematobium-infecties in verschillende delen van het dorp clusterden. 
Dit kwam overeen met de watercontactpatronen die de mensen rapporteerden (door 
middel van vragenlijsten): mensen uit de S. mansoni-cluster hadden watercontact op 
andere plaatsen dan mensen uit de S. haematobium-cluster en vice versa. Schistosoma 
haematobium-specifieke blaasafwijkingen waren geografisch homogeen verdeeld over 
het dorp. Daar staat tegenover dat mensen die aangrenzend aan de drukstbezochte 
watercontactplaats woonden (<100 m), statistisch gezien zes keer meer risico hadden 
op een ernstiger vorm van S. mansoni-specifieke leverfibrose dan mensen die verder 
weg woonden. Dit suggereert dat de cumulatieve blootstelling aan Schistosoma-eitjes 
in de loop van het leven misschien wel de belangrijkste etiologische factor is in de 
ontwikkeling van chronische schistosomiasis. 
Hoofdstuk vijf schetst vervolgens de immuunrespons van de menselijke gastheer 
tegen volwassen S. mansoni- en S. haematobium-wormen en tegen hun eieren, in relatie 
tot S. mansoni- en S. haematobium-infectie (n=200). Om de verworven immuunrespons 
in beeld te brengen, kwantificeerden we verschillende cytokine responsen (IL-10, IL-5, 
IFN-γ, TNF-α en IL-2) in bloedculturen 72 uur na stimulatie met worm- en eiantigenen. 
Schistosoma haematobium-antigenen bleken significant hogere cytokineresponsen op 
te wekken dan S. mansoni-antigenen. Dit suggereert dat de eerste soort meer 
immunogeen zou zijn, en is in overeenstemming met de bovengenoemde 
epidemiologische observaties: 1) dat de leeftijdscurve voor S. haematobium-infectie na 
de puberteit scherper daalde dan die van S. mansoni, en 2) dat S. haematobium-
specifieke blaasafwijkingen vaker voorkwamen dan S. mansoni-specifieke 
leverafwijkingen. Er konden geen andere immunologische verschillen tussen S. mansoni 
en S. haematobium aangetoond worden. Antigenen van beide soorten induceerden 
eenzelfde soort immuunrespons, onafhankelijk van het feit of de mensen van wie de 
bloedmonsters afkomstig waren met S. mansoni of S. haematobium geïnfecteerd 
waren. Het is welbekend dat Schistosoma-infecties de verworven immuunrespons 
onderdrukken en in de richting van een Th2-respons sturen. Dit wordt een 
gemodificeerde Th2-respons genoemd, en dit type respons werd hier voor beide 
Schistosoma-soorten aangetoond. Hoewel deze studie nog geen afdoende bewijs 
geeft, leken er op het eerste gezicht dus geen aanwijzingen te zijn voor 
immunologische interacties tussen de twee Schistosoma-soorten, bijvoorbeeld in de 
vorm van immunologische kruisreacties. 
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Hoofdstuk zes gaat dieper in op de responsen van het aangeboren immuunsysteem die 
ten grondslag liggen aan de bovengenoemde Schistosoma-specifieke, verworven 
immuunresponsen. Hiertoe bestudeerden we een andere populatie, namelijk een 
groep van Gabonese schoolkinderen (n=30) uit een gebied waar alleen S. haematobium 
voorkomt. Omdat het onderzoek naar het aangeboren immuunsysteem nog erg pril is, 
richtten wij ons op de tot nu toe best beschreven responsen, die van de zogenaamde 
‘Toll-like’ receptoren (TLR’s). Tegen de verwachting in vonden we dat de TLR-
responsen (TLR2 en TLR4) van de geïnfecteerde kinderen juist meer pro-inflammatoir 
waren dan die van de niet-geïnfecteerde kinderen, terwijl hun verworven responsen 
wel de kenmerkende immunosuppressie lieten zien. Dit toont aan dat er in ieder geval 
geen algemene onderdrukking van het immuunsysteem optreedt in schistosomiasis. 
Tegelijkertijd roept het de vraag op welk mechanisme dan wel bepalend is voor de 
gemodificeerde Th2-respons die zo kenmerkend is voor schistosomiasis. 
Hoofdstuk zeven sluit af met een algemene discussie en een kritische evaluatie van alle 
bevindingen. We concluderen dat de multidisciplinaire aanpak in dit proefschrift tot 
nieuwe inzichten in schistosomiasis heeft geleid. Dit was met enkel conventionele 
methoden niet mogelijk geweest. Ons onderzoek bracht een aantal nieuwe 
aanknopingspunten voor verder onderzoek naar de etiologie van Schistosoma-
specifieke morbiditeit in co-endemische gebieden aan het licht. Er zouden meer van 
dergelijke studies gedaan moeten worden om te bepalen in hoeverre de hier 
beschreven resultaten geëxtrapoleerd kunnen worden naar andere populaties. De 
huidige strategie om schistosomiasis te bestrijden is gebaseerd op massabehandeling 
met het medicijn praziquantel. Deze staat in schril contrast met de zeer focale 
verspreiding van schistosomiasis. Zelfs binnen één dorpje zijn er grote verschillen in 
infectie en ziekte waar te nemen. Verder geven onze onderzoeksresultaten aanleiding 
om te veronderstellen dat een dergelijke behandeling in co-endemische gebieden 
bepaalde infectie- en immunologische evenwichten kan verstoren, en daardoor 
negatieve gevolgen zou kunnen hebben op de volksgezondheid. Voor een effectievere 
ziektebestrijding zouden er nieuwe strategieën ontwikkeld moeten worden die wel 
rekening houden met de geografisch zeer focale ziektepatronen. Ook is meer inzicht 
nodig in de onderliggende mechanismen van coinfecties met verschillende 
Schistosoma-soorten, teneinde succesvolle strategieën te ontwikkelen om de ziekte op 





Le premier chapitre présente des informations générales sur la schistosomiase : Il s'agit 
d'une infection chronique causée par un ver parasite, qui atteint plus de deux-cent 
millions de personnes dans le monde, notamment en Afrique au sud du Sahara. Les vers 
adultes mâles et femelles peuvent vivre pendant des années en hôte de la circulation 
sanguine humaine. Au sein de cette dernière, les schistosomes produisent 
d'innombrables œufs excrétés par la suite par l'hôte. Quand ces œufs entrent dans 
l'eau douce, ils éclosent et les larves vont infecter une espèce particulière d'escargot. 
Dans cet hôte intermédiaire, les parasites se multiplient, ils reviennent dans l'eau, et 
peuvent alors infecter les humains à travers la peau quand ils entrent dans l'eau 
contaminée. Dans le sang humain, le cycle de vie du parasite commence alors à 
nouveau depuis le début. Dans les zones endémiques, les personnes sont en contact 
avec l'eau en permanence, et se réexposent donc à de nouvelles infections à 
Schistosoma, mais ces infections ne donnent habituellement pas de signes visibles 
immédiats de la maladie. Toutefois, une partie des œufs produits s’accumule avec le 
temps dans les organes de l'hôte. La réponse immunitaire de l'hôte contre ces œufs 
conduit à une fibrotisation progressive du tissu entourant les œufs. Dans les zones 
endémiques se crée ainsi insidieusement le tableau clinique typique de la 
schistosomiase chronique.  
La schistosomiase peut être causée par différentes espèces de Schistosoma. 
Schistosoma mansoni et S. haematobium sont mondialement prépondérants. 
Schistosoma mansoni à l’état adulte, vit dans les veines du mésentère et ses œufs sont 
excrétés via les selles d’une part, et s’accumulent d’autre part dans le foie. Quant au S. 
haematobium adulte, il vit principalement dans les veines des voies urinaires, et ses 
œufs sont excrétés via l'urine ou s'accumulent dans les organes voisins, par exemple, 
dans la paroi de la vessie. Dans certaines régions d'Afrique - où les populations en 
contact avec l'eau contaminée, à défaut d'autres sources d'eau, vivent dans des 
conditions sanitaires déplorables - la schistosomiase est un fait divers. Aussi, en raison 
du chevauchement géographique de S. mansoni et S. haematobium, il arrive souvent 
qu’une personne soit infectée par les deux espèces de ver (coïnfection), à l’instar du 
cas classique de mono-infection. Paradoxalement, nous en savons très peu sur ce type 
de coïnfection, et c'est donc un grand vide dans notre connaissance de la 
schistosomiase. L'objectif principal de cette thèse était dès lors d'en savoir plus à ce 
sujet. À cette fin, nous avons mené une étude transversale étendue auprès de deux 
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villages Ouolofs voisins, sur une péninsule aux rives du Lac de Guiers. Le 
chevauchement de S. mansoni et de S. haematobium rend cette zone du nord du 
Sénégal co-endémique. 
Le chapitre deux décrit les tendances épidémiologiques de l'infection auprès de la 
population de l'étude, notamment, dans les deux villages précités (n=857). Les 
infections par S. mansoni et S. haematobium ont été déterminées au moyen d'une 
détection au microscope des œufs du parasite dans les selles et les urines. Les taux 
d’infection s’élevaient respectivement à 61 et 50%. La plupart des infections étaient des 
coïnfections (53%). Le degré d’infection (nombre d’œufs) dans les cas de coïnfection 
s’avérait plus sévère que celui des mono-infections. De même, huit pourcent des 
personnes infectées présentaient un modèle atypique d’excrétion des œufs. En effet, le 
S. mansoni se retrouvait le plus souvent dans les urines plutôt que dans les selles, tandis 
que le S. haematobium transitait par la route normale, les urines. Ceci peut en partie 
s’expliquer par le fait que la femelle S. mansoni et le male S. haematobium parviennent 
à s’accoupler (‘accouplement hétérologue’). Les cas d’accouplement inverses (S. 
haematobium femelle et S. mansoni mâle) sont moins fréquents. Dans de tels cas, c’est 
la femelle qui détermine le phénotype de l'œuf et le mâle l'emplacement d'œufs. Les 
infections S. mansoni et S. haematobium présentaient de prime abord une distribution 
démographique similaire (selon l’âge, sexe, et village). Cependant, vu de plus près, les 
cas d’infection à S. haematobium diminuaient de façon plus prononcée après la puberté 
que les cas d’infection à S. mansoni. Ce constat nous porte à croire que S. haematobium 
pourrait provoquer une réponse immunitaire plus forte que S. mansoni. 
Le chapitre trois examine d’une part, les caractéristiques épidémiologiques spécifiques 
de la fibrose hépatique causée par S. mansoni, et d’autre part, les anomalies spécifiques 
de la vessie causée par S. haematobium. Une partie de la population de l'étude (n=403) 
a été examinée au moyen d'une échographie selon un protocole standardisé. Nous 
avons observé plus d’anomalies de la vessie que du foie (83% contre 27%). Ceci est 
probablement lié au fait que la morbidité propre à S. mansoni met plus de temps à se 
manifester. Les patrons d’infection et de morbidité en fonction de l’âge le suggéraient 
aussi: il se trouvait plus de 10 ans d’intervalle entre les pics d’infection et de morbidité 
de S. mansoni. Une telle différence n'a pas été observée pour S. haematobium. Ceci 
pourrait aussi signifier que S. haematobium est plus immunogène que S. mansoni, 
comme nous l'avons suggéré plus tôt. En effet, Il n'y avait pas d'association statistique 
entre l'infection à Schistosoma et la fibrose hépatique spécifique à S. mansoni au niveau 
individuel. Par contre, cette association a pu être établie dans la morbidité spécifique à 
S. haematobium. Le risque de ces anomalies était significativement élevé chez les 
personnes sévèrement infectées par S. haematobium  par rapport à celles légèrement 
infectées. Ainsi, semblait la présence de S. mansoni dans la coïnfection, jouer un rôle 
dans la protection contre les anomalies de la vessie liées à S. haematobium. C’est chez 
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les personnes porteuses d’œufs de S. mansoni dans les urines plutôt que dans les selles 
que ce phénomène était le plus prononcé; ceci serait probablement une résultante de 
l’interaction directe décrite antérieurement entre S. mansoni et S. haematobium chez 
les personnes souffrant d’une coïnfection sous la forme d’un accouplement 
hétérologue de vers. 
Dans le chapitre quatre, nous arrivons à mieux cartographier les patrons d'infection et 
de morbidité en combinant les analyses épidémiologiques classiques précitées avec la 
détection spatiale de clusters ou grappes, dans l'un des deux villages en question 
(n=599). Nous avons constaté que les infections à S. mansoni et S. haematobium se 
regroupaient dans différentes parties du village. Cela concordait avec les modèles de 
contact à l'eau rapportés par le biais de questionnaires: les personnes de la grappe S. 
mansoni ont été en contact avec l'eau dans des endroits autres que ceux de la grappe S. 
haematobium et vice versa. Géographiquement, les anomalies de la vessie spécifiques à 
S. haematobium étaient réparties de façon homogène dans le village. Cependant, les 
riverains du plan d’eau le plus fréquenté, couraient statistiquement six fois plus de 
risque d'avoir une forme plus grave de fibrose du foie spécifique à S. mansoni que ceux 
qui vivaient plus loin (>100m). Ceci suggère que l'exposition cumulative aux œufs de 
Schistosoma au cours de la vie, pourrait être le facteur étiologique le plus important 
dans le développement de la schistosomiase chronique. 
Le chapitre cinq poursuit en décrivant la réponse immunitaire de l'hôte humain contre 
les vers S. mansoni et S. haematobium adultes et contre leurs œufs (n=200). Pour avoir 
une idée de la réponse immunitaire acquise, nous avons quantifié de multiples 
réponses de cytokine (IL-10, IL-5, IFN-γ, TNF-α et IL-2) dans des cultures de sang 72 
heures après stimulation avec des antigènes de vers et d’œufs. Nous avons observé 
une plus forte réponse en cytokine aux antigènes S. haematobium qu’aux antigènes de 
S. mansoni. Cela suggère que la première espèce serait plus immunogène et confirme 
les observations épidémiologiques susmentionnés, à savoir: 1) Diminution de l’infection 
à S. haematobium après la puberté plus prononcée que pour S. mansoni, 2) Cas 
d’anomalies de la vessie spécifique à S. haematobium plus fréquent  que les anomalies 
hépatiques spécifiques à S. mansoni. Il n’a pas été relevé d'autres différences 
immunologiques entre S. mansoni et S. haematobium. Les antigènes des deux espèces 
induisent le même type de réponse immunitaire, indépendamment du fait que les 
personnes dont les échantillons de sang ont été tirés aient été infectées par S. mansoni 
ou S. haematobium. Il est bien connu que les infections à Schistosoma influencent la 
réponse immunitaire acquise, et la dirige dans la direction de la réponse Th2 : C'est la 
réponse Th2 modifiée, et ce type de réaction a été montré ici pour les deux espèces de 
Schistosoma. Bien que cette étude ne fournisse pas de preuves concluantes, il semblait 
à première vue, ne pas y avoir d’indication d'interactions immunologiques entre les 
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deux espèces de schistosomes, par exemple sous la forme de réactions 
immunologiques croisées. 
Le chapitre six se concentre sur les réponses du système immunitaire inné qui sous-
tendent les réponses immunitaires acquises spécifiques de Schistosoma 
susmentionnées. Pour ce faire, nous avons étudié une population différente, à savoir 
un groupe d'écoliers gabonais (n=30) issu d'une zone où seul survient S. haematobium. 
Etant donné que la recherche dans le système immunitaire inné en est encore à ses 
prémisses, nous nous sommes concentrés sur les réponses les mieux décrites jusqu'à 
présent, à savoir celles des récepteurs Toll-like (TLRs). Nous avons constaté que les 
réponses TLR (TLR2 et TLR4) des enfants infectés étaient, contre toute attente, plus 
pro-inflammatoire que celles des enfants non infectés, alors que leur système 
immunitaire acquis laissait voir la suppression caractéristique. Cela montre qu'il ne se 
produit, en tout cas, pas de suppression générale du système immunitaire dans la 
schistosomiase. Dans le même temps, il se pose la question du mécanisme déterminant 
pour la réponse Th2 modifiée qui est si caractéristique de la schistosomiase. 
Le chapitre sept conclut par une discussion générale et l'évaluation critique de tous les 
résultats. Nous en concluons que l'approche multidisciplinaire a donné de nouveaux 
éclairages sur la schistosomiase. En effet, cela n'aurait pas été possible avec les 
méthodes classiques uniquement. Notre recherche a fourni de nouveaux indices pour 
poursuivre les recherches sur l'étiologie de la morbidité spécifique à Schistosoma dans 
les zones co-endémiques. Il faudrait que d’autres études similaires soient menées afin 
de déterminer la mesure dans laquelle les résultats décrits ici pourraient faire l’objet 
d’une extrapolation à d’autres populations. 
La stratégie actuelle de lutte contre la schistosomiase est basée sur le traitement de 
masse au praziquantel. Ceci est en contraste frappant avec la distribution très focale de 
la schistosomiase. Ainsi, dans un même village, de grandes différences dans l'infection 
et dans la maladie peuvent être observées. En outre, les résultats de notre recherche 
laissent supposer qu’un tel traitement dans les zones co-endémiques, pourrait 
perturber certains équilibres infectieux et immunologiques et donc avoir des 
conséquences négatives sur la santé publique. 
Pour une lutte plus efficace contre la maladie, il faudrait développer de nouvelles 
stratégies qui prennent en compte les caractéristiques géographiques de la maladie. Il 
faudrait aussi plus d’éclaircissements sur les mécanismes sous-jacents de la 
schistosomiase et de la coïnfection avec différentes espèces de schistosomes, pour 
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